Status Report On Prison Health in The WHO European Region 2022
Status Report On Prison Health in The WHO European Region 2022
Status Report On Prison Health in The WHO European Region 2022
KEYWORDS
PRISONS
DELIVERY OF HEALTH CARE
HEALTH INFORMATION SYSTEMS
HEALTH STATUS
HEALTH WORKFORCE
Some rights reserved. This work is available under the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 IGO
licence (CC BY-NC-SA 3.0 IGO; https://creativecommons.org/licenses/by-nc-sa/3.0/igo).
Under the terms of this licence, you may copy, redistribute and adapt the work for non-commercial purposes, provided the work
is appropriately cited, as indicated below. In any use of this work, there should be no suggestion that WHO endorses any specific
organization, products or services. The use of the WHO logo is not permitted. If you adapt the work, then you must license your
work under the same or equivalent Creative Commons licence. If you create a translation of this work, you should add the following
disclaimer along with the suggested citation: “This translation was not created by the World Health Organization (WHO). WHO
is not responsible for the content or accuracy of this translation. The original English edition shall be the binding and authentic
edition: Status report on prison health in the WHO European Region 2022. Copenhagen: WHO Regional Office for Europe; 2023”.
Any mediation relating to disputes arising under the licence shall be conducted in accordance with the mediation rules of the
World Intellectual Property Organization.
Suggested citation. Status report on prison health in the WHO European Region 2022. Copenhagen: WHO Regional Office for
Europe; 2023. Licence: CC BY-NC-SA 3.0 IGO.
Cataloguing-in-Publication (CIP) data. CIP data are available at http://apps.who.int/iris.
Sales, rights and licensing. To purchase WHO publications, see http://apps.who.int/bookorders. To submit requests for
commercial use and queries on rights and licensing, see http://www.who.int/about/licensing.
Third-party materials. If you wish to reuse material from this work that is attributed to a third party, such as tables, figures or
images, it is your responsibility to determine whether permission is needed for that reuse and to obtain permission from the
copyright holder. The risk of claims resulting from infringement of any third-party-owned component in the work rests solely
with the user.
General disclaimers. The designations employed and the presentation of the material in this publication do not imply the
expression of any opinion whatsoever on the part of WHO concerning the legal status of any country, territory, city or area or of its
authorities, or concerning the delimitation of its frontiers or boundaries. Dotted and dashed lines on maps represent approximate
border lines for which there may not yet be full agreement. The mention of specific companies or of certain manufacturers’
products does not imply that they are endorsed or recommended by WHO in preference to others of a similar nature that are
not mentioned. Errors and omissions excepted, the names of proprietary products are distinguished by initial capital letters.
All reasonable precautions have been taken by WHO to verify the information contained in this publication. However, the published
material is being distributed without warranty of any kind, either expressed or implied. The responsibility for the interpretation
and use of the material lies with the reader. In no event shall WHO be liable for damages arising from its use.
Corrigendum
Status report on prison health in the WHO European Region 2022.
Copenhagen: WHO Regional Office for Europe; 2023
ISBN: 978-92-890-5867-4 (PDF)
ISBN: 978-92-890-5868-1 (print)
Page 6
Paragraph 9, line 1, “This publication was made possible by
funding from the Finnish Ministry of Social Affairs and Health
and from the United Kingdom Health Security Agency” should
be replaced by “This publication was made possible by funding
from the Finnish Ministry of Social Affairs and Health, from the
Federal Office of Public Health of Switzerland and from the
United Kingdom Health Security Agency”.
iii
iv
Contents
Acknowledgements vi
Abbreviations vii
Foreword viii
Preface ix
Executive summary x
Introduction 1
1. Methods 5
1.1 The WHO Prison Health Framework 5
1.2 HIPEDS 5
1.3 Data collection procedure 9
1.4 Data analysis 9
1.5 Data validation 11
2. Findings 13
2.1 Penal statistics 13
2.2 Inputs: prison health system 18
2.3 Outputs: health service delivery 25
2.4 Impacts: health outcomes 44
2.5 Influencing factors 47
2.6 Cross-cutting principles 52
3. Exploring the effects of governance arrangements for the delivery of health care in prisons 59
3.1 Health information systems 59
3.2 Delivery of health-care services 60
3.3 Environmental factors 62
3.4 Adherence to the principle of equivalence and other international standards 62
4. Limitations 65
6. Key messages 73
References 75
Annex 3. Raw data describing the process of death data transfer to the national
registration system 483
v
Acknowledgements
The WHO Regional Office for Europe would like to thank Further contributions were received by members of the
Filipa Alves da Costa, WHO European Office for the Health in Prisons Programme (HIPP)’s Steering Group:
Prevention and Control of Noncommunicable Diseases, Ruth Gray, South Eastern Health and Social Care Trust,
Denmark, for developing this publication; and Daniela Northern Ireland, United Kingdom (oral health indicators);
Correia, Institute of Public Health of University of Porto Ehab Salah, Prisons and HIV adviser, UNODC, Austria
(ISPUP), Portugal, as part of the work conducted by the (pregnancy indicators); Olivia Rope, Chief Executive Officer,
WHO Collaborating Centre on Behavioral and Social Penal Reform International, United Kingdom (gender-related
Determinants of Noncommunicable Diseases, for analysing indicators); Linda Montanari, Principal Scientific Analyst,
the data. The WHO Regional Office for Europe is also thankful European Monitoring Centre for Drugs and Drug Addiction,
to Sumudu Kasturiarachchi, WHO European Office for the Portugal (drug use indicators); Éamonn O’ Moore, National
Prevention and Control of Noncommunicable Diseases, Health and Justice Team, United Kingdom Health Security
Denmark, for support in the selection and interpretation Agency, United Kingdom (COVID-19-related indicators);
of external data for meaningful comparisons; and Elizaveta Merja Mikkola and Jussi Korkeamäki, Finnish National
Lebedeva, Tobacco Control Programme, WHO European Institute for Health and Welfare, Finland (health systems
Office for the Prevention and Control of Noncommunicable organization and financing indicators); Lara Tavoschi, Public
Diseases, Denmark, for input on tobacco control policies; Health Unit, University of Pisa, Italy (vaccine indicators); and
Sergei Bychkov, NCD Surveillance, WHO European Office Erika Duffel, European Centre for Disease Prevention and
for the Prevention and Control of Noncommunicable Control, Sweden (infectious disease indicators).
Diseases, Denmark, for support in survey development
The WHO Regional Office for Europe would also like to
for data collection and management; and Sofia Ribeiro,
acknowledge the focal points and WHO representatives
WHO European Office for the Prevention and Control of
who participated in the focus groups held both in Russian
Noncommunicable Diseases, Denmark, for critical revision
and in English to discuss aspects of data quality and
of the report.
strategies to improve the validity of responses. Particularly
The work was conducted under the technical guidance noteworthy, in this respect, were the contributions made by
of Carina Ferreira-Borges, Regional Advisor, Alcohol, Illicit Germany, Kazakhstan, Spain, Switzerland, Ukraine and the
Drugs and Prison Health, WHO Regional Office for Europe, United Kingdom. Thanks, too, to Maria Neufeld, Technical
Denmark. Officer, and Yanina Andersen, Public Health Specialist,
Alcohol, Illicit Drugs and Prison Health Programme, WHO
The structure used in this report follows the WHO Prison
Regional Office for Europe, Denmark, for facilitating these
Health Framework, a framework for assessment of
focus groups.
prison health system performance. This framework was
conceptualized with important contributions from Marieke The external reviewers of this report were Sunita
Verschuuren, WHO European Office for the Prevention Stürup-Toft, United Kingdom Health Security Agency,
and Control of Noncommunicable Diseases, Denmark; United Kingdom, and Lara Tavoschi, Public Health Unit,
Yanina Andersen, WHO European Office for the Prevention University of Pisa, Italy, for whose thoughtful comments
and Control of Noncommunicable Diseases, Denmark; we are extremely grateful.
Sunita Stürup-Toft, United Kingdom Health Security Agency,
Finally, this report would not be possible without the
United Kingdom; and Daniel Lopez-Acuña, WHO European
contribution of the focal points of the Member States of
Office for the Prevention and Control of Noncommunicable
the WHO European Region. Their time and expertise put
Diseases, Denmark.
into answering the Health In Prisons European Database
The indicators used in the survey resulted from refinements survey (HIPEDS) and providing additional responses and
made to those used in the previous (2019) iteration of this clarifications whenever requested during the validation
document, which were further refined by a Technical Expert process were crucial.
Group composed of Stuart Kinner and Louise Southalan,
This publication was made possible by funding from the
Justice Health Unit, Centre for Health Equity, Melbourne
Finnish Ministry of Social Affairs and Health, from the
School of Population and Global Health, University of
Federal Office of Public Health of Switzerland and from the
Melbourne, Australia; Emily Wang and Tyler Harvey, SEICHE
United Kingdom Health Security Agency.
Center for Health and Justice, Yale School of Medicine and
Yale Law School, United States of America.
vi
Abbreviations
vii
Foreword
“Prison health is public health” – and I know first-hand that This is particularly important for noncommunicable
this is not merely a memorable headline. In my early career, diseases (NCDs), as these are not yet prioritized to the same
my work as a medical doctor in a Siberian prison shaped extent as infectious diseases. The results in the current
my vision of prison health and my conviction that no one report show that only 17% of Member States could extract
should be left behind. But allow me to go one step further data on the rate of overweight or obesity in the prison
and highlight that not only is prison health a human right, population. Although this is a considerable improvement
but also that every individual is entitled to access health on the previous report, it is still suboptimal. For this reason,
care in the same conditions as any other person living in the WHO believes that it is a priority for prison health systems
community, throughout their life course. This is of utmost to invest in their health records, so that evidence-based
importance as prisons are not silos: they are embedded policies can be adopted.
in communities and the investment made in the health
of people in prison can become a community dividend. This report also shows that, upon release, less than 50%
Incarceration should never become either a synonym for of Member States provide a support service to help people
or a sentence to poorer health. Health is a human right as leaving prison to register with community health services,
dictated by United Nations conventions, and all citizens while less than 40% provide people with medication for
are entitled to good-quality health care regardless of their all health conditions. There is abundant evidence that a
legal status. significant proportion of people in contact with the justice
system have limited access to health care, before and after
The WHO Health in Prisons Programme (HIPP) aims to incarceration. All these facts call for greater investment in
improve the health of people living in detention and leave continuity of care.
no one behind in the ambitious goal of achieving universal
health coverage for all citizens. To achieve this aim, it was Nelson Mandela once said that “no one truly knows a
considered that the starting point should be an in-depth nation until one has been inside its jails. A nation should
analysis of the prison health-care system. The Health in not be judged by how it treats its highest citizens, but its
Prisons European Database (HIPED), open to the public and lowest ones.” WHO’s European Programme of Work clearly
containing data collected through a periodic survey sent states that we need concerted actions and partnerships
to Member States, facilitates monitoring and surveillance across intergovernmental and nongovernmental agencies,
of health in prisons. The data provide an indication of the without forgetting people with lived experience, to achieve
status of prison health in the WHO European Region and higher gains. Prisons are often neglected, and the area of
highlight areas of prison health policy that should be better prison health has for too long been the invisible part of
aligned with WHO guidance. This is a unique resource and, WHO’s work. It is time to change this narrative, contribute
as such, HIPP has been recognized since 2021 as the United to reducing inequalities and invest in the health of people
Nations hub for health information in prison. living in prisons.
viii
Preface
Improving prison health is improving public health. that serve the needs of Member States. So, it was a game
Incarceration should no longer be a sentence to poorer changer when, in 2019, the results of the first HIPED survey
health outcomes. Instead, it should be an opportunity to (HIPEDS) were published – the first ever comprehensive
access timely and quality-based health care, and to address report on prison health, providing a comprehensive
risk factors for both communicable and noncommunicable overview of the status of prison health in the WHO European
diseases, which will ultimately translate into health gains Region. The current publication covers not only health
throughout the life course. These gains are important not services and outcomes, but also other areas that have a
only for individuals but also for the population in general, as tremendous impact on health, such as behavioural factors
prisons are part of communities, and incarcerated people and the prison environment. This latest report shows that
will return to them upon completing their sentences. inequalities still exist across the Region, as incarcerated
people continue to have higher prevalence of disease
This publication was guided by the European Programme and worse outcomes when compared to the general
of Work, 2020–2025 – “United Action for Better Health” population. This means that there are many challenges
and provides important insights in the context of prison that remain to be tackled over the coming years and that
health into one of its core priorities: moving towards higher priority must be given to addressing the health-
universal health coverage. We must always bear in mind care needs of this vulnerable group. In addition, the report
that incarcerated people have the right to access the same shows how important it is to invest in robust surveillance
standards of health care, across prevention, diagnosis and systems in prisons that allow enhanced data collection and
treatment services, as the general population. Therefore, storage, and highlights the importance of integrating these
efforts must be made to drive equitable access and systems into national health information systems to ensure
coverage of services to people in prison, who so often have continuity of care.
been left behind.
Nevertheless – and in spite of the challenges that remain
However, we are only able to monitor and improve what – we are confident that the latest iteration of this report
we know, and this is no less true of prison health than it is will inspire Member States in their efforts, providing
of other areas. It is often said that information is the new a comprehensive basis for action towards achieving
gold, but data about prison health have historically been better prison health and better public health in the
as difficult to collect as the precious metal itself. This limits WHO European Region.
our ability to design and implement effective interventions
Dr NinO Berdzuli
Director, Division of Country Health Programmes,
WHO Regional Office for Europe
Dr Carina Ferreira-Borges
Re gional Advisor, Alcohol, Illicit Drugs and Prison He alth,
WHO Regional Office for Europe
ix
Executive summary
x
Further information on the correlation between the Post-exposure prophylaxis (PEP) against HIV was available
structure of HIPEDS and the structure of the current report in all prisons in 75.0% of Member States. However, less than
is given in section 1.2 below. 60% of Member States had pre-exposure prophylaxis (PrEP)
available in all prisons.
All data collected are from the year 2020, except when not
available; in such cases, the period of reporting is duly Only three Member States (8.3%) offered needles and
acknowledged. Data were mainly analysed descriptively. syringes free of charge in all prisons. Other products offering
Bivariate analysis was used to evaluate if countries where protection against bloodborne infections from risky drug-
the responsibility for delivery of prison health care lies related or sexual behaviours (such as disinfectants and
with the Ministry of Health perform differently from others lubricants) were also scarce; the most commonly available
(section 3). product was condoms, which were still offered by less than
half of Member States in all prisons. One Member State did
not offer soap free of charge in any of its prisons.
Key findings
The majority of Member States (62.9%) had policies in
Prison population place to promote physical activity, the lack of which is an
A total of 613 497 people living in prison establishments important risk factor for many noncommunicable diseases
was reported in the represented European countries. The (NCDs).
average number of people in prison per 100 000 inhabitants
in Europe was 107.3, ranging from 23.0 in San Marino to However, 60.0% of Member States reported that they
246.0 in Georgia. provided treatment areas for people with drug use
disorders either in a minority of prisons or not at all, while
Only five countries in the WHO European Region did not over 60% did not provide any promotional materials on safe
legally permit the use of life sentences. tattooing practices.
xi
the most favourable indicator for diabetes was access Secondary and tertiary care
to pharmacological treatment, which was provided for Arrangements/protocols were in place for transferring
over 95% of individuals. Oral health was an area calling people in all prisons to specialized institutions to treat
for greater investment of resources, as only 72.8% of cancer in 83.3% of Member States. In the case of severe
individuals had had access to one or more oral health visits mental health disorders, the comparable figure was 86.1%
in the previous year. of Member States.
xii
Mortality the most prevalent behaviours were smoking (63.1%
All Member States reported mortality data, 35 of which of the population) and drug use (17.8%). Overweight
could also indicate cause of death. The standardized (BMI 25.0–29.9 kg/m2) was found in 34.8% of the population;
all-cause mortality rate per 100 000 incarcerated people obesity (BMI ≥ 30.0 kg/m2) in 9.7%. Only 10.5% of the
was 42.5, as compared to 136.9 in the general population population could be considered physically active. Even
for the same region. The most common cause of death was though the data were derived from a minority of Member
suicide, followed by COVID-19 and then drug overdose. States, the estimates seem relatively well aligned with the
wider literature.
Prison environment
In more than 94% of Member States, people in all prisons Adherence to equivalence and
had access to showering and bathing facilities, with other international standards
water at a temperature appropriate to the climate. The In most Member States, health-care services were subject
situation was less good with respect to access to a toilet to the same accreditation procedures as in the general
in-cell in all prisons, which was reported in only 69.4% of community. In all Member States, health-care professionals
Member States. were subject to exactly the same ethical and professional
standards. However, despite these good practices,
In all Member States, people in all prisons were given the more than 22% of Member States reported that clinical
opportunity to spend at least one hour per day outdoors. decisions could be overruled or ignored by non-health-
In over 90% of Member States, in all prisons, facilities for care prison staff.
physical activity were available that people were allowed
to use at least once a week. Reducing health inequalities and addressing
the needs of special populations
The least favourable indicator in this domain was National standards to meet the needs of special
overcrowding, where nearly 20% of Member States (seven populations were mentioned by a majority of Member
countries) exceeded their official capacity. Also, nutritional States – most commonly for pregnant women and people
options available were suboptimal, with only 44.4% of who use drugs (both 90.0% of Member States), followed
Member States having diets adapted to meet gender needs. by people with physical disabilities (86.7%). Over a third
of Member States said that access to pregnancy tests
Health behaviours was not given upon admission. In 2020, 105 women were
Only 4–10 Member States (11.1–27.8%) were able to reported by 27 Member States to have given birth in prison,
provide data on health behaviours. Among those reporting, representing 0.6% of the females detained.
xiii
xiv
Introduction
It is estimated that around 11.5 million people are held in The Universal Declaration of Human Rights of 1948 (4) was
prison globally (1) and around 13% of those are detained created to ensure that:
in Europe. The number of people living in prison in
the European Union (EU) was around 463 700 in 2020, everyone has the right to a standard of living
a decrease of around 6.6% compared to 2019, which was adequate for the health and well-being of himself
mainly due to COVID-19 measures (2). and of his family, including food, clothing, housing
and medical care and necessary social services, and
According to Eurostat, the average incarceration rate in the right to security in the event of unemployment,
the EU in 2020 was 104 people per 100 000 population (2), sickness, disability, widowhood, old age or other
but this value varies widely from country to country. Other lack of livelihood in circumstances beyond his
sources that include countries outside the EU indicate that control.
the figure ranges from 30.7 per 100 000 in Liechtenstein up
to 328.1 per 100 000 in the Russian Federation (3). This declaration does not exclude people living in prison.
On the contrary, it specifically states that “everyone is
Imprisonment comprises both jails, where unsentenced entitled to all the rights and freedoms set forth in this
people are held, and prisons, where sentenced individuals Declaration, without distinction of any kind”.
are held. According to Eurostat (2), 19.1% of people
incarcerated were unsentenced. There is also wide Nonetheless, because it was felt that there was a need to
variability in this indicator, with the highest value (43.3%) provide States with detailed guidelines for protecting the
found in Luxembourg and the lowest in Romania (7.8%). rights of persons deprived of their liberty, from pretrial
The share of unsentenced people increased in 2020, again detainees to sentenced prisoners, the United Nations
probably as a result of the COVID-19 pandemic. developed the Standard Minimum Rules for the Treatment
of Prisoners, known as the Mandela Rules (5). In these
The variability in these figures is principally due to rules, a specific section is devoted to the right to health
differences in the penal systems and criminal laws that care, several aspects of which are highlighted. Rule 24
exist nationally. Some offences may be punishable by states that “The provision of health care for prisoners is
law in some countries but not in others; drug offences, a State responsibility” and that “Prisoners should enjoy
for example, are severely punished in some countries, the same standards of health care that are available in the
while in others consumption is addressed by noncriminal community, and should have access to necessary health-
diversion schemes. care services free of charge without discrimination on the
grounds of their legal status”. Rule 25 states that “Every
The profile of the prison population has consistently shown prison shall have in place a health-care service tasked
that females represent approximately 5% of the total prison with evaluating, promoting, protecting and improving the
population, with a slight increase observed from 2019 to physical and mental health of prisoners, paying particular
2020 (from 5.3% to 5.4%) (2). attention to prisoners with special health-care needs or
with health issues that hamper their rehabilitation”.
Introduction 1
However, such rules are intended to offer guidance (they substantially prevent disease transmission not only in
are not legally binding), and mechanisms and support are prison settings but also in the communities to which people
needed to facilitate their uptake. For this reason, structures leaving prison return (10).
such as the European Committee for the Prevention
of Torture and Inhuman or Degrading Treatment or In comparison with the general population, there is a high
Punishment (CPT) were created (6). According to this body, incidence of psychiatric conditions among people in prison.
“An inadequate level of health care can lead rapidly to Consequently, a doctor qualified in psychiatry should be
situations falling within the scope of the term ‘inhuman and attached to the health-care service of each prison, and
degrading treatment’” (7). The CPT performs regular visits to some of the nurses employed there should have had
prisons during which health-care services are audited and training in this field (7). While some mental health care
the following aspects are taken into consideration: can be provided in the primary care context, severe forms
of mental illness may require specialized treatment, so
(a) access to a doctor
mechanisms to ensure referral of severe cases are needed.
(b) equivalence of care
Suicide remains the leading cause of mortality in prisons
(c) patient’s consent and confidentiality
worldwide, but noncommunicable diseases (NCDs) are
(d) preventive health care
increasing and were reported (in 2018) to be the leading
(e) humanitarian assistance
cause of mortality in England and Wales (11). Among NCDs,
(f) professional independence
cardiovascular disease (CVD) and cancer play a central role,
(g) professional competence.
and while most cardiovascular conditions may be treated
and managed in primary care, the same is not true of
In addition to the CPT, some countries have created many types and stages of cancer. In such circumstances,
national bodies that have similar purposes. One example mechanisms to ensure access to specialized care are also
is His Majesty’s (HM) Inspectorate of Prisons, which is essential for people in prison living with cancer.
responsible for evaluating the extent and quality of
health care in prisons in England and Wales. In one of this
organization’s reports (8), it was stated that the quality of The interface between public
care varied greatly and that equivalence of health-care and prison health systems
services and health-care providers’ training were not always
ensured. In many countries in the WHO European Region, The Helsinki Conclusions – a set of conclusions reached
there are currently agencies in charge of inspecting prison following a major international prison health conference
services and a major concern of these agencies is evaluating that took place in Helsinki, Finland, in 2019 – highlight
equivalence of health care, compared to community the need to recognize health care delivered to people in
health services. prison as part of a pathway to and from community health
services (12). Therefore, in order to ensure that universal
Primary care is the most effective and efficient element of health coverage reaches those most in need – the poorest,
health care in any public health system; it is the foundation the most marginalized, women, children, and people
of prison health services and, as such, should be available with disabilities, as well as people in prison – efforts must
to every person living in prison. At a minimum, primary care be made to drive equitable access for these groups. The
interventions are required at the times of highest risk to the Mandela Rules (5) also state that:
health of those in prison – namely, at time of admission
and release. However, such interventions are also needed Health-care services should be organized in
to address health matters that arise in the course of close relationship to the general public health
imprisonment (9). administration and in a way that ensures
continuity of treatment and care, including for HIV,
It has also been acknowledged that testing for infectious tuberculosis and other infectious diseases, as well
diseases in European correctional facilities could as for drug dependence.
Introduction 3
1
4
1. Methods
1. Methods 5
Fig. 1. The WHO Prison Health Framework
Health [INFLUENCING
outcomes FACTORS]
[IMPACTS]
Health and well-being CONCEPTUALIZATION AND DEVELOPMENT OF THE FRAMEWORK
Communicable
Morbidity diseases Prison environment
NCDs
Mortality Mental health
Health behaviours
Oral health
As explained above, the various elements in the WHO Prison Health Framework are defined on the
basis of their specific relevance to prison health systems. The rationale for their selection is explained in
greater detail in the following sections.
Inputs to prison health systems (B) were assessed under (1) Health and well-being
four domains: (2) Morbidity
(3) Mortality.
(1) Responsible level of government administration
and responsible organization (2.2.1)
Morbidity was operationalized by requesting Member
(2) Financing of prison health care (2.2.2) States to report “diagnosis on record”, which could be
(3) Vision and strategic approach to prison health (2.2.3) used to estimate prevalence by dividing by the total prison
population. The conditions considered in this domain
(4) Health information system used to monitor the
were: TB, MDR-TB, HIV, HBV, HCV, STIs, COVID-19, mental
prison health system (2.2.4).
health disorders, drug use disorders, oral health problems,
diabetes, hypertension, CVDs and cancers.
The outputs of the prison health system (C) were also
assessed under four domains: For mortality, the main focus was on mortality rates of the
most important and common causes of death in prisons.
(1) Preventive services (2.3.1)
Mortality rates were considered for suicide, drug overdose
(2) Rehabilitation (2.3.2) and COVID-19. Other causes of death, categorized as
(3) Medical care (including primary care, secondary “other”, included CVDs, HIV/AIDS, cancers, and other
and tertiary care, and continuity of care) (2.3.3) broader categories that could not be disaggregated, such
as “natural causes”.
(4) Performance of the health-care system (including
availability of health-care staff and medicinal
The survey also aimed to assess two cross-cutting
products; accessibility; acceptability; and quality
principles: adherence to international standards for human
of care) (2.3.4).
rights; and addressing inequalities (assessed through the
availability/existence of standards and guidelines). We also
The areas assessed in HIPEDS in order to operationalize attempted to assess inequalities in the prison population
each of these four domains are shown in Table 2. by comparing the availability of health staff in prisons and
in the general population and by comparing mortality rates
The impact of the prison health system on health outcomes of the most common causes of death in prisons with the
(D) was assessed under three domains: values obtained in the general population.
1. Methods 7
Table 2. Domains and areas assessed in HIPEDS
Preventive services
Disease prevention Assessment of NCD risk factors, mental health problems, oral health, chronic
disease, COVID-19 immunization status, screening for infectious diseases (HIV, HBV,
HCV, STIs, COVID-19)
Screening for cancer (breast, cervical, colorectal)
Health protection Availability of hygienic and sanitary products
Health promotion Existence of health promotion materials and policies for physical activity in prisons
Smokefree policies in the prison setting
Treatment areas available for people with drug use disorders
Rehabilitation
Access to education and employment opportunities
Allocation to prison close to home (to maintain family links)
Medical care
Primary care Availability of contingency plans for managing the impact of infectious disease
outbreaks
Accessibility of laboratory tests for suspected infectious disease cases
Access to treatment: TB, HIV, HBV, HCV, STIs, mental health problems, drug use
disorders, diabetes mellitus, hypertension, CVD, cancer
Secondary and tertiary care Existence of transfer mechanisms for specialized care for severe mental health
disorders and cancer
Continuity of care Medication reconciliation at admission
Registration with community health services upon release from prison for HIV, TB,
HCV, drug dependence
COVID-19 testing upon release
Performance
Availability of health care Availability of health workforce
Acceptability Obtaining and documenting informed consent for health assessments and
interventions
Accessibility Availability of immunization for vaccine-preventable diseases
Access to HIV prophylaxis
Quality of care Regular assessments of availability of essential medicines
Availability of standardized procedures for reporting adverse drug reactions and
medication errors
Mechanisms in place for patient involvement in health care
Data analysis comprised descriptive analysis of all variables Occupancy level (an aspect of the prison environment as
and indicators, as well as composite indicators created from influencing factor) was calculated by using the total number
two or more variables, or data on total population obtained of people incarcerated by 31 December 2020 as numerator
from external sources (32–35). and the total official capacity as denominator.
1. Methods 9
1.4.2 Governance arrangements for
delivery of prison health care
Bivariate analysis was used to evaluate if countries where absolute numbers. Data from the prison dataset were given
responsibility for delivery of prison health care lay with the as full-time equivalents (FTEs), which were considered to be
Ministry of Health performed differently from others. For a reliable estimate, as in many countries – and particularly
this, marginal distributions were analysed. In view of the for certain specialties – use of part-time staff is common in
small number of observations, the variables of interest for the prison context.
this study were recoded as two-class variables according
to their natural tendency, and significant differences were 1.4.4 Morbidity data
assessed using Fisher’s exact test. Morbidity data were derived by adding together the total
number of people reported to have each of the diagnoses
1.4.3 Health-care staff availability on record during 2020, as indicated by the reporting
Ratios of prison staff and health-care staff per 1000 people Member States. The proportion of people with each of
incarcerated were calculated using the total number the diagnoses was calculated by dividing this figure by
of staff and the total number of people incarcerated by the prison population reported as of 31 December 2020 in
31 December 2020. Availability of health workforce was each Member State that provided data. All data presented
assessed only for the main categories of physicians, were compared with the scientific literature on prisons to
psychiatrists, dentists, nurses and total health-care staff. evaluate their reliability and against data reported for the
To make an assessment of the availability of health-care prison population taken from an external source, in this
staff whenever health-care access was needed, only full- case Global Burden of Disease 2019 (34). However, as 95%
time staff (or estimated full-time equivalent staff) was of the prison population is male, only data for males were
considered. For example, if a Member State said that two considered when using this source.
contract staff visited a prison for 2.5 days each per week, this
was considered as one full-time member of staff. 1.4.5 Access to treatment
Access to health-care and pharmacological treatment
As an indication of equality in availability of human is presented as absolute and relative frequencies; in the
resources for health, these data were compared with data case of the latter, the denominator was the total number
for the same categories of health-care staff available for of people diagnosed with the particular disease for a
the general population obtained from Eurostat and the given Member State, with both diagnosis and treatment
WHO Global Health Observatory database (36). Eurostat reported. As an exception, TB and MDR-TB were given
gives preference to the concept “practising staff”, as it best only as absolute frequencies, as the number of individuals
describes the availability of health-care resources (37). receiving treatment might be higher than the number
Common definitions of the distinct categories of health-care diagnosed, depending on the guidelines for treatment
professionals (doctors, dentists, etc.) were agreed with the adopted and the reporting period.
Organisation for Economic Co-operation and Development
and WHO; detailed definitions are available in CIRCABC Completion of treatment is presented as a relative
(Communication and Information Resource Centre for frequency of people with access to treatment.
Administrations, Businesses and Citizens) (37). For purposes
of comparison with the prison dataset, five indicators were 1.4.6 Behaviour data
extracted: total health-care staff (derived by adding health Behaviour data were derived by adding together the total
personnel to nursing and caring professionals), medical number of people reported to have engaged in each of
doctors, dentists (both extracted from health personnel) the relevant behaviours during 2020, as indicated by
and psychiatrists (extracted by disaggregating physicians the reporting Member States. The proportion of people
by medical specialty). showing each of the behaviours was calculated by dividing
this figure by the total prison population reported as of 31
Data obtained from Eurostat relate to human resources December 2020 in the Member States that provided data. All
available to provide health-care services in a country, data presented were compared with the scientific literature
irrespective of the sector of employment, and are given in on prisons to evaluate their reliability and against data
1.5 Data validation The second round of validation was conducted following
the data analysis and involved comparison with general
Data validation was conducted in two stages. The first round population data as far as possible. When numbers varied
of data validation, carried out between August 2021 and significantly, Member States were made aware and asked
January 2022, was conducted ahead of analysis. Focal to provide clarification of the data provided. The completed
points were contacted as needed to provide clarification country profiles were approved and validated by the
of missing or inconsistent data. Out-of-range values were focal points.
1. Methods 11
2
12
2. Findings
2. Findings 13
Fig. 2. Proportion of people in prison per 100 000 inhabitants, WHO European Region, 2020
Age structure
Elderly (> 50 years) 28 66 303 15.3
Elderly (> 65 years) 23 14 723 3.9
Youth (< 18 years) 32 2352 0.6
Origin
Migrants 29 107 497 23.4
Ethnic minority 6 22 195 24.4
2. Findings 15
Fig. 3 shows the number of people newly admitted to newly admitted to prison, representing 102.7 people per
prison per 100 000 inhabitants in Europe in the previous 100 000 inhabitants. This indicator ranged from 9.8 newly
year (2020). In the 28 countries in the European Region that admitted people per 100 000 inhabitants in Poland to 206.1
answered this question, there were a total of 366 701 people in France.
Fig. 3. Number of people newly admitted to prison per 100 000 inhabitants,
WHO European Region, 2020
Poland 9.8
San Marino 23.0
Armenia 35.2
Portugal 42.3
Estonia 48.5
Croatia 53.8
Lithuania 58.3
Greece 58.5
Italy 59.2
Bulgaria 76.1
Bosnia and Herzegovina 77.3
Czechia 86.5
Finland 95.5
Republic of Moldova 96.4
Austria 96.9
Slovenia 101.4
WHO European Region 102.7
Ireland 106.0
Netherlands 106.2
United Kingdom 106.4
Slovakia 116.5
Monaco 117.2
Hungary 120.2
Albania 125.8
Latvia 141.6
Denmark 156.8
Georgia 186.1
Cyprus 188.1
France 206.1
0 50 100 150 200 250
Fig. 4. Percentage of people in prison serving life sentences, WHO European Region, 2020
Ireland 9.9%
United Kingdom 9.4%
Greece 8.1%
Armenia 4.5%
Cyprus 4.2%
Albania 3.6%
Italy 3.3%
Luxembourg 3.2%
WHO European Region 3.2%
Ukraine 3.1%
Germany 3.1%
Bulgaria 3.0%
Belgium 2.1%
Latvia 2.1%
Lithuania 2.0%
Republic of Moldova 1.9%
Austria 1.7%
Estonia 1.7%
Malta 1.3%
Romania 0.9%
Georgia 0.8%
France 0.8%
Denmark 0.7%
Poland 0.7%
Slovakia 0.5%
Switzerland 0.5%
Netherlands 0.4%
Hungary 0.4%
Czechia 0.2%
Slovenia 0.0%
Monaco 0.0%
0 2 4 6 8 10
People in prison serving life sentence (%)
2. Findings 17
2.2 Inputs: prison health system
2.2.1 Organization
Organization of the prison health system was reported by seven Members States (19.4%); the most
operationalized using four questions. common situation was that the national government had
responsibility for prison health care but that national and
The first and second questions addressed responsibility for subnational governments were jointly responsible for the
health care, both in prisons and in the general community. general population (n = 3). All 36 Member States answered
The most common situation in the WHO European Region this question.
was that this responsibility was held by the national
government, for both prisons (n = 21) and the general The third question considered the government ministry
population (n = 18) (Fig. 5). All 36 Member States answered responsible for delivering prison health care. In 2020
this question. the most common situation was for this responsibility
to be shared between the Ministry of Health and the
In 29 of the 36 Member States (80.6%), the level of Ministry of Justice/the Interior (n = 20), followed by
government responsible for health care in prisons and responsibility falling exclusively to the Ministry of Justice/
the general population was the same; in most cases, the Interior (n = 8) (Fig. 7). There were seven countries where
responsibility belonged to the national government (n = 17) responsibility belonged to the Ministry of Health alone, and
or jointly to both national and subnational governments one where responsibility was attributed to the Ministry of
(n = 6) (Fig. 6). Different levels of responsibility for Health and the Ministry of Citizen Protection. All 36 Member
health care in prisons and the general population were States answered this question.
Fig. 5. Level of government responsible for health care in prisons and in the
general population
0 10 20 30 40 50 60 70
MemberStates
Member States(%)
(%)
General population Prisons
Shared between the Ministry of Health only Ministry of Health and Ministry of Justice/the
Ministry of Health and Ministry of Citizen Interior only
the Ministry of Protection
Justice/the Interior
2. Findings 19
The fourth and final question addressed responsibility for 2.2.2 Financing
the inspection of hygiene, nutrition and living conditions. Health financing in the prison health-care system is
In this domain, the most common situation was to have presented in three variables: the agency responsible for
responsibility shared between the Ministry of Health and funding the health-care system; how it is funded; and if
the Ministry of Justice/the Interior (n = 20), followed by the people in prison must pay out of pocket for their health-care
Ministry of Justice alone (n = 6) and the Ministry of Health service or products.
or health authorities alone (n = 5) (Fig. 8). There were two
Member States that mentioned other arrangements – In half of Member States, the Ministry of Justice was
namely, where the responsibility was attributed to an responsible for financing prison health care (n = 18),
inspector of prisons or to subnational governments. There followed by responsibility being shared between the
was one Member State that did not answer this question. Ministry of Health and the Ministry of Justice/the Interior
(n = 11) (Fig. 9). All 36 Member States answered this question.
Fig. 8. Agency or agencies responsible for inspection of prison hygiene, nutrition and
living conditions
0 10 20 30 40 50 60 70
Member States (%)
MinistryBoth MinistryMinistry
of Health, of Healthofand
Ministry of and
Justice/the Interior 30.6% (n = 11)
Citizen Protection competent
Ministry
Ministry of Justice
of Justice onlyonly
50.0% (n = 18)
Bothof
Ministry Ministry
Health, of Healthofand
Ministry Citizen
2.8% (n = 1)
Ministry
Protection and of Justice/the
competent Interior
health districts
0 10 20 30 40 50 60 70
Member States (%)
The second variable assessed the coverage given to people insurance (n = 20), it was worrying that nine Member States
in prison by any form of health insurance, either private or reported that there was no coverage by health insurance of
public, and how it compared with what was available to the any kind (Fig. 10). There was one Member State that did not
general population. Although the most common answer answer this question.
was that health care in prison was fully covered by health
Not covered
Fully byby
covered anyhealth
healthinsurance
insurance 57.1% (n = 20)
Partly covered
Covered by health
by a separate healthinsurance
insurance 8.6% (n = 3)
0 10 20 30 40 50 60 70
Member
MemberStates
States(%)(%)
2. Findings 21
For this variable, three Member States indicated “other any costs associated with general health-care services
situation”. This has been recoded as “fully covered by health (Fig. 11). However, in the case of prescription medication,
insurance” as the explanations given were that: this was true of only 26 Member States. Other health-care
expenses that might be incurred, such as visual aids,
(i) in general, health care for people in prison is fully prosthetics and supplements, were fully covered only in
covered by the prison system, but there are exceptions a minority of Member States (n = 16). All 36 Member States
in state-funded treatment programmes; answered this question.
(ii) primary care is covered by the prison system and the 2.2.3 Prison health system
remainder by the general public health system; and vision and strategy
This subdomain was operationalized by two variables: the
(iii) people in prison are entitled to necessary, sufficient first assessed the existence of health policies and strategies,
and appropriate medical services as dictated by law, the second their implementation.
considering economic efficiency and general standard
health insurance; thus, the statutory health-care Less than half the Member States (n = 15, 41.7%) reported
system must be equivalent; entitlement to medical that they had a national or subnational policy or strategy
benefits is suspended if the person in prison (or in for prison health, although an additional nine (25.0%)
preventive detention) has health insurance by virtue reported that such a policy was embedded in their wider
of a free employment relationship. national policy (Fig. 12). All 36 Member States answered
this question.
Irrespective of the existence (and type) of health insurance,
in 34 out of 36 Member States people in prison did not cover
80
(%)(%)
60
States
There
There is no policy/strategy at present, and is a national/subnational
no intention to develop one
41.7% (n = 15)
in the near future
prison health policy/strategy
There isnational/subnational
Prison health is part of another no policy/strategy at present,
(health)
2.8% (n = 1)
but one is envisaged for the future
policy/strategy
0 10 20 30 40 50 60 70
Member
MemberStates
States(%)
(%)
Of the 24 countries saying that they had a prison health for the policy or strategy had been adopted or was being
policy, either as a standalone policy or as part of another developed/planned (three did not answer) (Fig. 13).
policy, 21 (57.1%) mentioned that an implementation plan
Fig. 13. Proportion of Member States with an implementation plan for policy/strategy
NoImplementation
implementation plan at is
plan present
under development
and no such plan will be developed
or there are plans for development
57.1% (n = 12)
28.6% (n = 6)
2. Findings 23
2.2.4 Health information
Thirty-four of 36 countries (94.4%) reported that they had With respect to disease registration, prisons in most
a system for tracking deaths in prisons. Of these 34, all but Member States (n = 33) informed public health authorities
one recorded the cause of death and 14 regularly assessed about diseases among people living in prison. However,
the completeness and quality of all data on deaths sent only 15 Member States preserved individual imprisonment
to the national body responsible for civil registration and status in the process of transferring information to all
vital statistics (17 countries reported that they did not do disease registries, 15 preserved imprisonment status only
such an assessment, and two did not give a response for for infectious diseases, and three did not capture it in either
this indicator). disease registries or surveillance data. Of Member States
that stated that they informed public health authorities,
Thirty-one Member States explained the way in which only seven were able to provide a link to NCD datasets and
data on deaths and causes of death were transferred from nine in the case of infectious diseases.
the prison registration system to the body responsible for
national civil registration and vital statistics. There was a All Member States reported that they kept clinical health
formal data transfer system in 18 Member States; of these, records of people in prison. The most common format for
three stated that there was an electronic system to transfer health records in European prisons was still paper-based
death data, while four said that there was no regular (n = 16, 44.5%). However, 12 Member States said that they
formal mechanism to transfer death registration data to used a mixture of formats (33.3%), and eight kept electronic
the national registry. Seven Member States did not provide clinical health records (22.2%).
any further information on the process of data transfer (raw
data on the various transfer systems is given in Annex 3). In almost all Member States, all relevant information was
Training for physicians in filling in death certificates was recorded in health records (Fig. 14). All 36 Member States
provided in only 18 Member States (50.0%), while one answered this question.
Member State stated that death certificates were not filled
in by physicians (missing = 1).
Fig. 14. Proportion of Member States recording various types of information in the clinical
health record system
97.2% (n = 35)
Treatment and medication
Diagnoses established
2.8%
(n = 1)
97.2% (n = 35)
Visits to external care providers
Health behaviours
2.8%
(n = 1)
97.2% (n = 35)
2.8%
Diagnoses
Treatment established
and medication (n = 1)
97.2% (n = 35)
Health behaviours 2.8%
Vaccination (n = 1)
94.4% (n = 34)
5.6%
Vaccination
Screening test results (n = 2)
94.4% (n = 34)
5.6%
Visits toScreening testproviders
external care results (n = 2)
91.7% (n = 33)
8.3%
Screening tests performed
Screening tests performed (n = 3)
0 10 20 30 40 50 60 70 80 90 100
Member
MemberStates
States(%)
(%)
No Yes
Yes No
Fig. 15. Compatibility of health record systems used in prison and in the general population
0 10 20 30 40 50 60 70
Member States (%)
2. Findings 25
Fig. 16. Staff involved in making initial health assessments following admission
Physician or or
Physician “medical
“medicalassistant”
assistant” 2.9% (n = 1)
Physician
Physician only
only 31.4% (n = 11)
Physician
Physician andand nurse
nurse 20.0% (n = 7)
0 10 20 30 40 50 60 70
Member States (%)
Member States (%)
In the case of most Member States, these assessments were in all prisons in the country concerned (Fig. 17). One or two
very detailed, covering a wide range of diseases, vaccination Member States did not answer this question, depending
status and health behaviours, and were generally conducted on the variable.
Fig. 17. Types of disease and health behaviour covered in prison assessments
History of TB and current signs and symptoms were It should be noted that WHO recommends voluntary STI
reported by all Member States to be assessed at or soon after screening for all people in prison and that the United
reception for all people in prison. Almost 70% of Member Nations comprehensive package of services to address HIV,
States (n = 25) reported that diagnostic tests were offered HBV and HCV is used (41). Prison systems must therefore
in addition to clinical evaluation, and half of Member States ensure that all people in prison have easy access to testing,
(n = 18) reported that an additional assessment for MDR-TB which should never be mandatory, thus favouring an
was provided in the event of a positive test. opt-out approach.
Screening for diseases was common in most Member States The outlook was slightly different when it came to NCDs
and for most infectious diseases at or soon after admission, and particularly cancer, where two thirds of Member States
even though the methodology used to determine inclusion screened for cervical and breast cancer, and 58.3% for
varied from country to country (Fig. 18). There was only one colorectal cancer (Fig. 19). All 36 Member States answered
Member State that said that it did not screen for STIs upon this question.
Fig. 18. Screening for various infectious diseases at or soon after admission
20
18
18
16 15
14
States
MemberStates
14 13
12
12 11 11
ofofMember
10
10 9 9 9
8
8
Number
6
Number
4
2
2 1 1 1
0 0 0 0
0
HIV HCV HBV STI
HIV HCV HBV STIs
2. Findings 27
Fig. 19. Screening for various types of cancer in prisons
0 10 20 30 40 50 60 70 80
According to the Bangkok Rules (Rule 8), preventive syringes as part of an exchange programme (43). However,
health-care measures of relevance to women, such as Pap this same study found that there were more Member States
tests and screening for breast and gynaecological cancer, distributing lubricants free of charge. All 36 Member States
should be offered to female prisoners on the same basis as answered this question, but some variables were left blank
women of the same age in the outside community (42). Data in certain cases (one missing value for dental dams, two for
obtained in the survey suggest that this was not the case in condoms and three for lubricants).
around a third of Member States.
The situation was clearly much better in terms of offering
All Member States screening for cancer in prisons stated that protection from COVID-19 infection. All Member States
the same criteria applied as in the outside community and stated that people in prison had had access to hand
that there were no restrictions or differences in screening sanitizer/soap and water and face masks since the
practices in prison and the community. emergence of the pandemic, even though HIPEDS did not
assess whether such products were provided free of charge.
2.3.1.2 Health protection
Health protection was probably the area where most Space was created for adequate quarantine of contacts
diversity was found across Member States. In 35 Member and isolation of COVID-19 cases in all prisons in 33 Member
States, in all prisons, soap was provided free of charge to States (91.7%) and in most prisons in the other three
people living in prison (Fig. 20). Conversely, needles and (Fig. 21). However, the space created did not always follow
syringes were provided free of charge in only three Member CPT rules in all Member States (6). All 36 Member States
States, and lubricants in only four. An earlier study points to answered the initial question, but only 34 referred to the
a similar number of Member States providing needles and respect for CPT rules.
Fig. 21. Percentage of Member States providing space in prisons for quarantine and
isolation of COVID-19 cases
2.9% (n = 1)
8.3% (n = 3)
17.6% (n = 6)
50.0% (n = 17)
All prisons
6 m²
Most prisons
A minority of prisons
29.4% (n = 10)
No prisons
91.7% (n = 33)
a
CPT rules state that the minimum living space for a single-occupancy cell – excluding toilet space – should be 6 m², with a further
4 m² for each additional person (6).
2. Findings 29
2.3.1.3 Health promotion
Health promotion is a vast area, so only four indicators A better result was obtained for policies to promote
were chosen to characterize it: one focused on prevention physical activity, which 63.9% of Member States (n = 23)
of transmission of infectious diseases, two on prevention of reported that they had introduced (Fig. 23). All 36 Member
NCDs and one related to drug use. States answered this question. However, only two were
able to provide an Internet link to these policies and to
Less than half of Member States (n = 14) stated that they had describe them.
materials to promote safe tattooing practices, a relevant
health promotion strategy to prevent transmission of
bloodborne diseases (Fig. 22). All 36 Member States
answered this question.
Fig. 22. Percentage of Member States providing promotional materials on safe tattooing
practices in prisons
38.9% (n = 14)
Yes
No
61.1% (n = 22)
63.9% (n = 23)
Yes
No
36.1% (n = 13)
In terms of exposure to smoke, nearly three quarters Member States (5.6%) had such a policy in specific regions
of Member States (72.2%; n = 26) stated that they had a of the country (Fig. 24). All 36 Member States answered
smokefree policy implemented nationwide, while two this question.
22.2% (n = 8)
No smokefree policy
72.2% (n = 26)
2. Findings 31
However, it is important to note that partial regulations, 2.3.2 Rehabilitation
such as availability of smokefree cells, are insufficient, as Access to education and training opportunities was
they do not provide adequate protection against the harms reported by all Member States to be available in all
of secondhand smoke, which is known to have damaging (n = 27; 75.0%) or most prisons (n = 9; 25.0%) (Fig. 26).
health effects, including an increased risk of heart disease Only a single Member State reported providing access
and lung cancer (by 20% to 30%) in nonsmokers. to employment opportunities only in a minority of
prisons; most commonly, such access was provided in all
As reported in Global prison trends 2022 (44), around 20% (n = 32; 88.9%) or most prisons (n = 3; 8.3%). All 36 Member
of the worldwide prison population are held for drug States answered both these questions.
offences, suggesting that there is a high need for drug-
related services. Despite this, four Member States (11.4%) It was reported that people’s home location was taken
said that they had no treatment areas available to tackle into account “as much as possible” when allocating them
drug problems in any prison (Fig. 25), and nearly three to prisons in order to help maintain family relationships
quarters (65.7%) reported that accessibility was restricted. (n = 23; 63.9%), while another four Member States (11.2%)
One Member State did not answer this question. said that proximity to home was always considered.
However, nine Member States (25.0%) said that they
considered other factors when allocating people to prisons.
Fig. 25. Percentage of Member States with treatment areas for people with drug problems
11.4% (n = 4)
22.9% (n = 8)
In all prisons
In most prisons
In a minority of prisons
In no prisons
17.1% (n = 6)
48.6% (n = 17)
0 10 20 30 40 50 60 70 80 90 100
Member States (%)
Member States (%)
Communication permitted to help maintain family all but one imposed time restrictions and only three did so
relationships varied, as shown in Fig. 27, even within free of charge. Use of the Internet was less common; only
the same Member States (n = 35). Communication by 22 Member States allowed it, and all but two of these
telephone was allowed by all 36 Member States, although imposed time restrictions.
40
36 35
Number of Member States
30
25
22
20
14
10
10
0 0
0
Yes No
2. Findings 33
According to the Council of Europe’s prison rules, revised 2.3.3 Medical care
in 2020 (45): 2.3.3.1 Primary care
While most health-care services provided to people in prison
Prisoners shall be allowed to communicate as often are part of primary care, two main indicators were chosen to
as possible – by letter, telephone or other forms of characterize service delivery that were particularly relevant
communication – with their families, other persons in the context of the COVID-19 pandemic. Member States
and representatives of outside organisations, and to were asked if they had any preparedness contingency plans
receive visits from these persons … Communication for managing the impacts of infectious disease outbreaks
and visits may be subject to restrictions and (in general); and if suspected cases of infectious diseases
monitoring necessary for the requirements of had access to laboratory tests.
continuing criminal investigations, maintenance
of good order, safety and security, prevention of While most Member States reported that they had
criminal offences and protection of victims of crime, contingency plans in place in all prisons (n = 28; 77.8%), six
but such restrictions, including specific restrictions countries had no such plans in any prison (Fig. 28). All 36
ordered by a judicial authority, shall nevertheless Member States answered this question. However, when
allow an acceptable minimum level of contact. asked to provide links to any existing pandemic response
plans, only three Member States could do so, while five
could do so for policy response plans. The majority said
The survey data suggest that these rules were broadly that their plans were either not published or not publicly
followed, though the situation could be improved if more available, or that no link was available.
modern means of communication were adopted.
Access to laboratory tests was available in all prisons in
34 Member States (94.4%) (Fig. 29). One Member State
reported that no access to tests was provided; another that
access was limited to priority cases.
Fig. 28. Percentage of Member States having contingency plans for managing the impact of
an infectious disease outbreak in prisons
16.7% (n = 6)
2.8% (n = 1)
In most prisons
In a minority of prisons
In no prisons
77.8% (n = 28)
2.8% (n = 1)
2.8% (n = 1)
94.4% (n = 34)
Primary care was also characterized by exploring access Access to treatment in 2020 was assessed by considering
to pharmacological treatment and to recommended disease areas as indicators of primary care access (Table 4).
appointments for specific conditions.
Table 4. Access to and completion of treatment for various infectious diseases in prisons
a
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on
record, using the same reference year. Only countries providing both figures are considered for the calculations.
b
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to
treatment, using the same reference year. Only countries providing both figures are considered for the calculations.
c
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
2. Findings 35
In the case of NCDs, in most situations, treatment is Information on access to recommended primary care
instituted and tends to be continuous, without there visits was requested for oral health, diabetes and CVD, as
necessarily being a defined treatment end. For this reason, these have specific European guidelines where a minimum
a modified version of the previous table is used to present frequency for good-quality care is stipulated (46) (Table 6).
access to treatment of NCDs as a primary care indicator
(Table 5).
Table 6. Primary care visits as indicator of quality of care for selected NCDs in prisons
2.8% (n = 1) 2.8% (n = 1)
8.3% (n = 3)
In all prisons
In most prisons
In a minority of prisons
In no prisons
86.1% (n = 31)
2. Findings 37
Fig. 31. Percentage of Member States having arrangements/protocols for specialized
treatment of cancers in prisons
8.3% (n = 3)
2.8% (n = 1)
5.6% (n = 2)
In all prisons
In most prisons
In a minority of prisons
In no prisons
83.3% (n = 30)
27.8% (n = 10)
Yes
No
72.2% (n = 26)
11.1% (n = 4)
TB
TB 27
HCV
HCV 26
Druguse
Drug usedisorders
disorders 22
50.0% (n = 18)
0 5 10 15 20 25 30 40
Number of Member States
Number of Member States
Yes, for all conditions
Yes, for some conditions
No
2. Findings 39
2.3.4 Health system performance
2.3.4.1 Availability
The availability of the health service delivery system was One important aspect to bear in mind when comparing and
assessed by considering the availability of health-care staff. interpreting the rates of health-care staff per 1000 people in
Table 7 shows the number of health-care staff in prisons in prison and in the community is the meaning of the concept
Europe, in total and disaggregated by category; also shown of equivalence of care. Equivalence does not in fact imply
is the number of staff per 1000 people in prison and in the equality in the distribution of resources so much as equity,
general population. in the sense that resources should be allocated in a way that
fairly reflects different needs. It has been established that
According to the Association for the Prevention of people in detention more frequently have mental health
Torture (53): and drug use disorders, so a greater investment is needed,
for example, to achieve a higher ratio of psychiatrists to
The number and specialty of the health care staff people in prison (53).
available will be dependent on the size of the
prison, but as a minimum there should be a general In 72.2% of Member States (n = 26) there was access in
physician and sufficient nursing staff to meet the all prisons to mental health counsellors (including peer
daily needs. A psychiatrist, as well as a psychologist support and external providers – not specifically for mental
and nurses with training in psychiatric care, should health disorders but offering support for maintenance of
also be available at a frequency related to the size of well-being as required) (Fig. 34). Only one Member State
the prison population. Again, their role must not be reported that this option was not available in any of
confined simply to the treatment of mental illness its prisons. All 36 Member States answered this question.
but must include the promotion of the mental
well-being of the prison population and staff, and
the prevention of self-harm and suicide, as well as
all forms of physical or psychological violence.
a
Data for physicians and dentists are available for 2020, while the latest available data for psychiatrists are from 2013. Data for the category of
nurses in the general population also include midwifery staff and are available for 2020.
2.8% (n = 1)
13.9% (n = 5)
In all prisons
11.1% (n = 4)
In most prisons
In a minority of prisons
In no prisons
72.2% (n = 26)
2.3.4.2 Accessibility
Access to immunization against vaccine-preventable as recommended by WHO (54), was reported to be available
diseases was very good across all Member States, with the in all prisons in only 24 Member States (66.7%); clearly there
highest access observed for COVID-19, for which 88.6% of is room for improvement in this area. Moreover, availability
Member States stated that they provided vaccination in was assessed but not coverage. Coverage data through the
all prisons (Fig. 35). There were between one and three RISE-Vac project (55) is likely to provide some additional
Member States not answering this question, depending on useful information from participating Member States.
the variable. On a negative note, vaccination against HBV,
Fig. 35. Percentage of Member States providing vaccination against various infections in prisons
2. Findings 41
Access to HIV prophylaxis, including pre-exposure 2.3.4.3 Acceptability
prophylaxis (PrEP) and post-exposure prophylaxis The most common situation in the WHO European Region
(PEP), was relatively high across Member States (Fig. 36). is that informed consent is obtained before any health
All 36 Member States answered this question. However, intervention is provided, including health assessments and
the level of access still fell short of the recommendations screening tests. However, this process was documented
made by the United Nations Programme on HIV and AIDS in only 15 Member States (41.7%) (Fig. 37). All 36 Member
(UNAIDS) (56): according to the 2025 global AIDS targets, States answered this question. It is a matter of concern that
15% of people in prison should use PrEP in high-risk two Member States acknowledged that they did not even
settings, and 90% should have access to PEP. seek informed consent.
Fig. 36. Percentage of Member States providing access to HIV prophylaxis in prisons
PrEP
PrEP
PEP
PEP
0 10 20 30 40 50 60 70 80 90 100
Fig. 37. Informed consent for screening tests and health assessments obtained from people
in prison
Informed consent
Informed consent obtained and documented for any obtained for
intervention 52.8% (n = 19)
any health intervention
Informed
Informed consent obtained consent
for any healthnot obtained
intervention 5.6% (n = 2)
for health interventions
0 10 20 30 40 50 60 70
Member States
Member States (%)
(%)
0 10 20 30 40 50 60 70 80 90 100
MemberStates
Member States (%)
(%)
Yes No
2. Findings 43
Fig. 39. Standardized protocol in place for identifying and helping people at risk of
suicide/self-harm
13.9% (n = 5)
11.1% (n = 4)
Standardized protocol
for suicide
75.0% (n = 27)
No, assessments
never conducted
19.4% (n = 7)
2. Findings 45
This table suggests that, across all conditions, there may be Previous reports have acknowledged gaps in knowledge of
some underreporting by Member States, when comparison the prevalence of certain conditions in European prisons,
is made with systematic reviews published on prevalence namely on active and latent TB (58).
of such conditions in similar populations (for some
conditions, however, the literature identified for prisons
was not considered to be suitable, either because of the 2.4.3 Mortality
low quality of the studies or lack of comparability of the All Member States reported mortality data. Disaggregation
data reported). The differences identified are more visible by cause of death was possible only for 27–35 Member
for NCDs, which may result from there being less focus on States, depending on the cause. Standardized all-cause
these in prisons. mortality rate per 100 000 incarcerated people was 42.5,
as compared to 136.9 in the general population (Table 9).
Nonetheless, assuming that some values are underreported,
the prevalence of most infectious diseases is considerably The data obtained confirm that suicide remained a major
higher in prisons than in the general community, the cause of death in prisons. Previous reports had suggested
exception being STIs, for which only 16 Member States that the risk of suicide among people in European
reported data. Mental health and drug use disorders were prisons was seven times higher than that of the general
also reported to represent a considerably higher share population (70). This is a higher ratio than the one identified
of the prison population compared to the community. in the current report, even though the standardized rate in
Conversely, prevalence of NCDs was lower in prisons prison was very similar (105 per 100 000 people in prison).
than in the community, although careful interpretation of It has also been suggested that a considerable proportion
these data is needed as very few Member States reported of people who commit suicide in prison have drug-related
them. Moreover, in certain situations, the values reported problems (58).
were zero (even after validation had been requested from
Member States), which suggests that NCDs may be ignored
in some prisons.
a
The cumulative mortality rate for COVID-19 was estimated by combining the total cumulative number of deaths due to COVID-19 between 22
January 2020 and 31 December 2020 obtained from the Our World in Data database (35) and the EU population as of 1 January 2020 obtained
from Eurostat (69). Data were reported for males only.
2. Findings 47
It is important to remember two stipulations of the Mandela confinement; specific stipulations are given, such as that
Rules (5), neither of which is likely to be respected in the maximum duration should never amount to “more
situations of overcrowding: than 22 hours a day without meaningful human contact”
and that it should only be used exceptionally and “for the
[Rule 12.1] Where sleeping accommodation is in shortest period possible and never amount to torture or
individual cells or rooms, each prisoner shall occupy inhuman or degrading treatment or punishment”. However,
by night a cell or room by himself or herself. If for the maximum duration of solitary confinement is in practice
special reasons, such as temporary overcrowding, set by national law. When solitary confinement is imposed,
it becomes necessary for the central prison the people affected “shall be visited daily”. However, there
administration to make an exception to this rule, it is are also reports suggesting that such measures, particularly
not desirable to have two prisoners in a cell or room. for pretrial detention, have been part of Scandinavian
prison practice for many years (71), which may explain
[Rule 13] All accommodation provided for the the higher values reported by such countries. Moreover,
use of prisoners and in particular all sleeping the current survey was conducted during the COVID-19
accommodation shall meet all requirements of pandemic; according to Penal Reform International, prisons
health, due regard being paid to climatic conditions in the United States saw a 500% increase over previous
and particularly to cubic content of air, minimum levels in the use of solitary confinement in June 2020 (72).
floor space, lighting, heating and ventilation.
The third indicator looked at sanitation conditions,
The second indicator looked at the use of solitary which were subdivided into having access to a toilet
confinement as a punitive measure. In the 22 Member States in-cell and having access to showering and bathing
that answered the question, a total of 7978 individuals were facilities of appropriate temperature. While the second
held in solitary confinement in 2020, representing 2.9% of of these facilities was ensured in all prisons in 94.4% of
the annual prison population. A higher value (4.3%) was Member States, only 69.4% reported in-cell toilets in all
reported in Global prison trends 2022 (39). The Council of prisons (Fig. 42). All 36 Member States answered these
Europe’s prison rules, revised in 2020 (45), regulate solitary two questions.
Showering and
Showering and bathing facilities
bathing facilities
Toilet
Toiletin-cell
in-cell
0 10 20 30 40 50 60 70 80 90 100
Member
Member States
States (%)(%)
[Rule 15] The sanitary installations shall be adequate 1. Every prisoner who is not employed in outdoor work
to enable every prisoner to comply with the needs shall have at least one hour of suitable exercise in
of nature when necessary and in a clean and decent the open air daily if the weather permits.
manner.
2. Young prisoners, and others of suitable age and
[Rule 16] Adequate bathing and shower installations physique, shall receive physical and recreational
shall be provided so that every prisoner can, and training during the period of exercise. To this end,
may be required to, have a bath or shower, at a space, installations and equipment should be
temperature suitable to the climate, as frequently as provided.
necessary for general hygiene according to season
and geographical region, but at least once a week in
a temperate climate. Every Member State respected the first part of this rule,
stipulating that people in prison should be allowed to
Insufficient sanitation facilities have also been reported in spend at least one hour per day outdoors (Fig. 43). However,
Global prison trends 2022 (39). two Member States did not make physical activity facilities
available in all prisons, and three did not give people the
The fourth indicator looked at available infrastructure and opportunity to use these facilities at least once a week. All
procedures to ensure that people in prison have access to 36 Member States answered these three questions.
Fig. 43. Access to fresh air and the opportunity and means to engage in physical activity
in prisons
100.0% (n = 36)
Access to physical
Access to physical activity facilities
activity facilities
0 10 20 30 40 50 60 70 80 90 100
MemberStates
Member States (%)
(%)
2. Findings 49
The fifth indicator looked at access to food and nutritional obesity more frequently (73). Consumption habits, notably
options and their adaptation to cultural and gender needs, of ultraprocessed foods during detention (74), have also
as stipulated by Mandela Rule 22 (5): been held accountable for short- and long-term negative
consequences, including the development or aggravation
Every prisoner shall be provided by the prison of NCDs.
administration at the usual hours with food of
nutritional value adequate for health and strength, It should be mentioned that having nutritional options
of wholesome quality and well prepared and served. adapted to health needs is, of course, equally important,
but this information was not collected in HIPEDS.
The survey data indicate that adaptation to cultural needs
was respected in most Member States, but more needed to
be done to ensure that women in detention were also given 2.5.2 Health behaviours
food of adequate nutritional value for their health needs Health behaviours were characterized by asking Member
(Fig. 44). All 36 Member States answered both questions. States, for a total of seven variables, the number of people in
prison adopting a certain behaviour (Table 10). Even though
Previous research has shown that people in prison tend to all Member States said that this information was recorded
gain weight (28) and – even though women represent only in their clinical records, most also acknowledged that there
around 5% of the prison population – women are more were limitations in their ability to extract such data. For this
vulnerable to have low physical activity and to be diagnosed reason, this was the domain where Member States had most
with eating disorders, and thus to display abdominal difficulty in providing valid information.
In all prisons
In a minority Yes
of prisons No
In no prisons
88.9% (n = 32)
Obese (BMI ≥ 30.0 kg/m2) 4 1764 (9.71) 8.0–56.0% (76) 21.8% (38)a
(95% CI: 9.29–10.15) Important gender
inequalities (75)
Drug users (last 12 months)b 10 10 129 (17.81) Male prisoners 5.6% of people
(95% CI: 17.49–18.12) 10–48% aged 15–64 used
Females 30–60% (78) drugs at least once
Physically active (exercising 4 638 (10.48) 46.2% for UK (75) 75% (81)
≥ 150 minutes/week) (95% CI: 9.74–11.28)
a
European Health Information Gateway 2016 data for males only.
b
We cannot verify when these statistics were collected in prisons. The point of assessment would imply if the people in prison had consumed
alcohol, drugs or tobacco while in prison or if they had consumed them within the 12 months before they entered prison.
c
For the reason given in the previous note, the population-level statistic for current alcohol drinkers is not given here; instead, we give the
population-level statistics and prison statistics reported in the literature to indicate alcohol use dependence, which we believe will add more
value to this discussion.
In spite of the low level of reporting by Member States, this morbidity domain, this is apparent when comparisons are
table suggests that, across all behaviours, there may be made with published systematic reviews on the prevalence
some underreporting. Even though less visible than in the of such conditions in similar populations.
2. Findings 51
2.6 Cross-cutting principles
2.6.1 Adherence to international standards
for human rights and good prison health
Nine indicators were taken into account when (9) existence of national health-care complaints system for
characterizing the first cross-cutting principle. These were: people in prison.
0 10 20 30 40 50 60 70 80
Member
Member States
States (%) (%)
Fig. 46. Standards and accreditation procedures for health-care services in prisons
and the community
5.6% (n = 2)
44.4% (n = 16)
50.0% (n = 18)
2. Findings 53
Fig. 47. Clinical independence of prison health staff
22.2% (n = 8)
77.8% (n = 28)
Most Member States (n = 24; 68.6%) stated that they did not and living conditions (Fig. 48). One Member State did not
have publicly available reports on prison hygiene, nutrition answer this question.
Fig. 48. Public availability of reports on prison hygiene, nutrition and living conditions
31.4% (n = 11)
68.6% (n = 24)
27.8% (n = 10)
Available
Not available
72.2% (n = 26)
2. Findings 55
Fig. 50. Availability of national standards to meet the health needs of special populations
in prison
0 10 20 30 40 50 60 70 80 90 100
No MemberStates
Yes
Member States (%)
(%)
Yes No
When asked if these national standards were based on had the option to be attended by female health-care staff.
international ones, six Member States answered “no” and Three quarters of Member States (n = 27; 75.0%) answered
20 answered “yes” (four did not answer). positively, while nine stated that such an arrangement
could not be guaranteed.
There are several standards and guidance documents
issued to support population subgroups in the general There was a range of positions adopted on access to
population, such as the International Standards for People pregnancy tests. Most commonly, pregnancy tests were
with Drug Use Disorders (85), that are also applicable to not made available (n = 14; 38.9%), but in around a third
people in detention. of Member States they were made available at regular
intervals (n = 12; 33.3%), and in the remainder they
Member States were asked if their prisons had were made available only once (n = 10; 27.8%) (Fig. 52).
health-related information products for people in prison, All 22 Member States that gave access to pregnancy tests
such as brochures and leaflets, in multiple languages. Just stated that the option of prenatal care or termination was
over half (n = 19; 52.8%) reported that these were available available in the event of a positive result.
in all prisons (Fig. 51). All 36 Member States answered
this question. In the 27 Member States that responded to the third
question, a total number of 105 women were reported to
There were three questions dealing with women’s health have given birth in prison in 2020, representing 0.6% of the
and specific needs. All 36 Member States answered the females in prison.
first two questions. The first asked if women in prison
19.4% (n = 7)
In all prisons
In most prisons
In a minority of prisons
In no prisons
16.7% (n = 6)
52.8% (n = 19)
11.1% (n = 4)
27.8% (n = 10)
38.9% (n = 14)
No
33.3% (n = 12)
2. Findings 57
3
58
3. Exploring the effects of governance arrangements for
the delivery of health care in prisons
WHO and the United Nations Office on Drugs and Crime hypothesized that two possible models could lead to better
have concluded that (i) managing and coordinating all health-care provision: responsibility lying exclusively with
relevant agencies and resources contributing to the health the Ministry of Health; and responsibility shared between
and well-being of prisoners is a whole-of-government the Ministry of Health and the Ministry of Justice. We tried
responsibility; and (ii) health ministries should provide to put countries into one or other of these groups, and then
and be accountable for health-care services in prisons used the grouping as the main variable in an attempt to
and advocate healthy prison conditions (84). However, understand four major aspects that characterize prison
there is insufficient evidence about the effects of different health systems.
governance arrangements, beyond case studies of good
practice that illustrate these principles.
3.1 Health information systems
In 2020 WHO issued a policy brief which described the
governance arrangements for prison health in three First, we considered health information systems –
European countries (86). In two of these countries, specifically, their ability to provide data on behaviours,
responsibility for prison health lay with the Ministry of morbidity and mortality indicators (Table 11).
Health; in the other, responsibility lay with the Ministry
of Justice, but health-care delivery was assured through Regardless of the groupings made, the data suggest
a formal collaboration with the Ministry of Health. The that the differences identified in the ability to report
arrangements in each country seemed to show positive health information data cannot be explained by diverse
results, although there was some room for improvement in arrangements in the responsibility for the delivery of health
terms of documenting health outcomes. In light of this, we care in prisons.
Table 11. Association between governance arrangements and health information systems
in prison
3. Exploring the effects of governance arrangements for the delivery of health care in prisons 59
3.2 Delivery of health-care services
Next, we looked at delivery of health-care services (iii) availability of PrEP and PEP (preventive services)
(Table 12). This was operationalized by considering:
(iv) primary care quality (following recommendations
(i) availability of needles and syringes (health for oral health visits and ophthalmology visits in the
protection) case of diabetes).
a
Two-tailed Fisher’s exact test. Values below 0.05 show significant differences in proportions, according to the significance level defined for the
statistical analysis. Values between 0.05 and 0.10 are considered trends.
Needles and syringes tended to be distributed more There was a marginally significant increase in the frequency
frequently when responsibility for delivery of health services of PEP distribution when responsibility for delivery of health
was exclusively under the Ministry of Health, even though services was shared between the Ministry of Health and
the difference only indicated a trend (p-value = 0.089). This the Ministry of Justice. No further differences were noted
trend was not, however, replicated in the distribution of in preventive services.
other health protection products.
3. Exploring the effects of governance arrangements for the delivery of health care in prisons 61
3.3 Environmental factors
Next, we looked at the effect of different governance The data suggest that, when responsibility for delivery of
arrangements on environmental factors, using adaptation health services was exclusively under the Ministry of Health,
of diets to meet gender needs as an example (Table 13). there was more frequent adoption of national standards for
However, no significant differences were identified. special populations – notably, LGBTQI+ (80.0% vs 24.0%,
p-value = 0.031) and ethnic minorities (80.0% vs 28.0%,
p-value = 0.047). The same trend was observed for people
3.4 Adherence to the principle with learning disabilities, despite the lack of power for
statistically significant results (100.0% vs 48.0%). However,
of equivalence and other
an arrangement in which responsibilities were under the
international standards Ministry of Health or shared between the Ministry of Health
and the Ministry of Justice seemed to be more favourable
Finally, we looked at the relationship between prison with respect to clinical independence, when compared to
governance arrangements and the level of adherence to the being exclusively under the Ministry of Justice (10.7% vs
principle of equivalence and other international standards 62.5%, p-value = 0.006).
(Table 14).
Gender-adapted diets
Yes 1 (14.3) 15 (51.7) 11 (39.3) 5 (62.5)
No 6 (85.7) 14 (48.3) 0.104 17 (60.7) 3 (37.5) 0.422
a
Two-tailed Fisher’s exact test. Values below 0.05 show significant differences in proportions, according to the significance level defined for the
statistical analysis. Values between 0.05 and 0.10 are considered trends.
COVID-19 vaccine
implementation plan
LGBTQI+
Ethnic minorities
Clinical independence
a
Two-tailed Fisher’s exact test. Values below 0.05 show significant differences in proportions, according to the significance level
defined for the statistical analysis. Values between 0.05 and 0.10 are considered trends.
3. Exploring the effects of governance arrangements for the delivery of health care in prisons 63
4
64
4. Limitations
The mortality and prevalence data in prisons used for cannot easily be made with these data. Rates adjusted
this report were calculated using the number of people for age, sex and social class would be needed to allow
in detention as of 31 December 2020 as the population of sound conclusions to be drawn, and these were not
exposure, while we used the cumulative number of cases available for the prison population. We attempted to
and deaths for the year 2020. While it is acknowledged that correct for this by using mortality and prevalence rates
the prison population is relatively small yet dynamic, it was for the general population over 20 years of age and by
assumed for the report that the rate of change of the prison drawing comparisons with males only, since the female
population stayed relatively constant, allowing the end-of- representation in prisons is only 5% of the total population.
year population figure to be used.
When exploring governance arrangements for the delivery
An important limitation of this report is that, while its aim of prison health care (section 3), some trends were revealed.
is to provide an overview of the performance of prison However, the limited sample size reduced the potential to
health systems and of the health status profile of people further explore the effect of different organizational models,
living in prison in the whole WHO European Region, only as shown by p-values that often could only point towards
36 of 53 Member States responded. While comparisons trends. Notwithstanding, given the limited data published
are made with WHO European Region data for the general on evidence of the impact of governance in the delivery of
population, these should be interpreted with caution as prison health care, we believe the data provided are still of
some of the missing countries are large and represent an value, even though cautious interpretation is needed.
important share of the prison population of the Region.
Moreover, irrespective of their size, these missing countries For most countries, the period to which HIPEDS data refer
may also have particular features in their organization and was 2020. However, for some external sources, the reference
functioning that would be relevant in characterizing the year was different, making direct comparison more difficult.
prison health system as a whole.
Countries that consist of multiple regions, cantons or
For those countries that were represented, there were also nations posed a particular challenge, as the option to use
substantial limitations in the availability of data across nationally aggregated data presented in a uniform and
many indicators, notably for behaviour and morbidity consistent manner was not generally available. Some
variables. This may be because some countries do not countries (such as Switzerland in the case of workforce)
collect these data at national level; because data are opted to indicate “missing data” whenever there were no
collected but cannot be extracted in an aggregate manner; aggregate national data, while others (such as England and
or perhaps – in the case of certain variables (such as Wales in the case of the United Kingdom) indicated the
those associated with population profiles) – because of situation in the regions that represented a larger proportion
inconsistencies between the HIPED indicators and the of the prison population and highlighted any exceptions
countries’ data collection processes and systems (such as whenever appropriate. Others still (such as Germany)
the age cutoff used). delivered a regional report, leaving national aggregation to
be done by HIPP. For this reason, the validity of the country
Comparisons of conditions and risk factors between the profiles of these countries may vary.
incarcerated population and the community at large
4. Limitations 65
5
66 Introduction 66
5. Discussion and conclusions
This report builds on the evidence gathered in a previous (such as insufficient capacity for health service delivery).
report on prison health in the WHO European Region Therefore, it is recommended that alternative measures
published in 2019 (87). Although this earlier report was of incarceration should be considered for offences that
innovative in creating a source of information that explored do not present a high risk to society and for which more
the prison health system, adopting for the most part a effective measures, such as diversion to treatment for drug
health systems perspective, several limitations or caveats use disorders, exist (88).
were nevertheless acknowledged. In particular, there were
difficulties obtaining valid data on behaviours. For example, The aim of Strategic Objective 3, as stated in Annex 3 to the
only 0.5% of Member States reported the proportion of Follow-up to the Political Declaration of the Third High-level
people who were overweight; in the current report, we Meeting of the General Assembly on the Prevention
were able to obtain estimates from 13.9% of Member and Control of Non-communicable Diseases (89), is to
States, which is far from ideal but represents a significant ensure that there is an adequate number, availability and
improvement in countries’ capacity to extract data from distribution of skilled health workers to deliver an essential
their health information systems. A similar improvement package of oral health services to meet population needs.
was seen in other domains described in the Prison Health However, our data showed that there are severe deficiencies
Framework, notably in the morbidity domain. For example, in the number of dentists working in prison, suggesting that
in the previous report 20.5% of Member States were able to additional investments in this skilled workforce are needed.
give the proportion of people diagnosed with hypertension,
while 51.3% and 41.0% did so for TB and HIV, respectively; In addition, the median number of mental health workers,
in the current report, the respective figures for hypertension worldwide, is 13 per 100 000 in the general population.
were 77.8% of Member States, and for TB and HIV 69.4%. However, the current report shows that there are some
Nonetheless, we are aware that, for all morbidity estimates, deficiencies in the ratio between the size of the prison
underreporting is very likely, which suggests that it is a high health workforce and the number of people in prison,
priority to invest in health information systems that particularly with respect to psychiatrists, given the high
allow aggregate data to be extractible, to assist monitoring demand for mental health services in the prison population.
of individuals over time, including at moments of transition According to the Mandela Rules (Rule 25), prisons should
to and from the community. retain a sufficient number of specialists on their staff,
including psychiatrists and psychologists (5). Therefore, it is
Even though we did not ascertain respect for all Mandela important that there is investment in the mental health
Rules, compliance with some of those assessed was workforce in prisons so that equity of care can be assured.
seen in the great majority of Member States (5). However,
there are still improvements needed in ensuring clinical People with disabilities have the right to equal recognition
independence in more than one fifth of Member States. before the law (90). This includes people with intellectual
Moreover, greater investment is needed in assuring equity disabilities, cognitive impairments, psychosocial
in standards of care, for example, by achieving a higher disabilities and other mental disabilities. There are also
ratio of psychiatrists to people in prison. Equally worrying well-established principles to protect persons with mental
is that one fifth of Member States reported overcrowding, illness (91). However, WHO recognizes that some people
which has various negative consequences on health with mental health disorders may be admitted to prison for
both directly (such as violence, mental health impacts relatively minor offences, which could potentially be dealt
and transmission of infectious diseases) and indirectly with in the community if appropriate treatment and support
1. Consider adoption of noncustodial measures in 7. Consider prisons as an ideal setting to ensure access
place of incarceration for offences where diversion to immunization for vaccine-preventable diseases,
to treatment promises to be more beneficial and by providing a full course of vaccination against
effective. HBV, seasonal influenza, DTP and MMR for all newly
admitted people.
2. Invest in the prison health workforce by providing
conditions and career pathways that encourage 8. Create structures that facilitate transition to the
professionals to dedicate themselves to working community and ensure continued access to health
for this vulnerable population. Set up the necessary care.
conditions that allow international standards,
especially clinical independence, to be respected. 9. Invest in health information systems that
allow aggregate data to be extractible, to assist
3. Include prison settings and people living in prison monitoring of individuals over time, including at
in all relevant national health strategies, from moments of transition to and from the community
preparedness plans to prevention of disease (interoperability).
(including immunization and screening) and disease
control and management.
The data collected in HIPEDS represent an important
4. Increase access to psychosocial support and attempt to provide comparable data on prison health
pharmacological treatment for mental health systems in the WHO European Region. This report builds
disorders. on previous findings published in the 2019 Status report on
prison health (87) and lays a foundation for future work to
5. Invest in a comprehensive response to bloodborne generate comprehensive and comparable data on prison
viruses in prisons, which must include at minimum: health in Europe and globally. Interest has been expressed
access to screening for drug use and drug use in expanding HIPEDS to other regions beyond Europe and to
disorders; referral to appropriate support and, if extend its scope to include children in juvenile detention. It
necessary, treatment interventions with referral to has been argued that exclusion of people in prison from the
treatment services for drug use disorders and to PEP; service coverage index contributes to an overestimation of
and access to materials and products that prevent coverage and masks inequities in care, hampering progress
risk factors and unsafe practices contributing to towards the United Nations Sustainable Development
bloodborne, sexual and vertical transmission. Goals (104). However, for full coverage information, health
information systems must progress to the point where
6. Assure screening and referral for breast, cervical and coverage can be consistently assessed before, during and
colorectal cancer in all Member States. after periods of incarceration.
6. Key messages 73
74
References*
1 Global prison trends 2022. London: Penal Reform 11 Stürup-Toft S, O’Moore EJ, Plugge EH. Looking behind
International; 2022 (https://cdn.penalreform.org/ the bars: emerging health issues for people in prison. Br
wp-content/uploads/2022/05/GPT2022.pdf). Med Bull. 2018;125(1):15–23. doi: 10.1093/bmb/ldx052.
2 Prison statistics. Luxembourg City: Eurostat; 12 Leaving no one behind in prison health: the
2022 (https://ec.europa.eu/eurostat/statistics- Helsinki conclusions. Copenhagen: WHO
explained/index.php?title=Prison_statistics). Regional Office for Europe; 2020 (https://apps.
who.int/iris/handle/10665/352128).
3 Incarceration rates in selected European countries in
2021. Hamburg: Statista; 2021 (https://www.statista. 13 High 5s project: standard operating protocol assuring
com/statistics/957501/incarceration-rate-in-europe). medication accuracy at transitions in care. Geneva:
World Health Organization; 2014 (https://cdn.
4 Universal Declaration of Human Rights. New York
who.int/media/docs/default-source/integrated-
(NY): United Nations; 1948 (https://www.un.org/en/
health-services-(ihs)/psf/high5s/h5s-sop.pdf).
about-us/universal-declaration-of-human-rights).
14 Ranapurwala SI, Shanahan ME, Alexandridis AA,
5 United Nations standard minimum rules for the
Proescholdbell SK, Naumann RB, Edwards D Jr et
treatment of prisoners (Mandela Rules). Vienna: United
al. Opioid overdose mortality among former North
Nations Office on Drugs and Crime; 2015 (https://
Carolina inmates: 2000–2015. Am J Public Health.
www.unodc.org/documents/justice-and-prison-
2018;108(9):1207–13. doi: 10.2105/AJPH.2018.304514.
reform/Nelson_Mandela_Rules-E-ebook.pdf).
15 Binswanger IA, Stern MF, Deyo RA, Heagerty PJ,
6 European committee for the prevention of torture and
Cheadle A, Elmore JG et al. Release from prison: a
inhuman or degrading treatment or punishment (CPT)
high risk of death for former inmates. N Engl J Med.
[about page]. Strasbourg: Council of Europe; 2022
2007;356(2):157–65. doi: 10.1056/NEJMsa064115.
(https://www.coe.int/en/web/cpt/about-the-cpt).
16 Waters R. After prison, healthy lives built on access
7 Health care services in prisons. European Committee
to care and community. Health Aff (Millwood).
for the Prevention of Torture and Inhuman or Degrading
2019;38(10):1616–21. doi: 10.1377/hlthaff.2019.01163.
Treatment or Punishment. Strasbourg: Council of
Europe; 1993 (https://rm.coe.int/16806ce943). 17 Wang EA, Hong CS, Shavit S, Sanders R, Kessell E,
Kushel MB. Engaging individuals recently released
8 Reed J, Lyne M. The quality of health care in prison:
from prison into primary care: a randomized
results of a year’s programme of semistructured
trial. Am J Public Health. 2012;102(9):e22–
inspections. BMJ. 1997;315(7120):1420–4.
e29. doi: 10.2105/AJPH.2012.300894.
doi: 10.1136/bmj.315.7120.1420.
18 Wang EA, Lin HJ, Aminawung JA, Busch SH,
9 Fraser A. Primary health care in prisons. In:
Gallagher C, Maurer K et al. Propensity-matched
Moeller L, Stöver H, Jürgens R, Gatherer A, Nikogosian
study of enhanced primary care on contact with the
H et al., editors. Health in prisons: a WHO guide
criminal justice system among individuals recently
to the essentials in prison health. Copenhagen:
released from prison to New Haven. BMJ Open.
WHO Regional Office for Europe; 2007 (https://
2019;9(5):e028097. doi: 10.1136/bmjopen-2018-028097.
apps.who.int/iris/handle/10665/107829).
19 What are social determinants of health? National
10 Tavoschi L, Vroling H, Madeddu G, Babudieri S,
Center for HIV, Viral Hepatitis, STD, and TB
Monarca R, Vonk Noordegraaf-Schouten M et al.
Prevention (NCHHSTP) social determinants of
Active case finding for communicable diseases in
health: frequently asked questions. Atlanta (GA):
prison settings: increasing testing coverage and
Centers for Disease Control and Prevention (https://
uptake among the prison population in the European
www.cdc.gov/nchhstp/socialdeterminants/
Union/European Economic Area. Epidemiol Rev.
faq.html#what-are-social-determinants).
2018;40(1):105–20. doi: 10.1093/epirev/mxy001.
*
All references were accessed on 12 August 2022.
References 75
20 Western B, Pettit B. Incarceration and social 30 Brose LS, Simonavicius E, McNeill A. Maintaining
inequality. Daedalus. 2010;139(3):8–19. abstinence from smoking after a period of enforced
doi: 10.1162/daed_a_00019. abstinence: systematic review, meta-analysis
21 Dolan K, Wirtz AL, Moazen B, Ndeffo-Mbah M, and analysis of behaviour change techniques
Galvani A, Kinner SA et al. Global burden of HIV, with a focus on mental health. Psychol Med.
viral hepatitis, and tuberculosis in prisoners and 2018;48(4):669–78. doi: 10.1017/S0033291717002021.
detainees. Lancet. 2016;388(10049):1089–1102. 31 WHO prison health framework: a framework for
doi: 10.1016/S0140-6736(16)30466-4. assessment of prison health system performance.
Copenhagen: WHO Regional Office for Europe; 2021
22 Hofstraat SHI, Falla AM, Duffell EF, Hahné SJM,
(https://apps.who.int/iris/handle/10665/344561).
Amato-Gauci AJ, Veldhuijzen IK et al. Current
prevalence of chronic hepatitis B and C virus 32 Eurostat [online database]. Luxembourg City:
infection in the general population, blood donors Eurostat (https://ec.europa.eu/eurostat/
and pregnant women in the EU/EEA: a systematic en/web/main/data/database).
review. Epidemiol Infect. 2017;145(14):2873–85. 33 World Prison Brief [online database]. London:
doi: 10.1017/S0950268817001947. Institute for Crime and Justice Policy Research
23 Kamarulzaman A, Reid SE, Schwitters A, Wiessing L, (https://www.prisonstudies.org).
El-Bassel N, Dolan K et al. Prevention of transmission of 34 Global Burden of Disease (GBD) 2019 study results.
HIV, hepatitis B virus, hepatitis C virus, and tuberculosis Seattle (WA): Institute for Health Metrics and Evaluation;
in prisoners. Lancet. 2016;388(10049):1115–26. 2019 (https://vizhub.healthdata.org/gbd-results).
doi: 10.1016/S0140-6736(16)30769-3. 35 Cumulative confirmed COVID-19 deaths by
24 Moazen B, Saeedi Moghaddam S, Silbernagl MA, world region. In: Our World in Data [online
Lotfizadeh M, Bosworth RJ, Alammehrjerdi Z et al. database] (https://ourworldindata.org/
Prevalence of drug injection, sexual activity, tattooing, grapher/cumulative-covid-deaths-region?c
and piercing among prison inmates. Epidemiol Rev. ountry=IND~USA~GBR~CAN~DEU~FRA).
2018;40(1):58–69. doi: 10.1093/epirev/mxy002. 36 Health workforce. Global Health Observatory: themes.
25 Cords O, Martinez L, Warren JL, O’Marr JM, Walter KS, Geneva: World Health Organization; 2022 (https://www.
Cohen T et al. Incidence and prevalence of tuberculosis who.int/data/gho/data/themes/health-workforce).
in incarcerated populations: a systematic review and 37 Health care resources. Eurostat metadata. Luxembourg
meta-analysis. Lancet Public Health. 2021;6(5):e300– City: Eurostat (https://ec.europa.eu/eurostat/
e308. doi: 10.1016/S2468-2667(21)00025-6. cache/metadata/en/hlth_res_esms.htm).
26 Warmsley R. Prison health care and the extent 38 European Health Information Gateway: indicators
of prison overcrowding. Int J Prisoner Health. explorer. Copenhagen: WHO Regional Office for Europe;
2005;1(1):3–12. doi: 10.1080/17449200500156897. 2022 (https://gateway.euro.who.int/en/hfa-explorer).
27 Baranyi G, Fazel S, Langerfeldt SD, Mundt AP. 39 Global prison trends 2022: executive summary.
The prevalence of comorbid serious mental London: Penal Reform International; 2022
illnesses and substance use disorders in prison (https://cdn.penalreform.org/wp-content/
populations: a systematic review and meta- uploads/2022/05/GPT2022-Exec-summary-EN.pdf).
analysis. Lancet Public Health. 2022;7(6):e557– 40 Wang EA, Pletcher M, Lin F, Vittinghoff E, Kertesz SG,
e568. doi: 10.1016/S2468-2667(22)00093-7. Kiefe CI et al. Incarceration, incident hypertension,
and access to health care: findings from the
28 Gebremariam MK, Nianogo RA, Arah OA.
Coronary Artery Risk Development in Young Adults
Weight gain during incarceration: systematic
(CARDIA) study. Arch Intern Med. 2009;169(7):687–
review and meta-analysis. Obes Rev.
93. doi: 10.1001/archinternmed.2009.26.
2018;19(1):98–110. doi: 10.1111/obr.12622.
41 HIV prevention, treatment and care in prisons and
29 Munday D, Leaman J, O’Moore É, Plugge E. The other closed settings: a comprehensive package
prevalence of non-communicable disease in of interventions. Vienna: United Nations Office
older people in prison: a systematic review and on Drugs and Crime; 2013 (https://www.unodc.
meta-analysis. Age Ageing. 2019;48(2):204– org/documents/hiv-aids/HIV_comprehensive_
12. doi: 10.1093/ageing/afy186. package_prison_2013_eBook.pdf).
References 77
63 Chacowry Pala K, Baggio S, Tran NT, 73 Lagarrigue A, Ajana S, Capuron L, Féart C, Moisan
Girardin F, Wolff H, Gétaz L. Blood-borne and MP. Obesity in French inmates: gender differences
sexually transmitted infections: a cross-sectional and relationship with mood, eating behavior and
study in a Swiss prison. BMC Infect Dis. physical activity. PLoS One. 2017;12(1):e0170413.
2018;18(1):539. doi: 10.1186/s12879-018-3445-6. doi: 10.1371/journal.pone.0170413.
64 Kim H, Hughes E, Cavanagh A, Norris E, 74 Audi C, Santiago SM, Andrade M,
Gao A, Bondy SJ et al. The health impacts of the Assumpção D, Francisco P, Segall-Corrêa AM et al.
COVID-19 pandemic on adults who experience Ultra-processed foods consumption among inmates
imprisonment globally: a mixed methods in a women’s prison in São Paulo, Brazil. Rev Esp
systematic review. PLoS One. 2022;17(5):e0268866. Sanid Penit. 2018;20(3):87–94. PMID: 30908571.
doi: 10.1371/journal.pone.0268866. 75 Herbert K, Plugge E, Foster C, Doll H. Prevalence
65 Akaji E, Ashiwaju M. Oral health status of a sample of risk factors for non-communicable diseases
of prisoners in Enugu: a disadvantaged population. in prison populations worldwide: a systematic
Ann Med Health Sci Res. 2014;4(4):650–3. review. Lancet. 2012;379(9830):1975–82.
doi: 10.4103/2141-9248.139365. doi: 10.1016/S0140-6736(12)60319-5.
66 Steel Z, Marnane C, Iranpour C, Chey T, Jackson 76 Choudhry K, Armstrong D, Dregan A. Systematic
JW, Patel V et al. The global prevalence of review into obesity and weight gain within male
common mental disorders: a systematic review prisons. Obes Res Clin Pract. 2018;12(4):327–
and meta-analysis 1980–2013. Int J Epidemiol. 35. doi: 10.1016/j.orcp.2018.02.003.
2014;43(2):476–93. doi: 10.1093/ije/dyu038. 77 Alokan DS, Kabir Z. Tobacco use among
67 Baranyi G, Scholl C, Fazel S, Patel V, Priebe S, Mundt people incarcerated in western Europe: a
AP. Severe mental illness and substance use disorders systematic review and meta-analysis. Tob
in prisoners in low-income and middle-income Use Insights. 2022;15:1179173X221096641.
countries: a systematic review and meta-analysis of doi: 10.1177/1179173X221096641.
prevalence studies. Lancet Glob Health. 2019;7(4):e461– 78 Fazel S, Bains P, Doll H. Substance abuse
e471. doi: 10.1016/S2214-109X(18)30539-4. and dependence in prisoners: a systematic
68 Fazel S, Yoon IA, Hayes AJ. Substance use review. Addiction. 2006;101(2):181–91.
disorders in prisoners: an updated systematic doi: 10.1111/j.1360-0443.2006.01316.x.
review and meta-regression analysis in recently 79 Global status report on alcohol and health 2018.
incarcerated men and women. Addiction. Geneva: World Health Organization; 2018 (https://
2017;112(10):1725–39. doi: 10.1111/add.13877. apps.who.int/iris/handle/10665/274603).
69 EU population in 2020: almost 448 million 80 World drug report 2022. Vienna: United Nations
[news release]. Luxembourg City: Eurostat; Office on Drugs and Crime; 2022 (https://
2020 (https://ec.europa.eu/eurostat/ www.unodc.org/unodc/en/data-and-
documents/2995521/11081093/3- analysis/world-drug-report-2022.html).
10072020-AP-EN.pdf/d2f799bf-4412-05cc-
81 Global action plan on physical activity 2018–2030:
a357-7b49b93615f1#:~:text=On%201%20
more active people for a healthier world. Geneva:
January%202020%2C%20the,States%20
World Health Organization; 2018 (https://apps.
on%201%20January%202019).
who.int/iris/handle/10665/272722).
70 Rabe K. Prison structure, inmate mortality and
82 Why people living and working in detention
suicide risk in Europe. Int J Law Psychiatry.
facilities should be included in national COVID-19
2012;35(3):222–30. doi: 10.1016/j.ijlp.2012.02.012.
vaccination plans: advocacy brief. Copenhagen:
71 Solitary confinement. London: Penal Reform WHO Regional Office for Europe; 2021 (https://
International (https://www.penalreform.org/issues/ apps.who.int/iris/handle/10665/341497).
prison-conditions/key-facts/solitary-confinement).
83 Pont J, Enggist S, Stöver H, Williams B, Greifinger R,
72 Global prison trends 2021: solitary confinement. Wolff H. Prison health care governance: guaranteeing
London: Penal Reform International; 2021 clinical independence. Am J Public Health.
(https://www.penalreform.org/global-prison- 2018;108(4):472–6. doi: 10.2105/AJPH.2017.304248.
trends-2021/solitary-confinement).
References 79
80 Introduction 80
Annex 1. Country profiles
United Kingdom
4917
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
3579
82
Albania
23
Number of prison
n %
establishments
Females 77 1.6
in the country
Pregnant 0 0.0
LGBTIQ 2 0.0
Mean length of incarceration per individual Under 18 21 0.4
over the last 12-month period: MISSING Above 50 863 17.6
Above 65 174 3.5
Unsentenced and serving life Migrants 87 1.8
sentences individuals: Minorities MISSING MISSING
FTE
Nurses 159
Physicians 48
Psychiatrists 6
Dentists 20
83
Albania
ACCEPTABILITY
QUALITY OF CARE
Yes/No % Member States with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
84
Albania
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs).
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
85
Albania
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
86
Albania
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 2 (7.7)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same
reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same
reference year.
87
Albania
D: HEALTH OUTCOMES
Mental health
disorders
Cancer HEALTH AND WELL-BEING
REHABILITATION
Access to: MORTALITY
Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
programmes opportunities
75.0 88.9
88
Albania
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 0 (0.0)
HIV
Active HIV diagnosis 8 (0.2)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 26 (0.5)
Hepatitis B
Chronic HBV (HBsAg) 31 (0.6)
COVID-19
SARS-Co-V2 infection laboratory confirmed 142 (2.9)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 157 (3.2)
Hypertension
Diagnosis on record 228 (4.6)
Cardiovascular Disease
Diagnosis on record 97 (2.0)
Cancer
Diagnosis on record 10 (0.2)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
89
Albania
E: PRISON ENVIRONMENT
A minority
Offered at Most prisons Most prisons Most prisons
of prisons
F: HEALTH BEHAVIOURS
90
Albania
91
Armenia 2 959 694
Population, 2020
Upper middle
Income group
US$ 4 266
Gross national income per capita
1042
92
Armenia
12
Number of prison
n %
establishments
Females 46 2.3
in the country
Pregnant 3 6.5
Under 18 5 0.3
Mean length of incarceration per individual
Above 50 MISSING MISSING
over the last 12-month period: MISSING
Above 65 MISSING MISSING
FTE
Nurses 76
Physicians 56
Psychiatrists 6
Dentists 8
93
Armenia
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
NO
Standardized process for reporting 41.7
medication errors in prisons
NO
Standardized process for reporting 55.6
adverse drug events in prisons
94
Armenia
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs).
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
95
Armenia
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
96
Armenia
Hepatitis B
0 (0.0)
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period 1439 (73.2)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 60 (100.0)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 311 (100.0)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 311 (100.0)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 311 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is c alculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference
year.
97
Armenia
MORTALITY
Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
In all prisons In all prisons incarcerated (general pop.)
people
98
Armenia
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 6 (0.3)
HIV
Active HIV diagnosis 27 (1.4)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 308 (15.7)
Hepatitis B
Chronic HBV (HBsAg) 15 (0.8)
COVID-19
SARS-Co-V2 infection laboratory confirmed 39 (2.0)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 60 (3.1)
Hypertension
Diagnosis on record 311 (15.8)
Cardiovascular Disease
Diagnosis on record 311 (15.8)
Cancer
Diagnosis on record 20 (1.0)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where
data has been provided for the same reference year.
99
Armenia
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
100
Armenia
YES
Yes, and they are repeated YES
at regular intervals
101
Austria 8 901 064
Population, 2020
High
Income group
US$ 48 588
Gross national income per capita
8626
102
Austria
Under 18 85 1.0
Mean length of incarceration per individual
Above 50 1 364 16.1
over the last 12-month period: 27 months
Above 65 224 2.6
Migrants 4 292 50.6
Unsentenced and serving life
Minorities MISSING MISSING
sentences individuals:
n (%) Disabled MISSING MISSING
Number of unsentenced/remand prisoners 1684 (19.9)
Number of individuals serving life sentences 147 (1.7) Physically disabled MISSING MISSING
Figure 3.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
Nurses 233.7
a
Source: Eurostat (2020)
Physicians 24.8
Psychiatrists 12.8
Dentists Missing
ACCEPTABILITY
Proportion of prison establishments where these are available to be administered to eligible prisoners:
QUALITY OF CARE
104
Austria
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs.
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
105
Austria
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
106
Austria
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 6(-) a
Individuals completing TB treatment over the last 12-month period 6 (100.0)
Multidrug-resistant Tuberculosis (MDRTB)
Individuals receiving MDR-TB treatment over the last 12-month period 1(-) a
Individuals completing MDR-TB treatment over the last 12-month period 1 (100.0)
HIV
Individuals with HIV who received treatment over the last 12-month period 201 (100.0)
Individuals completing HIV treatment over the last 12-month period 201 (100.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 64 (7.8)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 64 (100.0)
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 245 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 245 (100.0)
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 35 (100.0)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 35 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 14 (100.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
107
Austria
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer Assessments of perceived well-being (or
disorders
life satisfaction): No, it has never been done.
Assessments conducted regularly were reported by
19.4% of Member States (n = 7).
In all prisons In all prisons
MORTALITY
REHABILITATION Total Mortality Mortality
mortality rates per rates per
Access to: 100 000 100 000 people
incarcerated (general pop.)
people
Total deaths 29 341.9 1139.3 a
108
Austria
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 6 (0.1)
HIV
Active HIV diagnosis 201 (2.4)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 824 (9.7)
Hepatitis B
Chronic HBV (HBsAg) 245 (2.9)
COVID-19
SARS-Co-V2 infection laboratory confirmed 175 (2.1)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 130 (1.5)
Hypertension
Diagnosis on record 340 (4.0)
Cardiovascular Disease
Diagnosis on record 35 (0.4)
Cancer
Diagnosis on record 14 (0.2)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where
data has been provided for the same reference year.
109
Austria
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Currently use tobacco products 6285 (74.1) 5916 (74.6) 370 (67.1)
Use/have used drugs (last 12 months) 3350 (39.5) 3172 (40) 182 (32.9)
Clarification: Absolute numbers estimated from reported percentages, females and total number of people living in prison.
110
Austria
111
Belgium 11 522 440
Population, 2020
High
Income group
US$ 45 189
Gross national income per capita
10 381
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
MISSING
Number of individuals serving life sentences 222 (2.1) Physically disabled MISSING MISSING
Figure 4.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
Nurses 205
8
Physicians 30
a
Source: Eurostat (2019)
Psychiatrists 17
8
Dentists 10
ACCEPTABILITY
Proportion of prison establishments where these are available to be administered
to eligible prisoners:
Offered at % Member States with “All prisons”
DTP All prisons 55.9
Human Papilloma virus All prisons 69.4
Hepatitis A All prisons 83.3
Hepatitis B All prisons 61.8
Seasonal flu All prisons 52.9
MMR All prisons 57.6
Meningococcal vaccination All prisons 91.4
Pneumococcal vaccination All prisons 57.6
COVID-19 All prisons 91.4
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on NO 88.9
the availability of essential medicines
114
Belgium
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases legally
required (notifiable diseases). Public
health authorities being informed for
both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
115
Belgium
Note: cancer screening was indicated to be performed whenever indicated by the physician or on request of the patient if considered useful by the physician.
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
116
Belgium
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 13 (-) a
Individuals completing TB treatment over the last 12-month period 8 (61.5)
Multidrug-resistant Tuberculosis (MDRTB)
Individuals receiving MDR-TB treatment over the last 12-month period 1 (-) a
Individuals completing MDR-TB treatment over the last 12-month period 1 (100.0)
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 54 (missing)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
117
Belgium
118
Belgium
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 9 (0.1)
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
SARS-Co-V2 infection laboratory confirmed 1271 (12.2)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where
data has been provided for the same reference year.
119
Belgium
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Data recorded in individual electronic clinical files but not available for extraction in aggregate manner.
120
Belgium
YES NO
121
Bosnia and 3 280 815 Upper middle US$ 6 082
Herzegovina Population, 2020 Income group Gross national income per capita
2374
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
2535
122
Bosnia and
Herzegovina
14
Number of prison
establishments n %
in the country Females 60 2.5
Pregnant 1 1.7
LGBTIQ 3 0.1
Mean length of incarceration per individual Under 18 3 0.1
over the last 12-month period: 40 months Above 50 319 13.4
Above 65 148 6.2
Unsentenced and serving life Migrants 132 5.6
Minorities 53 2.2
sentences individuals:
n (%) Disabled 142 6.0
Number of unsentenced/remand prisoners 218 (9.2) Physically disabled 134 94.4
Intellectually disabled 8 5.6
Not legally permitted
Number of individuals serving life sentences
in the country
FTE
Total staff 90
Nurses 64
Physicians 22
Psychiatrists 3
Dentists 6
123
Bosnia and
Herzegovina
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
124
Bosnia and
Herzegovina
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs. Public
health authorities being informed for
both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
125
Bosnia and
Herzegovina
% Member States
with “Yes 66.7 58.3 66.7
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
126
Bosnia and
Herzegovina
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period 2 (66.7)
Individuals completing HIV treatment over the last 12-month period 2 (100.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 13 (26.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 6 (46.2)
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 4 (36.4)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 2 (50.0)
Sexually Transmitted Infections (STIs)
Individuals with STIs who received treatment over the last 12-month period 1 (25.0)
Individuals completing STI treatment over the last 12-month period 1 (100.0)
Oral health
Individuals with oral health visit over the last 12-month period 1856 (78.2)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 492 (92.7)
Cardiovascular Disease
322 (90.4)
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 356 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 16 (80.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
127
Bosnia and
Herzegovina
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being (or life
satisfaction):
Yes, regularly (for example once every year or
In all prisons In all prisons
once every two years). Assessments conducted
regularly were reported by 19.4% of Member States
(n = 7).
% Member States with “All prisons”
Access to mental health counsellors:
Mental health disorders Cancer In most prisons. Having mental health counsellors
86.1 83.3 in all prisons was reported by 72.2% of Member
States (n =36).
REHABILITATION MORTALITY
Access to: Total Mortality rates Mortality
mortality per 100 000 rates per
incarcerated 100 000 people
people (general pop.)
Total deaths 22 926.7 1482.9 a
Suicide 3 126.4 27.1 a
Drug overdose 0 0.0 0.5 a
Education and training Employment COVID-19 3 126.4 124.1 b
programmes opportunities Cardiovascular 2 84.3 678.2 a
disease
a
Source: Global Burden of Disease database, according to the most recent data available
In most prisons In most prisons (2019), (As the female prison population is 2.5%, the general population data is given only for
males over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source)
% Member States with “All prisons”
128
Bosnia and
Herzegovina
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 3 (0.1)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 50 (2.1)
Hepatitis B
Chronic HBV (HBsAg) 11 (0.5)
COVID-19
SARS-Co-V2 infection laboratory confirmed 164 (6.9)
Oral health
Individuals keeping 21 or more natural teeth 532 (22.4)
Diabetes Mellitus
Diagnosis on record 185 (7.8)
Hypertension
Diagnosis on record 531 (22.4)
Cardiovascular Disease
Diagnosis on record 356 (15.0)
Cancer
Diagnosis on record 20 (0.8)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
129
Bosnia and
Herzegovina
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Use/have used drugs (last 12 months) 178 (7.5) 173 (7.5) 5 (8.3)
130
Bosnia and
Herzegovina
YES
Yes, and they are repeated YES
at regular intervals
131
Bulgaria 6 951 482 Upper middle US$ 10 079
Population, 2021 Income group Gross national income per capita
6251
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
5287
132
Bulgaria
Number of prison
establishments
in the country
12 Social characterization of people in prison
n %
Females 192 3.1
Pregnant MISSING MISSING
Under 18 30 0.5
Mean length of incarceration per individual
Above 50 936 15.0
over the last 12-month period: MISSING
Above 65 MISSING MISSING
Number of individuals serving life sentences 186 (3.0) Intellectually disabled MISSING MISSING
Figure 6.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
9.1
Total staff 206
33.0
Nurses 65 4.4
10.4
Physicians 23 a
Source: Eurostat (2019)
3.7
3 0.1
Psychiatrists 0.5
1.1
Dentists 6
1.0
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
134
Bulgaria
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs).
Public health authorities being informed
for both IDs and for NCDs was reported Information registered in clinical records:
by 45.5% of Member States (n =33).
% Member
Keep clinical health records Yes/No States with
of people in prison: “Yes”
Yes, in some prisons we keep paper- Screening tests performed YES 91.7
based clinical health-records and in Screening tests results YES 94.4
others we keep electronic clinical
Vaccination 97.2
health records. Electronic clinical health YES
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
135
Bulgaria
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
136
Bulgaria
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 25 (missing)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
137
Bulgaria
D: HEALTH OUTCOMES
Mental health
disorders
Cancer HEALTH AND WELL-BEING
Assessments of perceived well-being (or life
satisfaction):
Yes, on an ad hoc basis. Assessments conducted
In all prisons In all prisons
regularly were reported by 19.4% of Member States
(n = 7).
% Member States with “All prisons”
Access to mental health counsellors:
Mental health disorders Cancer In all prisons. Having mental health counsellors in
86.1 83.3 all prisons was reported by 72.2% of Member States
(n =36).
REHABILITATION MORTALITY
Access to: Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
138
Bulgaria
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 2 (0.0)
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
MISSING
SARS-Co-V2 infection laboratory confirmed
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
139
Bulgaria
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Though these indicators are recorded in the clinical file of each inmate, the country could not provide an aggregate value that can be reported here.
140
Bulgaria
YES NO
141
Croatia 4 058 165
Population, 2020
High
Income group
US$ 14 132
Gross national income per capita
3531
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
2185
142
Croatia
23
Number of prison
n %
establishments
in the country Females 188 5.3
Pregnant 2 1.1
Mean length of incarceration per individual LGBTIQ MISSING MISSING
over the last 12-month period: MISSING
Under 18 32 0.9
Figure 7.2: Health-care staff a available in prison and in the general population
Ratio per 1000 people
FTE 0 10 20 30 40 50
10.9
Total staff 151
42.8
Nurses 84 6.8 a
Outsourced medical staff
23.8 working only part-time not
included. Therefore, data is
Physicians 28 3.5 not comparable with
7.9 other profiles.
b
Source: Eurostat (2019)
Psychiatrists 7 0.2
2.0
Dentists 0.9
4
1.1
143
Croatia
ACCEPTABILITY
Proportion of prison established with vaccines available:
a
In general, prisoners have access to health care
and treatment measures in the same extent as other
% Member States with “All prisons” citizens. Therefore, if prison health-care cannot
provide some measure within the prison system it is
Post Exposure a Pre-exposure provided in the public health system, including HIV
postexposure prophylaxis (PEP). So, in all prisons,
77.8 58.3 PEP would be available for prisoners, if necessary.
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
144
Croatia
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs).
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
145
Croatia
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
146
Croatia
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period MISSING
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
147
Croatia
MORTALITY
In most prisons In all prisons a Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
% Member States with “All prisons” incarcerated (general pop.)
people
a
In all prisons but limited depending to the size and type of prison Drug overdose 0 0.0 2.9 a
148
Croatia
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
MISSING
Active TB diagnosis
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
MISSING
SARS-Co-V2 infection laboratory confirmed
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
149
Croatia
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Records are kept in each prisoner’s individual medical file. However, no records for requested diagnosis are kept on national level, so the data could only be
extracted by manually searching the individual files.
150
Croatia
YES
NO NO
a
Only if women ask for the test, or the medical doctor indicates testing
151
Cyprus 888 005
Population, 2020
High
Income group
US$ 27 681
Gross national income per capita
1670
152
Cyprus
5
Number of prison
n %
establishments
Females 30 5.0
in the country
Pregnant 0 0.0
LGBTIQ 1 0.2
Under 18 4 0.7
Mean length of incarceration per individual over
Above 50 MISSING MISSING
the last 12-month period: MISSING
Above 65 MISSING MISSING
Number of individuals serving life sentences 25 (4.2) Intellectually disabled MISSING MISSING
Figure 8.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
Total staff 29
48.2
5.5
Nurses 17.5
29.9
4.3
Physicians 3
5.0 a
Source: Eurostat (2019)
Psychiatrists 1 0.1
1.7
Dentists 1 1.1
1.7
153
Cyprus
ACCEPTABILITY
Proportion of prison establishments where these are available to be administered to eligible prisoners:
QUALITY OF CARE
Yes/No % Member States with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
154
Cyprus
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs. Public
health authorities being informed for
both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
155
Cyprus
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
156
Cyprus
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period 881 (146.3)
Mental health disorders
Individuals who have received treatment for any mental health disorder over the last 12-month period 260 (missing)
Substance Use Disorders
Individuals who have received pharmacological treatment for a substance use disorder over the last 12-month period 114 (missing)
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period 49 (missing)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits (excluding ophthalmology and 9 (100.0)
other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period 9 (100.0)
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 9 (100.0)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 50 (100.0)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 3 (100.0)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 3 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 1 (100.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
157
Cyprus
MORTALITY
Total Mortality rates Mortality
In all prisons In all prisons mortality per 100 000 rates per
incarcerated 100 000 people
people (general pop.)
158
Cyprus
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 4 (0.7)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 13 (2.2)
Hepatitis B
Chronic HBV (HBsAg) 0 (0.0)
COVID-19
SARS-Co-V2 infection laboratory confirmed 0 (0.0)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 9 (1.5)
Hypertension
Diagnosis on record 50 (8.3)
Cardiovascular Disease
Diagnosis on record 3 (0.5)
Cancer
Diagnosis on record 1 (0.2)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
159
Cyprus
E: PRISON ENVIRONMENT
a
Prisoners can use exercise facilities every day
b
Besides the normal menu, 7 different menus meeting religion, health and vegetarian needs are offered.
F: HEALTH BEHAVIOURS
Clarification: Even though health behaviours are evaluated during the initial interview but are not kept in a database. They are kept in the personal files of the inmates. These
evaluations help the administration on their decision inter alia regarding the distribution (allocation) of the inmates to wings and specifically to cells with inmates that they have
compatible features and needs in order to make their accommodation more comfortable and reduce any stressful factors.
160
Cyprus
YES
Yes, and they are repeated YES
at regular intervals
161
Czechia 10 693 939
Population, 2020
High
Income group
US$ 22 933
Gross national income per capita
19286
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
9251
162
Czechia
35
Number of prison
n %
establishments
Females 1 574 8.2
in the country
Pregnant MISSING MISSING
Under 18 44 0.2
Mean length of incarceration per individual over
Above 50 3 023 15.7
the last 12-month period: MISSING
Above 65 337 1.8z
Migrants 1 531 7.9
Unsentenced and serving life
Minorities MISSING MISSING
sentences individuals:
n (%) Disabled MISSING MISSING
Figure 9.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE 0 5 10 15 20 25
15.4
Total staff 480.1
24.9
8.6
Nurses 348.6
18.1
4.1
Physicians 131.5 6.8 a
Source: Eurostat (2019)
0.2
Psychiatrists 4.6 0.2
0.7
Dentists 20.4 1.1
163
Czechia
ACCEPTABILITY
Proportion of prison established with vaccines available:
In no prisons In no prisons
QUALITY OF CARE
Yes/No % Member States with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
164
Czechia
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs. Public
health authorities being informed for
both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
165
Czechia
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
166
Czechia
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 3 (-) a
Individuals completing TB treatment over the last 12-month period 2 (66.7)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 213 (37.4)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 29 (85.3)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period 131(missing)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits (excluding ophthalmology MISSING
MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same ref-
erence year.
167
Czechia
D: HEALTH OUTCOMES
Mental health
disorders
Cancer HEALTH AND WELL-BEING
Assessments of perceived well-being (or life
satisfaction):
Yes, on an ad hoc basis. Assessments conducted
In all prisons In all prisons
regularly were reported by 19.4% of Member States
(n = 7).
% Member States with “All prisons”
Access to mental health counsellors:
Mental health disorders Cancer
In all prisons. Having mental health counsellors in
86.1 83.3 all prisons was reported by 72.2% of Member States
(n =36).
REHABILITATION MORTALITY
Total Mortality rates Mortality
Access to: mortality per 100 000 rates per
incarcerated 100 000 people
people (general pop.)
168
Czechia
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 3 (0.0)
HIV
Active HIV diagnosis 52 (0.3)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 570 (3.0)
Hepatitis B
Chronic HBV (HBsAg) 34 (0.2)
COVID-19
MISSING
SARS-Co-V2 infection laboratory confirmed
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
169
Czechia
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Although all data are recorded in individual electronic clinical files, the coding system used does not allow extraction in aggregate manner. The only exception is
drug use (including alcohol), because these behaviors are monitored throughout imprisonment.
170
Czechia
171
Denmark 5 822 763
Population, 2020
High
Income group
US$ 61 063
Gross national income per capita
9132
172
Denmark
55
Number of prison
n %
establishments
Females 185 4.5
in the country
Pregnant MISSING MISSING
Under 18 9 0.2
Mean length of incarceration per individual over
Above 50 474 11.6
the last 12-month period: MISSING
Above 65 MISSING MISSING
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) on
full-time equivalents (FTEs) and ratio (per 1000 people) for a known year:
Figure 10.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
30.8
Total staff 103
25.2
Nurses 71 10.1
17.4
Physicians 4.2
13 a
Source: Eurostat (2018)
3.2
Psychiatrists 0.2
0 0.0
Dentists 0.7
2
0.5
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
Yes/No % Member States with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
174
Denmark
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs. Public
health authorities being informed for
both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
175
Denmark
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
176
Denmark
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period MISSING
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period 0 (0.0)
Mental health disorders
Individuals who have received treatment for any mental health disorder over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Data recorded in individual health journals but not available for extraction in aggregate manner due to data confidentiality.
177
Denmark
a
Source: Global Burden of Disease database, according to the most recent data available
(2019), (As the female prison population is 4.5%, the general population data is given only for
People are allowed to continue their family males over 20 years)
relationships by web communication: b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
No. Most Member States report “Yes, with available in open source).
178
Denmark
MORBIDITY
Number and proportion of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
MISSING
Active TB diagnosis
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
MISSING
SARS-Co-V2 infection laboratory confirmed
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
Clarification: Data recorded in individual health journals but not available for extraction in aggregate manner due to data confidentiality.
179
Denmark
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Data recorded in individual health journals but not available for extraction in aggregate manner due to data confidentiality.
180
Denmark
181
Estonia 1 328 889
Population, 2020
High
Income group
US$ 23 054
Gross national income per capita
2341
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
644
182
Estonia
3
Number of prison
n %
establishments
Females 96 4.1
in the country
Pregnant MISSING MISSING
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) on
full-time equivalents (FTEs) and ratio (per 1000 people) for a known year:
Figure 11.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE 0 10 20 30 40 50
13.1
Total staff 108.7
46.5
Nurses 60 6.3
25.6
3.5
Physicians 16.5 a
Source: Eurostat (2019)
7.1
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
Yes/No % Member States with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
184
Estonia
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
No. Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
185
Estonia
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
186
Estonia
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 5 (-) a
Individuals completing TB treatment over the last 12-month period 5 (100.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 136 (24.4)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 3 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Data on NCD diagnoses and treatment is recorded in individual clinical files but not available for extraction in aggregate manner.
187
Estonia
(2019), (As the female prison population is 4.1%, the general population data is given only for
males over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source).
188
Estonia
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 5 (0.2)
HIV
Active HIV diagnosis 254 (10.9)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 558 (23.8)
Hepatitis B
Chronic HBV (HBsAg) 3 (0.1)
COVID-19
SARS-Co-V2 infection laboratory confirmed 231 (9.9)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
Clarification: Data on NCD diagnoses and treatment is recorded in individual clinical files but not available for extraction in aggregate manner.
189
Estonia
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
a
Reported as zero as consequence of the smoke free policy implemented in prisons nationwide.
Clarification: Data on NCD diagnoses and treatment is recorded in individual clinical files but not available for extraction in aggregate manner.
190
Estonia
YES NO
191
Finland 5 525 292
Population, 2020
High
Income group
US$ 49 160
Gross national income per capita
2595
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
5278
192
Finland
26
Number of prison
n %
establishments
Females 182 7.4
in the country
Pregnant MISSING MISSING
sentences individuals:
n (%) Minorities MISSING MISSING
Figure 12.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE 0 10 20 30 40 50 60 70 80
37.0
Total staff 190 73.2
14.1
Nurses 127 48.9
3.2
Physicians 6 2.3 a
Source: Eurostat (2014)
0.2
Psychiatrists
6 2.3
Dentists 0.7
5 1.9
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
Yes/No % Member States with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
194
Finland
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs. Public
health authorities being informed for
both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
195
Finland
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
196
Finland
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period MISSING
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
Clarification: Although data are recorded in individual electronic clinical files but not available for extraction in aggregate manner.
197
Finland
198
Finland
MORBIDITY
Number and proportion of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
MISSING
Active TB diagnosis
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
MISSING
SARS-Co-V2 infection laboratory confirmed
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
Clarification: Although data are recorded in individual electronic clinical files but not available for extraction in aggregate manner.
199
Finland
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Although data are recorded in individual electronic clinical files but not available for extraction in aggregate manner.
200
Finland
YES
Yes, and they are repeated YES
at regular intervals
201
France 66 859 768
Population, 2020
High
Income group
US$ 38 780
Gross national income per capita
62673
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
138711
202
France
188
Number of prison
n %
establishments
Females 791 1.3
in the country
Pregnant MISSING MISSING
Figure 13.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE 0 10 20 30 40 50
Nurses 1 414.0
22.6
203
France
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
Yes/No % Member States with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
204
France
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
No 1. Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
1
Clarification: In France, the law provides for the creation of an information
system to identify people with notifiable diseases (article L3113-1 of the public
health code). These are subject to the mandatory transmission of individual
data to the health authority by doctors and managers of public and private
medical biology services and laboratories. However, there is no operating
system for notifiable diseases specific to the penitentiary environment.
Information registered in clinical records:
% Member
Yes/No States with
“Yes”
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
205
France
HEALTH PROTECTION
Products offered free of charge:
% Member States
with “All prisons” 97.2 47.1 12.1 8.3
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
206
France
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period MISSING
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
MISSING
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
Clarification: In France, the law provides for the creation of an information system to identify people with notifiable diseases. The rest is subject to medical secrecy.
207
France
MORTALITY
Total Mortality rates Mortality
mortality per 100 000 rates per
In all prisons In most prisons incarcerated 100 000 people
people (general pop.)
208
France
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 34 (0.1)
HIV
Active HIV diagnosis 1381 (2.2)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 3248 (5.2)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
SARS-Co-V2 infection laboratory confirmed 1173 (1.9)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 2707 (4.3)
Hypertension
Diagnosis on record 10828 (17.3)
Cardiovascular Disease
Diagnosis on record 4737 (7.6)
Cancer
Diagnosis on record 1354 (2.2)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
Clarification: In France, the law provides for the creation of an information system to identify people with notifiable diseases. The rest is subject to medical secrecy. Therefore, all
data reported is extracted from ad-hoc studies published in the scientific literature (selected by the prison focal point).
209
France
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: In France, the law provides for the creation of an information system to identify people with notifiable diseases. The rest is subject to medical secrecy. “Any person treated by a
health professional or a health establishment has the right to respect for his private life and to the secrecy of medical information concerning him.” (Regulation No. 2016/679 of the European
Parliament and of the Council of April 27, 2016). Although the prison focal point provided data from the Ministry of Social Affairs and Health for the proportion of individuals in prison smoking
and drinking, these data were not considered as it was from 2012.
210
France
YES NO MISSING
211
Georgia 3 716 858
Population, 2020
Upper middle
Income group
US$ 4 255
Gross national income per capita
9143
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
6918
212
Georgia
Number of prison
establishments
in the country
13 Social characterization of people in prison
Females 333
n %
3.6
Pregnant 2 0.6
Number of individuals serving life sentences 73 (0.8) Intellectually disabled MISSING MISSING
FTE
Psychiatrists 12 1.3
Dentists 9 1.0
213
Georgia
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
214
Georgia
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs. Public
health authorities being informed for
both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
215
Georgia
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
216
Georgia
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 47 (-) a
Individuals completing TB treatment over the last 12-month period 24 (51.1)
HIV
Individuals with HIV who received treatment over the last 12-month period 90 (100.0)
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 320 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 308 (96.2)
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 1 (2.2)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 0 (0.0)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 180 (100.0)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 526 (100.0)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period 38 (100.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
217
Georgia
D: HEALTH OUTCOMES
Mental health
disorders
Cancer HEALTH AND WELL-BEING
Assessments of perceived well-being (or life
satisfaction):
Yes, regularly (for example once every year or
In all prisons In all prisons
once every two years). Assessments conducted
regularly were reported by 19.4% of Member States
% Member States with “All prisons” (n = 7).
REHABILITATION
Access to: MORTALITY
Total Mortality rates Mortality
mortality per 100 000 rates per
incarcerated 100 000 people
people (general pop.)
218
Georgia
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 90 (1.0)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 320 (3.5)
Hepatitis B
Chronic HBV (HBsAg) 45 (0.5)
COVID-19
SARS-Co-V2 infection laboratory confirmed 12 (0.1)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 180 (2.0)
Hypertension
Diagnosis on record 526 (5.8)
Cardiovascular Disease
Diagnosis on record 204 (2.2)
Cancer
Diagnosis on record 38 (0.4)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
219
Georgia
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: SPS is currently working on the new advanced IT infrastructure where medical module will be covered. Hence, in the future we will be in a position to include and
provide indicated data on health behaviors.
220
Georgia
YES
Yes, and they are repeated YES
at regular intervals
221
Germany 83 166 711
Population, 2020
High
Income group
US$ 46 252
Gross national income per capita
58004
Methodological note: Germany is divided into 16 federal states (Länder), who have the competence for legislation on prison law and for the execution of the prison sentence. Therefore, the
focal point has considered more correct to provide an answer per federal state, which was analysed independently and then aggregated. Aggregation was conducted taking three approaches,
depending on the type of variable: Nominal or dichotomous variables (e.g., yes/no): assuming the response of most Länder and indicating in the profile how many Länder gave such an
answer. Whenever there are exceptions believed to be relevant, these are indicated as a comment or footnote to the data presented.
Ordinal data (e.g., all prisons, most prisons…): an intermediate response was considered to account for the diversity of federal states, with extreme answers (all prisons vs no prisons) only
being assumed in case answered by all federal states.
Numerical data (mortality, morbidity and behaviors), a similar approach could not be used because most federal states provided no data. Therefore, two types of data have been used:
a. Published data from external sources indicating the federal state and year it refers to, and also indicating the proportion of prison population covered (as indicated by World Prisons Brief).
b. Whenever data has been reported by federal states, the sum of federal states providing complete answers is given and using the sum of population as denominator to estimate proportions.
In certain variables, when the national response for Germany is presented, a comparison is made with the most common answer from the other Member States that have participated in
HIPEDS.
222
Germany
a
Remand prisoners
223
Germany
Figure 15.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
a
Source: Eurostat (2019)
Physicians 329 4.5
5.7
224
Germany
ACCEPTABILITY
% Member States
Offered at
with “All prisons”
Most prisons (15 federal states all; 1 federal state
DTP 72.2
most; % FS with “all prisons”: 93.75)
Most prisons (9 federal states all prisons; 1 federal state most; 5 federal
Human Papilloma virus 52.9
states minority; 2 federal states none; % FS with “all prisons”: 56.25)
Most prisons (12 federal states all; 3 federal states most;
Hepatitis A 55.9
1 federal state none; % FS with “all prisons”: 75.00)
Most prisons (12 federal states all; 3 federal states most;
Hepatitis B 69.4
1 federal state none; % FS with “all prisons”: 75.00)
Most prisons (14 federal states all; 2 federal states
Seasonal flu 83.3
most; % FS with “all prisons”: 87.50)
Most prisons (11 federal states all; 2 federal states most; 2 federal
MMR 61.8
states minority; 1 federal state none; % FS with “all prisons”: 68.75)
Most prisons (10 federal states all; 2 federal states most; 1 federal
Meningococcal vaccination 52.9
state minority; 3 federal states none; % FS with “all prisons”: 62.50)
Most prisons (11 federal states all; 3 federal states most;
Pneumococcal vaccination 57.6
2 federal states none; % FS with “all prisons”:68.75)
Most prisons (15 federal states all; 1 federal state
COVID-19 91.4
most; % FS with “all prisons”: 93.75)
Proportion of prison establishments where people in prison have access to HIV prophylaxis:
225
Germany
HEALTH INFORMATION
Inform public health
authorities about diseases
amongst prisoners:
Yes, for infectious diseases
only (11 FS: 73.33%; 2 FS stated
“for both IDs and NCDs”: Information registered in clinical records:
13.33; 2 FS stated “no”:13.33;
% Member
and 1 FS could not provide an Yes/No States with
answer given the diversity “Yes”
of arrangements within the Screening tests performed YES 91.7
state). Public health authorities (all FS: 100.00)
being informed for both IDs and Screening tests results YES 94.4
for NCDs was reported by 45.50% (all FS: 100.00)
of Member States (n =33).
Vaccination YES 97.2
(all FS: 100.00)
Keep clinical health records Health behaviours YES 97.2
of people in prison: (all FS: 100.00)
Yes, in some prisons we keep paper- Diagnoses established YES 97.2
based clinical health-records and in (all FS: 100.00)
others we keep electronic clinical
Visits to external care providers YES 94.4
health records (reported by 9 federal
(all FS: 100.00)
states; 7 federal states reported paper-
Treatment and medications 97.2
based only). Electronic clinical health YES
C: HEALTH SERVICES
PREVENTIVE SERVICES
Number of unique individuals receiving a health examination following admission:
Not available (21 113 provided by 7 regions; the other 9 stated data was not recorded, even if in
many a comment was added to say “all people entering prison undergo an initial evaluation”)
DISEASE PREVENTION
History of TB and current signs and symptoms assessed on or close to reception for all
people in prison:
Yes, clinical assessment and diagnostic tests are made and when the test is positive, additional
assessment for MDR-TB is ensured (9 regions marked this option). Most Member States report “Yes,
clinical assessment and diagnostic tests are made and when the test is positive, additional assessment for
MDR-TB is ensured” (50%, out of n =36).
226
Germany
1
Risk-based for 6 federal states, opt-in for 6 federal states (37.5% of FS) and opt-out for 4 federal states
(13 federal states; 3 FS stated Yes (14 federal states; 2 FS stated Yes (13 federal states; 3 FS stated
no; % FS with “yes”:81.25) no; % FS with “yes”:87.5) no; % FS with “yes”: 81.25)
% Member
States with “Yes” 66.7 58.3 66.7
In BW, although yes was answered, a comment was added to say “if necessary”; therefore, not counted
HEALTH PROTECTION
Products offered free of charge:
% Member States
with “All prisons”
97.2 47.1 12.1 8.3
% Member States
with “All prisons”
30.6 28.6 72.2
227
Germany
HEALTH PROMOTION
Number and proportion of people diagnosed that received 1 or completed 2 treatment over the
last 12 months:
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 21 (-) a (reported by BB,
BW, TH and SN)
Individuals completing TB treatment over the last 12-month period 12 (92.3) (reported by BB and SN)
Multidrug-resistant Tuberculosis (MDRTB)
Individuals receiving MDR-TB treatment over the last 12-month period 2 (-) a (reported by BB, SN and BW)
Individuals completing MDR-TB treatment over the last 12-month period 0 (100) (reported by BB and SN)
HIV
Individuals with HIV who received treatment over the last 12-month period 25 (47.2) b
18 (94.7) c
Individuals completing HIV treatment over the last 12-month period 2 (11.1)
228
Germany
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 31 (5.2) b
12-month period 52 (24.8) c
Individuals who following antiviral treatment achieved sustained viral response over the last 16 (30.8) c
12-month period
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 8 (100.0) c
12-month period
Individuals who following antiviral treatment achieved sustained viral response over the last 3 (37.5) c
12-month period
Sexually Transmitted Infections (STIs)
Individuals with STIs who received treatment over the last 12-month period 10 (100.0) c
Individuals completing STI treatment over the last 12-month period 10 (100.0) c
Oral health
Individuals with oral health visit over the last 12-month period 8390 (14.5) c
Mental health disorders
Individuals who have received treatment for any mental health disorder over the last 12-month 1083 (94.1) c
period
Substance Use Disorders
Individuals who have received pharmacological treatment for a substance use disorder over the 1341 (88.7) b
last 12-month period 1543 (86.7) (reported by TH and SN)
Individuals who have received pharmacological treatment for an opioid use disorder over the last 497 (Not available) b
12-month period 295 (19.1) c
3.357 (41.9) d
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits 94 (80.3) c
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the 57 (48.7) c
last 12-month period
Individuals who have received pharmacological treatment for diabetes over the last 12-month 111 (94.9) c
period
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 579 (92.2) c
12-month period
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 151 (68.0) c
12-month period
Individuals who have received pharmacological treatment for cardiovascular disease over the 115 (51.8) c
last 12-month period
Cancer
Individuals who have received treatment for cancer over the last 12-month period 16 (64.0) c
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
b
Absolute numbers and prevalence data indicated for infectious diseases extracted from a published report which represents the region of Baden-Wuerttemberg, which hosts 6568
people in prison (11% of total prison population). This option was taken because data for this region is up to date (2019) and more exhaustive and most of the regions were not able to
provide morbidity data.
c
HCV data reported by 4 regions and proportion calculated using the total number of HCV diagnosis reported for the same 4 regions. HIV, TB and oral health data reported by 3 regions.
Diabetes, cancer and hypertension data reported by 2 regions. CVD reported by one region. The same methodology was used.
d
Data on substitution therapy obtained from a national report, where the total number of people with Opioid use disorder reported was 8.014
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
229
Germany
230
Germany
D: HEALTH OUTCOMES
a
Values indicated are a sum of all federal states (n =16)
b
Source: Eurostat (2018)
c
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data
was not available in open source).
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 9 (0.1) a
39 (0.2) b
Multidrug-resistant Tuberculosis (MDRTB)
Active MDR-TB diagnosis 0 (0.0) a
2 (0.0) a.a
HIV
Active HIV diagnosis 53 (0.8) a
112 (0.4) c
Hepatitis C
Chronic HCV infection (HCV RNA positive) 596 (9.1) a
1411 (6.6) b
Hepatitis B
Chronic HBV (HBsAg) 264 (4.0) a
347 (1.6) b
Sexually Transmitted Infections (STIs)
STI diagnosis (last 12-month) 8 (0.1) a
18 (0.2) d
COVID-19
SARS-Co-V2 infection laboratory confirmed 857 (1.6) e
Oral health
Individuals keeping 21 or more natural teeth MISSING
231
Germany
Number and proportion 1 of unique individuals living in prison diagnosed with (contd):
n (%)
Mental health disorders
Mental disorder diagnosis on record 6437 (98.0) a
5838 (54.2) f
Psychotic disorder diagnosis on record 529 (18.9) g
Recorded suicide attempt events (last 12-month) 7 (0.3) g
35 (0.5) a
Substance Use Disorders
Active drug use disorder (last 12-month) 15,726 (27.0) h
11,212 (40.8) i
Diabetes Mellitus
Diagnosis on record 117 (2.8) j
Hypertension
Diagnosis on record 628 (15.0) j
Cardiovascular Disease
Diagnosis on record 222 (7.9) g
Cancer
Diagnosis on record 25 (6.0) j
a
Absolute numbers and prevalence data indicated for infectious diseases only represents the region of Baden-Wuerttemberg, which hosts 6568 people in prison (11% of total prison
population). This option was taken because data for this region is up to date (2019) and more exhaustive and most of the regions were not able to provide morbidity data.
a.a
Baden-Wuerttemberg reported data for HIPEDS. Total population considered 6570.
b
Data reported by five regions, the prevalence is estimated considering the total population in these same regions (Baden-Wurtenburg, 6568; Bavaria, 9653; Bradenburg, 118; Sachen,
2796; Thueringern, 1402; total=21,537)
c
Data reported by six regions, the prevalence is estimated considering the total population in these same regions (Baden-Wurtenburg, 6568; Bavaria, 9653; Bradenburg, 118; Hessen,
4233; Sachen, 2796; Thueringern, 1402; total=25,770)
d
Data reported by four regions, the prevalence is estimated considering the total population in these same regions (Bradenburg, 118; Thueringern, 1402; Sachen, 2796; Baden-
Wurtenburg, 6568; total=11,886)
e
Data reported by 13 regions, the prevalence is estimated considering the total population in these same regions (n =53,178)
f
Data reported by three regions, the prevalence is estimated considering the total population in these same regions (Baden-Wutenburg, 6570; Sachen, 2796; Thueringern, 1402;
total=10768)
g
Data reported by one region, the prevalence is estimated considering the total population in this same region (Sachen, 2796).
h
Obtained from the Annual fact sheet on substance-related addiction problems in German prisons (03/2021) which includes data from 15 of the 16 federal states, available at https://
www.berlin.de/justizvollzug/_assets/senjustv/sonstiges/fact-sheet_sucht_substitution_im_justizvollzug_2021.pdf
i
Data reported by 6 regions (Thueringern, 1402; Sachen, 2796; Bavaria, 9653; Baden-Wurtenburg, 6568; Hessen, 4233; Rhineland-Palatine; total=27,492)
j
Data reported by 2 regions (Thueringern, 1402 and Sachen, 2796; total=4198)
1
Note that the numbers presented are not national, but they represent figures provided by some of the federal states, as indicated between brackets and in footnotes to the table.
Whenever percentages are presented, these are calculated considering the total population only in the same federal states providing the data. In addition, it is important to note
that the prevalence estimates are presented considering all diagnoses on record throughout the year, but the denominator only considers the total number of prison population by
31.12.2020, so values should be interpreted with caution.
Note: there were 3 regions that indicated missing for all diseases listed.
232
Germany
E: PRISON ENVIRONMENT
a
Answer provided by 16 regions.
b
Answer provided by 8 regions; 7 regions answered “no” and 1 region said “not applicable” as only men are hosted
F: HEALTH BEHAVIOURS
a
Data reported by one federal state and proportions estimated for the same federal state (SN, which hosts a total of 2796 individuals in prison).
b
Absolute numbers and prevalence data indicated extracted from a published report which represents the federal state of Baden-Wuerttemberg, which holds 6568 people in prison
(11% of total prison population).
c
Data reported by two federal states (SN, 2796; BY, 9653; total=12,449) and proportions estimated for the same federal states.
d
Data reported by three federal states (SN, 2796; BY, 9653; RP, 2838; total=15,287) and proportions estimated for the same federal states.
233
Germany
National standards to meet the health needs of special populations in prison: Yes, for all special
populations (most standards referred by 2-4 regions, in 6 regions “none”, in 4 regions “same
as outside”, in 2 regions “not applicable at the federal level” and in 1 region “unknown”).
National standards to meet the health needs of special populations based on
relevant international standards: No (answer indicated by 7 regions).
Health related information products for people in prison in multiple languages: In all prisons
(answer indicated by 12 regions). Most Member States report “In all prisons” (52.8%, out of n =36).
a
Answer indicated by 14 regions (1 not applicable and 1 invalid); b Answer indicated by 6 regions, which stated “not by routine, only when needed/upon
suspicion” (2 answered “yes, and regularly repeated” and 6 answered “no”); c Answer provided by 7 regions (2 answered “no” and 7 “missing/NA”)
Number of women who gave birth whilst in prison in the last 12 months:
n =37 (1.12% of all women living in prison) – data obtained from 13 regions
(2 regions provided no data and another region indicated “not applicable).
234
235
Greece 10 718 565
Population, 2020
High
Income group
US$ 17 647
Gross national income per capita
6267
236
Greece
Number of prison
establishments
in the country
34 Social characterization of people in prison
n %
Females 527 4.6
Pregnant 2 0.4
a
Foreign inmates, i.e., inmates with a nationality other than Greek
Figure 16.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE 0 2 4 6 8 10 12
3.4
Nurses 71
6.2
Physicians 50 a
Source: Eurostat (2019)
4.3
0.3
Psychiatrists 2
0.2
Dentists 5
0.4
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
Yes/No % Member States with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
238
Greece
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Missing. Public health authorities being
informed for both IDs and for NCDs was
reported by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
239
Greece
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
240
Greece
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 6 (-) a
Individuals completing TB treatment over the last 12-month period 4 (66.7)
Multidrug-resistant Tuberculosis (MDRTB)
Individuals receiving MDR-TB treatment over the last 12-month period 0 (-) a
Individuals completing MDR-TB treatment over the last 12-month period 0 (-)
HIV
Individuals with HIV who received treatment over the last 12-month period 110 (100.0)
Individuals completing HIV treatment over the last 12-month period 110 (100.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 0 (0.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 2 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 2 (100.0)
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
75 (62.5)
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period 8 (6.7)
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 95 (79.2)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 170 (100.0)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 58 (93.5)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 62 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 23 (92.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Although data are recorded in individual electronic clinical files but not available for extraction in aggregate manner.
241
Greece
D: HEALTH OUTCOMES
Mental health
disorders
Cancer HEALTH AND WELL-BEING
Assessments of perceived well-being
(or life satisfaction):
No, it has never been done. Assessments
In most prisons In all prisons
conducted regularly were reported by 19.4% of
Member States (n = 7).
% Member States with “All prisons”
Access to mental health counsellors:
Mental health disorders Cancer
In a minority of prisons. Having mental health
86.1 83.3 counsellors in all prisons was reported by 72.2% of
Member States (n =36).
REHABILITATION
MORTALITY
Access to:
Total Mortality rates Mortality
mortality per 100 000 rates per
incarcerated 100 000 people
people (general pop.)
Homicide 1 8.8 -
In all prisons In all prisons
a
Source: Global Burden of Disease database, according to the most recent data available
(2019), (As the female prison population is 4.6%, the general population data is given only for
% Member States with “All prisons” males over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
Education and training Employment available in open source).
programmes opportunities
75.0 88.9
242
Greece
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 6 (0.1)
HIV
Active HIV diagnosis 110 (1.0)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 36 (0.3)
Hepatitis B
Chronic HBV (HBsAg) 2 (0.0)
COVID-19
SARS-Co-V2 infection laboratory confirmed 7 (0.1)
Oral health
Individuals keeping 21 or more natural teeth 205 (1.8)
Diabetes Mellitus
Diagnosis on record 120 (1.1)
Hypertension
Diagnosis on record 170 (1.5)
Cardiovascular Disease
Diagnosis on record 62 (0.5)
Cancer
Diagnosis on record 25 (0.2)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
243
Greece
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification 1: SPS is currently working on the new advanced IT infrastructure where medical module will be covered. Hence, in the future we will be in a position to include and
provide indicated data on health behaviors.
Clarification 2: Smoking status is part of the initial assessment made but it is not tracked during imprisonment, considered a constantly changing variable. The remaining variables
are not part of the initial assessment.
244
Greece
NO NO
Number of women
who gave birth
whilst in prison in
the last 12 months:
n =5 (1.0% of all women
living in prison).
245
Hungary 9 769 526
Population, 2020
High
Income group
US$ 16 075
Gross national income per capita
11740
246
Hungary
33
Social characterization of people in prison
Number of prison
establishments n %
in the country Females 1 288 7.7
Pregnant MISSING MISSING
Under 18 29 0.2
Mean length of incarceration per individual
Above 50 2 952 17.6
over the last 12-month period: 31 months
Above 65 289 1.7
Migrants 997 6.0
Unsentenced and serving life Minorities MISSING MISSING
sentences individuals:
Disabled 251 1.5
n (%)
Number of unsentenced/remand prisoners 3421 (20.4) Physically disabled MISSING MISSING
Number of individuals serving life sentences 67 (0.4) Intellectually disabled 251 100.0
Figure 17.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE 0 5 10 15 20 25 30 35
13.2
Total staff 509
30.4
Physicians 95 3.5 a
Source: Eurostat (2019)
5.7
Psychiatrists 17 0.2
1.0
Dentists 0.7
34
2.0
247
Hungary
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
248
Hungary
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs).
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
249
Hungary
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
250
Hungary
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period 17 (94.4)
Individuals completing HIV treatment over the last 12-month period 0 (0.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 64 (48.9)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 3 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Most data are recorded in individual electronic clinical files but not available for extraction in aggregate manner.
251
Hungary
252
Hungary
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 18 (0.1)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 131 (0.8)
Hepatitis B
Chronic HBV (HBsAg) 3 (0.0)
COVID-19
SARS-Co-V2 infection laboratory confirmed 508 (3.0)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year
Clarification: Most data are recorded in individual electronic clinical files but not available for extraction in aggregate manner.
253
Hungary
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Data recorded in individual electronic clinical files but not available for extraction in aggregate manner.
254
Hungary
YES NO
255
Ireland 4 964 440
Population, 2020
High
Income group
US$ 85 422
Gross national income per capita
3650
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
5263
256
Ireland
12
Number of prison
n %
establishments
Females 146 4.0
in the country
Pregnant 6 4.1
Under 18 0 0.0
Mean length of incarceration per individual
Above 50 478 13.1
over the last 12-month period: 33 months
Above 65 114 3.1
Migrants 569 15.6
Unsentenced and serving life sentences Minorities MISSING MISSING
individuals:
Disabled MISSING MISSING
n (%)
Number of unsentenced/remand prisoners 660 (18.1) Physically disabled MISSING MISSING
Number of individuals serving life sentences 360 (9.9) Intellectually disabled MISSING MISSING
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) on
full-time equivalents (FTEs) and ratio (per 1000 people) for a known year:
Figure 18.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE 0 10 20 30 40 50 60
Nurses 151.0
41.4
14.0 3.5
Physicians 3.8
a
Source: Eurostat (2020)
7.0 0.2
Psychiatrists 1.9
2.5
Dentists 0.6
257
Ireland
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
258
Ireland
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs)
that are notifiable. Public health
authorities being informed for both
IDs and for NCDs was reported by
45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
259
Ireland
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
260
Ireland
n (%)
Tuberculosis (TB)
6 (1 active case &
Individuals receiving TB treatment over the last 12-month period
5 latent cases) a
Individuals completing TB treatment over the last 12-month period MISSING
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period 96
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 55
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period 1293 b
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
b
Data provided by the Drug Treatment Centre Board (DTCB).
1
Proportion cannot be presented as denominators (diagnoses) were missing.
Clarification: This data is recorded on each patient’s file, as part of their individual electronic record. However, it has not been possible to collate such data, as PHMS is an electronic health-
care record system, and not a reporting tool.
261
Ireland
time restrictions” (38.9%, out of n =36). Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was
b
262
Ireland
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 1 (0.0)
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
SARS-Co-V2 infection laboratory confirmed 23 (0.6)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
263
Ireland
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Data recorded in individual electronic clinical files but not available for extraction in aggregate manner.
264
Ireland
265
Italy 59 641 488
Population, 2020
High
Income group
US$ 31 834
Gross national income per capita
53364
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
35280
266
Italy
198
Social characterization of people in prison
Number of prison
establishments n %
in the country Females 2 265 4.2
Pregnant MISSING MISSING
Figure 19.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE 0 5 10 15 20 25
20.8
Total staff MISSING
6.1
Nurses 1067
20.0
534 4.0 a
Source: Eurostat (2020)
Physicians 10.0
0.2
Psychiatrists 107
2.0
0.9
Dentists 107
2.0
267
Italy
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
268
Italy
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
MISSING Public health authorities being
informed for both IDs and for NCDs was
reported by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
269
Italy
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
270
Italy
Number and proportion of people diagnosed that received or completed treatment over the
last 12 months:
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period MISSING
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
271
Italy
a
Source: Global Burden of Disease database, according to the most recent data available
People are allowed to continue their family (2019), (As the female prison population is 4.2%, the general population data is given only for
relationships by web communication: males over 20 years)
No. Most Member States report “Yes, with Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
b
272
Italy
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
MISSING
Active TB diagnosis
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
SARS-Co-V2 infection laboratory confirmed 6351 (11.9)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
273
Italy
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Although data are recorded in individual electronic clinical files, the current legislation in Italy on health care for prisoners (Legislative Decree 230/99 and subsequent
additions) does not allow the Department of the Penitentiary Administration to access this information, not even in aggregate form.
274
Italy
275
Latvia 1 907 675
Population, 2020
High
Income group
US$ 17 703
Gross national income per capita
3095
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
2702
276
Latvia
9
Number of prison Social characterization of people in prison
establishments
n %
in the country
Females 253 8.2
Pregnant MISSING MISSING
Under 18 11 0.4
Mean length of incarceration per individual
over the last 12-month period: MISSING Above 50 416 13.4
Above 65 113 3.7
Migrants MISSING MISSING
Figure 20.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
9.0
Total staff 99
32.0
4.4
Nurses 49
15.8
41 3.3
Physicians a
Source: Eurostat (2019)
13.3
2 0.2
Psychiatrists
0.7
0 0.7
Dentists
0.0
277
Latvia
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
278
Latvia
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs. Public
health authorities being informed for
both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
279
Latvia
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
280
Latvia
HIV
Individuals with HIV who received treatment over the last 12-month period 403 (79.2)
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 442 (42.6)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 401 (90.7)
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 9 (21.4)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 2 (22.2)
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Diabetes Mellitus
44 (45.8)
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period 31 (32.3)
96 (100.0)
Individuals who have received pharmacological treatment for diabetes over the last 12-month period
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 630 (93.5)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 380 (85.4)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 224 (50.3)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 19 (17.9)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed with active TB.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
281
Latvia
D: HEALTH OUTCOMES
Mental health Cancer
disorders
HEALTH AND WELL-BEING
Assessments of perceived well-being
(or life satisfaction):
In most prisons In all prisons Yes, on an ad hoc basis. Assessments conducted
regularly were reported by 19.4% of Member States
% Member States with “All prisons” (n = 7).
Access to mental health counsellors:
Mental health disorders Cancer
In a minority of prisons. Having mental health
86.1 83.3
counsellors in all prisons was reported by 72.2% of
Member States (n =36).
REHABILITATION
MORTALITY
Access to:
Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
282
Latvia
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 509 (16.4)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 1038 (33.5)
Hepatitis B
Chronic HBV (HBsAg) 42 (1.4)
COVID-19
SARS-Co-V2 infection laboratory confirmed 365 (11.8)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 96 (3.1)
Hypertension
Diagnosis on record 674 (21.8)
Cardiovascular Disease
Diagnosis on record 445 (14.4)
Cancer
Diagnosis on record 106 (3.4)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
283
Latvia
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
284
Latvia
285
Lithuania 2 794 090
Population, 2020
High
Income group
US$ 20 232
Gross national income per capita
5320
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
1630
286
Lithuania
8
Number of prison Social characterization of people in prison
establishments n %
in the country Females 252 4.7
Pregnant 3 1.2
Under 18 22 0.4
Mean length of incarceration per individual
Above 50 746 14.0
over the last 12-month period: 33 months
Above 65 MISSING MISSING
Figure 21.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
15.5
Total staff 167
31.4
101 7.7
Nurses 19.0
4.6 a
Source: Eurostat (2019)
Physicians 25
4.7
0.2
Psychiatrists 8
1.5
1.0
Dentists 5
0.9
287
Lithuania
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
288
Lithuania
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs.
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
289
Lithuania
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
290
Lithuania
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 43 (-)a
Individuals completing TB treatment over the last 12-month period 10 (23.3)
Multidrug-resistant Tuberculosis (MDRTB)
Individuals receiving MDR-TB treatment over the last 12-month period 8 (-)a
Individuals completing MDR-TB treatment over the last 12-month period 1 (12.5)
HIV
Individuals with HIV who received treatment over the last 12-month period 131 (55.3)
Individuals completing HIV treatment over the last 12-month period 0 (0.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 23 (missing)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 23 (100.0)
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period 106 (missing)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits 62 (86.1)
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period 72 (100.0)
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 72 (100.0)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 1006 (100.0)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 847 (84.2)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 24 (92.3)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
291
Lithuania
D: HEALTH OUTCOMES
Mental health
disorders
Cancer HEALTH AND WELL-BEING
Assessments of perceived well-being
(or life satisfaction):
Yes, on an ad hoc basis. Assessments conducted
In all prisons In all prisons
regularly were reported by 19.4% of Member States
(n = 7).
% Member States with “All prisons”
Access to mental health counsellors:
Mental health disorders Cancer
In all prisons. Having mental health counsellors in
86.1 83.3 all prisons was reported by 72.2% of Member States
(n =36).
REHABILITATION MORTALITY
Access to: Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
a
Source: Global Burden of Disease database, according to the most recent data available (2019),
% Member States with “All prisons” (As the female prison population is 4.7%, the general population data is given only for males over
20 years)
75.0 88.9
292
Lithuania
MORBIDITY
Number and proportion1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 23 (0.4)
HIV
Active HIV diagnosis 237 (4.5)
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
SARS-Co-V2 infection laboratory confirmed 529 (9.9)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 72 (1.4)
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
Diagnosis on record 1006 (18.9)
Cancer
Diagnosis on record 26 (0.5)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
293
Lithuania
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Use/have used drugs (last 12 months) 1035 (19.5) 987 (19.5) 48 (19.0)
Clarification: The indicators with missing data are not collected upon admission.
294
Lithuania
YES NO
295
Luxembourg 626 108
Population, 2020
High
Income group
US$ 116 356
Gross national income per capita
296
Luxembourg
Under 18 1 0.2
Mean length of incarceration per individual Above 50 MISSING MISSING
over the last 12-month period: MISSING
Above 65 MISSING MISSING
Figure 22.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
20.6
Total staff 30
60.1
15 11.4
Nurses 30.1
4 2.9 a
Source: Eurostat (2017)
Physicians 8.0
0.2
Psychiatrists 3
6.0
1.0
Dentists 1
2.0
297
Luxembourg
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
298
Luxembourg
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs.
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
299
Luxembourg
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
300
Luxembourg
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 3 (-) a
Individuals completing TB treatment over the last 12-month period 3 (100.0)
Multidrug-resistant Tuberculosis (MDRTB)
Individuals receiving MDR-TB treatment over the last 12-month period MISSING
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period 6 (100.0)
Individuals completing HIV treatment over the last 12-month period 6 (100.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 23 (28.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 40
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 13 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 1 (7.7)
Sexually Transmitted Infections (STIs)
Individuals with STIs who received treatment over the last 12-month period 15 (100.0)
Individuals completing STI treatment over the last 12-month period 6 (40.0)
Oral health
Individuals with oral health visit over the last 12-month period 15 (3.0)
Mental health disorders
Individuals who have received treatment for any mental health disorder over the last 12-month period 441 (100.0)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 44 (100.0)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 48 (100.0)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 48 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 1 (100.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
301
Luxembourg
D: HEALTH OUTCOMES
Mental health
disorders
Cancer HEALTH AND WELL-BEING
Assessments of perceived well-being (or life
satisfaction):
Yes, on an ad hoc basis. Assessments conducted
In all prisons In all prisons
regularly were reported by 19.4% of Member States
(n = 7).
% Member States with “All prisons”
Access to mental health counsellors:
Mental health disorders Cancer
In all prisons. Having mental health counsellors in
86.1 83.3 all prisons was reported by 72.2% of Member States
(n =36).
REHABILITATION MORTALITY
Access to: Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
a
Source: Global Burden of Disease database, according to the most recent data available (2019),
In all prisons In all prisons (As the female prison population is 4.4%, the general population data is given only for males over
20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
% Member States with “All prisons” available in open source).
302
Luxembourg
MORBIDITY
Number and proportion1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
MISSING
Active TB diagnosis
HIV
Active HIV diagnosis 6 (1.2)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 82 (16.4)
Hepatitis B
Chronic HBV (HBsAg) 13 (2.6)
COVID-19
SARS-Co-V2 infection laboratory confirmed 9 (1.8)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 31 (6.2)
Hypertension
Diagnosis on record 44 (8.8)
Cardiovascular Disease
Diagnosis on record 48 (9.6)
Cancer
Diagnosis on record 1 (0.2)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
303
Luxembourg
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
304
Luxembourg
YES
Yes, and they are repeated YES
at regular intervals
305
Malta 514 564
Population, 2020
High
Income group
US$ 28 946
Gross national income per capita
865
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
1090
306
Malta
3
Number of prison Social characterization of people in prison
establishments n %
in the country Females 57 6.6
Pregnant 2 3.5
LGBTIQ 15 1.7
Under 18 18 2.1
Mean length of incarceration per individual Above 50 96 11.1
over the last 12-month period: MISSING Above 65 33 3.8
Migrants 408 47.2
Figure 23.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
19.7
Total staff 34
39.3
7.9
Nurses 26
30.1
4.1
Physicians 4 a
Source: Eurostat (2019)
4.6
3 0.1
Psychiatrists 3.5
0.5
Dentists 1
1.2
307
Malta
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
308
Malta
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs.
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
309
Malta
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
310
Malta
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 16 (-) a
Individuals completing TB treatment over the last 12-month period 14 (87.5)
Multidrug-resistant Tuberculosis (MDRTB)
Individuals receiving MDR-TB treatment over the last 12-month period 0 (-) a
Individuals completing MDR-TB treatment over the last 12-month period 0 (-)
HIV
Individuals with HIV who received treatment over the last 12-month period 4 (80.0)
Individuals completing HIV treatment over the last 12-month period 4 (100.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 37 (60.7)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 30 (81.1)
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 27 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 3 (11.1)
Oral health
Individuals with oral health visit over the last 12-month period 411 (47.5)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 30 (100.0)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 30 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 4 (100.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
311
Malta
312
Malta
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 1 (0.1)
HIV
Active HIV diagnosis 5 (0.6)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 61 (7.1)
Hepatitis B
Chronic HBV (HBsAg) 27 (3.1)
COVID-19
SARS-Co-V2 infection laboratory confirmed 70 (8.1)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 41 (4.7)
Hypertension
Diagnosis on record 85 (9.8)
Cardiovascular Disease
Diagnosis on record 30 (3.5)
Cancer
Diagnosis on record 4 (0.5)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
313
Malta
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Use/have used drugs (last 12 months) 337 (39) 302 (37.4) 35 (61.4)
314
Malta
315
Monaco 39 244
Population, 2020
High
Income group
US$ 173 688
Gross national income per capita
15 * Not available
46
316
Monaco
1
Social characterization of people in prison
Number of prison
establishments n %
in the country
Females 2 13.3
Pregnant 0 0.0
LGBTIQ 0 0.0
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) in
prisons on full-time equivalents (FTEs) and ratio (per 1000 incarcerated people) for a known year:
FTE
Nurses 3 200.0
1
Physicians 66.7
1 66.7
Psychiatrists
1
Dentists 66.7
317
Monaco
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
318
Monaco
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs).
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
319
Monaco
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
320
Monaco
Oral health
Individuals with oral health visit over the last 12-month period 0 (-)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits 0 (-)
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period 0 (-)
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 0 (-)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 0 (-)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 0 (-)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 0 (-)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 0 (-)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
321
Monaco
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being
(or life satisfaction):
Yes, regularly (for example once every year or
once every two years). Assessments conducted
In all prisons In all prisons
regularly were reported by 19.4% of Member States
(n = 7).
% Member States with “All prisons”
Access to mental health counsellors:
Mental health disorders Cancer In all prisons. Having mental health counsellors in
86.1 83.3 all prisons was reported by 72.2% of Member States
(n =36).
REHABILITATION
MORTALITY
Access to:
Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
322
Monaco
MORBIDITY
Number and proportion1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 0 (0.0)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 0 (0.0)
Hepatitis B
Chronic HBV (HBsAg) 0 (0.0)
COVID-19
SARS-Co-V2 infection laboratory confirmed 0 (0.0)
Oral health
Individuals keeping 21 or more natural teeth 0 (0.0)
Diabetes Mellitus
Diagnosis on record 0 (0.0)
Hypertension
Diagnosis on record 0 (0.0)
Cardiovascular Disease
Diagnosis on record 0 (0.0)
Cancer
Diagnosis on record 0 (0.0)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
323
Monaco
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: The numbers reported are for the newly admitted people to prisons in 2020, instead number of people in prison by 31.12.2020.
324
Monaco
325
Netherlands 17 407 585
Population, 2020
High
Income group
US$ 52 396
Gross national income per capita
9483
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
18494
326
Netherlands
30
Social characterization of people in prison
Number of prison
establishments n %
in the country Females 446 4.7
Pregnant MISSING MISSING
Under 18 0 0.0
Mean length of incarceration per individual
Above 50 1 504 15.9
over the last 12-month period: 1 months
Above 65 177 1.9
Migrants 2 032 21.4
Unsentenced and serving life Minorities MISSING MISSING
sentences individuals:
Disabled MISSING MISSING
n (%)
Number of unsentenced/remand prisoners 4357 (45.9) Physically disabled MISSING MISSING
Number of individuals serving life sentences 41 (0.4) Intellectually disabled MISSING MISSING
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) on
full-time equivalents (FTEs) and ratio (per 1000 people) for a known year:
Figure 25.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
10.7
Nurses 250
26.4
3.7 Source: Eurostat (2019)
Physicians 25
a
2.6
0.2
Psychiatrists 10
1.1
Dentists 10
0.6
1.1
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
328
Netherlands
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs).
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
329
Netherlands
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
330
Netherlands
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Data recorded in individual electronic clinical files but not available for extraction in aggregate manner as a special module is needed for extraction.
331
Netherlands
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being (or life
satisfaction):
Yes, on an ad hoc basis. Assessments conducted
regularly were reported by 19.4% of Member States
In all prisons In all prisons
(n = 7).
Access to mental health counsellors:
% Member States with “All prisons”
In all prisons. Having mental health counsellors in
Mental health disorders Cancer all prisons was reported by 72.2% of Member States
86.1 83.3 (n =36).
MORTALITY
REHABILITATION Total Mortality Mortality
Access to: mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
a
Source: Global Burden of Disease database, according to the most recent data available (2019),
In all prisons In all prisons (As the female prison population is 4.7%, the general population data is given only for males
over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source).
% Member States with “All prisons”
332
Netherlands
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
SARS-Co-V2 infection laboratory confirmed 331 (3.5)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
Clarification: Data recorded in individual electronic clinical files but not available for extraction in aggregate manner as a special module is needed for extraction.
333
Netherlands
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Data recorded in individual electronic clinical files but not available for extraction in aggregate manner as a special module is needed for extraction.
334
Netherlands
NO
Yes, and they are repeated YES
at regular intervals
335
Poland 37 958 138
Population, 2020
High
Income group
US$ 15 742
Gross national income per capital
67894
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
3725
336
Poland
Number of prison
establishments
in the country
120 Social characterization of people in prison
Females
n
3 056
%
4.5
Pregnant MISSING MISSING
n (%)
Disabled MISSING MISSING
Number of unsentenced/remand prisoners 8692 (12.8)
Number of individuals serving life sentences 479 (0.7) Physically disabled MISSING MISSING
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) on
full-time equivalents (FTEs) and ratio (per 1000 people) for a known year:
Figure 26.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
5.1
Nurses 853
12.6
2.4
Physicians MISSING
a
Source: Eurostat (2017)
0.1
Psychiatrists 32 0.5
Dentists MISSING
0.4
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
338
Poland
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs.
Public health authorities being
informed for both IDs and for
NCDs was reported by 45.5%
of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
339
Poland
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
340
Poland
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
MISSING
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
Clarification: Missing data on diagnosis and treatment refers to data not collected.
341
Poland
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being (or life
satisfaction):
No, it has never been done. Assessments
conducted regularly were reported by 19.4% of
In all prisons In all prisons
Member States (n = 7).
Access to mental health counsellors:
% Member States with “All prisons”
In no prisons. Having mental health counsellors
Mental health disorders Cancer in all prisons was reported by 72.2% of Member
86.1 83.3 States (n =36).
MORTALITY
REHABILITATION Total Mortality Mortality
Access to: mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
a
Source: Global Burden of Disease database, according to the most recent data available
(2019), (As the female prison population is 4.5%, the general population data is given only for
In all prisons In all prisons males over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source).
% Member States with “All prisons”
342
Poland
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 334 (0.5)
HIV
Active HIV diagnosis 33 (0.0)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 227 (0.3)
Hepatitis B
Chronic HBV (HBsAg) 18 (0.0)
COVID-19
SARS-Co-V2 infection laboratory confirmed 603 (0.9)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
Clarification: Missing data on diagnosis and treatment refers to data not collected.
343
Poland
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
344
Poland
YES
Yes, and they are repeated YES
at regular intervals
345
Portugal 10 295 909
Population, 2020
High
Income group
US$ 22 194
Gross national income per capital
11412
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
4357
346
Portugal
Under 18 38 0.3
Mean length of incarceration per individual Above 50 2 204 19.3
over the last 12-month period: MISSING
Above 65 474 4.2
Migrants 1 764 15.5
Unsentenced and serving life
sentences individuals: Minorities MISSING MISSING
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) in
prisons on full-time equivalents (FTEs) and ratio (per 1000 incarcerated people) for a known year:
347
Portugal
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
348
Portugal
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only
(IDs). Public health authorities
being informed for both IDs and
for NCDs was reported by 45.5%
of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
349
Portugal
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
350
Portugal
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period 386 (87.3)
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 81 (8.4)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Health data is recorded in a physical clinical process, thus not available for extraction and analysis.
351
Portugal
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being (or life
satisfaction):
Yes, on an ad hoc basis. Assessments conducted
regularly were reported by 19.4% of Member States
In all prisons In all prisons
(n = 7).
Access to mental health counsellors:
% Member States with “All prisons”
In all prisons. Having mental health counsellors in
Mental health disorders Cancer all prisons was reported by 72.2% of Member States
86.1 83.3 (n =36).
MORTALITY
REHABILITATION Total Mortality Mortality
Access to: mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
a
Source: Global Burden of Disease database, according to the most recent data available
(2019), (As the female prison population is 7.0%, the general population data is given only for
In all prisons In all prisons males over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source).
% Member States with “All prisons”
352
Portugal
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
MISSING
Active TB diagnosis
HIV
Active HIV diagnosis 442 (3.9)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 965 (8.5)
Hepatitis B
Chronic HBV (HBsAg) 182 (1.6)
COVID-19
SARS-Co-V2 infection laboratory confirmed 520 (4.6)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
Clarification: Health data is recorded in a physical clinical process, thus not available for extraction and analysis.
353
Portugal
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Health data is recorded in a physical clinical process, thus not available for extraction and analysis.
354
Portugal
355
Republic 2 620 495 Upper middle US$ 4 525
of Moldova Population, 2020 Income group Gross national income per capital
2527
356
Republic of Moldova
Number of prison
establishments
in the country
17 Social characterization of people in prison
Females
n
372 5.8
%
LGBTIQ 2 0.0
Under 18 61 1.0
Mean length of incarceration per individual Above 50 498 7.8
over the last 12-month period: MISSING Above 65 219 3.4
Migrants 53 0.8
Unsentenced and serving life sentences
Minorities MISSING MISSING
individuals:
n (%) Disabled 209 3.3
Number of unsentenced/remand prisoners 983 (15.3) Physically disabled MISSING MISSING
Number of individuals serving life sentences 122 (1.9) Intellectually disabled MISSING MISSING
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) in
prisons on full-time equivalents (FTEs) and ratio (per 1000 incarcerated people) for a known year:
Nurses 144.5
Physicians 105
Psychiatrists 11
Dentists 8
357
Republic of Moldova
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
88.9
Assessments performed in prisons on
NO
the availability of essential medicines
358
Republic of Moldova
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only
(IDs). Public health authorities
being informed for both IDs and
for NCDs was reported by 45.5%
of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
359
Republic of Moldova
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
360
Republic of Moldova
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period 97 (-) a
Individuals completing TB treatment over the last 12-month period 80 (1150.0)
Multidrug-resistant Tuberculosis (MDRTB)
Individuals receiving MDR-TB treatment over the last 12-month period 20 (-) a
Individuals completing MDR-TB treatment over the last 12-month period 17 (164.7)
HIV
Individuals with HIV who received treatment over the last 12-month period 139 (85.8)
Individuals completing HIV treatment over the last 12-month period 7 (5.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 66 (28.3)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 55 (83.3)
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 94 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 4 (4.3)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits
79 (92.9)
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period 62 (72.9)
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 82 (96.5)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 472 (80.5)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 275 (100.0)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 275 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 31 (100.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
361
Republic of Moldova
a
Source: Global Burden of Disease database, according to the most recent data available
(2019), (As the female prison population is 5.8%, the general population data is given only for
males over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source).
362
Republic of Moldova
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 162 (2.5)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 233 (3.6)
Hepatitis B
Chronic HBV (HBsAg) 94 (1.5)
COVID-19
SARS-Co-V2 infection laboratory confirmed 166 (2.6)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 85 (1.3)
Hypertension
Diagnosis on record 586 (9.1)
Cardiovascular Disease
Diagnosis on record 275 (4.3)
Cancer
Diagnosis on record 31 (0.5)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same
country where data has been provided for the same reference year.
363
Republic of Moldova
E: PRISON ENVIRONMENT
A minority
Offered at All prisons All prisons All prisons of prisons
F: HEALTH BEHAVIOURS
364
Republic of Moldova
YES NO
365
Romania 19 328 838
Population, 2020
Upper middle
Income group
US$ 12 956
Gross national income per capital
MISSING
366
Romania
Number of prison
establishments
in the country
44 Social characterization of people in prison
Females
n
862
%
4.0
Pregnant MISSING MISSING
n (%)
Disabled MISSING MISSING
Number of unsentenced/remand prisoners 2040 (9.4)
Physically disabled MISSING MISSING
Number of individuals serving life sentences 187 (0.9)
Intellectually disabled MISSING MISSING
Figure 29.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
7.5
Nurses 526
24.2
3.2
Physicians 168 a
Source: Eurostat (2019)
7.7
10 0.1
Psychiatrists
0.5
Dentists 27 0.9
1.2
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
88.9
Assessments performed in prisons on
YES
the availability of essential medicines
368
Romania
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only
(IDs). Public health authorities
being informed for both IDs and
for NCDs was reported by 45.5%
of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
369
Romania
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
370
Romania
HIV
Individuals with HIV who received treatment over the last 12-month period 384 (95.0)
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Diabetes Mellitus
MISSING
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Although all penitentiaries keep record of patients with chronic diseases, the information is not available via a digital register and could not be obtained in a short notice.
371
Romania
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being (or life
satisfaction):
Yes, on an ad hoc basis. Assessments conducted
regularly were reported by 19.4% of Member States
In all prisons In all prisons
(n = 7).
Access to mental health counsellors:
% Member States with “All prisons”
In all prisons. Having mental health counsellors in
Mental health disorders Cancer all prisons was reported by 72.2% of Member States
86.1 83.3 (n =36).
REHABILITATION MORTALITY
Access to: Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
372
Romania
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 180 (0.8)
HIV
Active HIV diagnosis 404 (1.9)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 1017 (4.7)
Hepatitis B
Chronic HBV (HBsAg) 888 (4.1)
COVID-19
SARS-Co-V2 infection laboratory confirmed 859 (4.0)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
Diagnosis on record 70 (0.3)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
Clarification: Although all penitentiaries keep record of patients with chronic diseases, the information is not available via a digital register and could not be obtained in a short notice.
373
Romania
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Records of health behaviors are kept within penitentiary units but are not available for extraction in aggregated manner.
374
Romania
YES NO
375
San Marino 34 735
Population, 2020
High
Income group
US$ 45 515
Gross national income per capital
376
San Marino
1
Number of prison Social characterization of people in prison
establishments n %
in the country Females 1 12.5
Pregnant 0 0.0
LGBTIQ 0 0.0
Mean length of incarceration per individual Under 18 0 0.0
over the last 12-month period: 1 month Above 50 2 25.0
Above 65 1 12.5
Unsentenced and serving life Migrants 3 37.5
sentences individuals:
Minorities 0 0.0
n (%)
Disabled 0 0.0
Number of unsentenced/remand prisoners 7 (87.5)
Not legally Physically disabled 0 MISSING
Nurses MISSING
Physicians MISSING
Psychiatrists MISSING
Dentists MISSING
377
San Marino
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
378
San Marino
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
No. Public health authorities
being informed for both IDs and
for NCDs was reported by 45.5%
of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
379
San Marino
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
380
San Marino
PROVISION OF PRIMARY CARE
Suspected cases of an infectious disease with access to laboratory tests:
Yes, everyone in prison has access to laboratory tests when these are necessary. Most Member States
report “Yes, everyone in prison has access to laboratory tests when these are necessary” (94.4%, out of n =36).
Number and proportion of people diagnosed that received 1 or completed 2 treatment over the
last 12 months:
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
MISSING
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Although all penitentiaries keep record of patients with chronic diseases, the information is not available via a digital register and could not be obtained in a short notice.
381
San Marino
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being (or life
satisfaction):
No, it has never been done. Assessments
conducted regularly were reported by 19.4% of
In all prisons In no prisons
Member States (n = 7).
Access to mental health counsellors:
% Member States with “All prisons”
In all prisons. Having mental health counsellors in
Mental health disorders Cancer all prisons was reported by 72.2% of Member States
86.1 83.3 (n =36).
MORTALITY
REHABILITATION Total Mortality Mortality
Access to: mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
Suicide 0 0 26.7 a
a
Source: Global Burden of Disease database, according to the most recent data available (2019),
(As the female prison population is 12.5%, the general population data is given only for males
In all prisons In all prisons over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source).
382
San Marino
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 0 (0.0)
HIV
Active HIV diagnosis 0 (0.0)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 0 (0.0)
Hepatitis B
Chronic HBV (HBsAg) 0 (0.0)
COVID-19
SARS-Co-V2 infection laboratory confirmed 0 (0.0)
Oral health
Individuals keeping 21 or more natural teeth 0 (0.0)
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
383
San Marino
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Despite keeping paper-based clinical health-records of each inmate, the country could not provide an aggregate value that can be reported here.
384
San Marino
385
Slovakia 5 457 873
Population, 2020
High
Income group
US$ 19 266
Gross national income per capital
10519
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
6360
386
Slovakia
18
Number of prison Social characterization of people in prison
establishments n %
in the country Females 658 6.3
Pregnant MISSING MISSING
Under 18 24 0.2
Mean length of incarceration per individual
Above 50 2 071 19.7
over the last 12-month period: MISSING
Above 65 164 1.6
Migrants 219 2.1
Unsentenced and serving life
Minorities MISSING MISSING
sentences individuals:
n (%) Disabled MISSING MISSING
Physicians 79 7.5
Psychiatrists 10 1.0
Dentists 8 0.8
387
Slovakia
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
388
Slovakia
HEALTH INFORMATION
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
389
Slovakia
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
390
Slovakia
HIV
Individuals with HIV who received treatment over the last 12-month period 5 (100.0)
Individuals completing HIV treatment over the last 12-month period 0 (0.0)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 289 (75.5)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 2 (8.0)
MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period
Oral health
Individuals with oral health visit over the last 12-month period 16718
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 681 (missing)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 3658 (98.3)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 693 (89.5)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 690 (99.6)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 765 (96.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
391
Slovakia
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being (or
life satisfaction): No, it has never been done.
Assessments conducted regularly were reported by
19.4% of Member States (n = 7).
In most prisons In no prisons
REHABILITATION MORTALITY
Access to: Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
a
Source: Global Burden of Disease database, according to the most recent data available
% Member States with “All prisons” (2019), (As the female prison population is 6.3%, the general population data is given only for
males over 20 years)
392
Slovakia
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 5 (0.0)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 383 (3.6)
Hepatitis B
Chronic HBV (HBsAg) 25 (0.2)
COVID-19
SARS-Co-V2 infection laboratory confirmed 1010 (9.6)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 733 (7.0)
Hypertension
Diagnosis on record 3723 (35.4)
Cardiovascular Disease
Diagnosis on record 774 (7.4)
Cancer
Diagnosis on record 797 (7.6)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
393
Slovakia
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Use/have used drugs (last 12 months) 2357 (22.4) 2046 (20.7) 311 (47.3)
Clarification: The missing data presented is justified by the insufficient adoption of the health information system by health professionals - data on blood pressure, height,
weight and BMI have separate fields in the electronic medical record, but health professionals put these data in the body of the medical report, from where the system
cannot extract these specific data.
394
Slovakia
NO NO
395
Slovenia 2 095 861
Population, 2020
High
Income group
US$ 25 489
Gross national income per capital
2125
396
Slovenia
13
Number of prison %
n
establishments Females 41 3.2
in the country
Pregnant 5 12.2
Under 18 14 1.1
Mean length of incarceration per individual Above 50 120 9.2
over the last 12-month period: 78 months
Above 65 24 1.8
Migrants MISSING MISSING
Total number of health-care staff (physicians, nurses, nursing assistants, etc., including external service providers) on full-time
equivalents (FTEs) and ratio (per 1000 people) for a known year:
Figure 32.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
15 10.3
Nurses
11.6
3 3.3
Physicians 2.3
a
Source: Eurostat (2019)
0 0.2
Psychiatrists
0.0
0 0.7
Dentists
0.0
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
398
Slovenia
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious
diseases only (IDs).
Public health authorities being
informed for both IDs and for
NCDs was reported by 45.5%
of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
399
Slovenia
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
400
Slovenia
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
Clarification: Missing data is justified because NCDs are screened and treated in Slovenia upon symptoms or when a person is of specific age and this is a national policy for NCD. There is
no centralized database for NCDs in prisons – GPs, who are external providers, hold their records in various databases and thus cannot be extracted.
401
Slovenia
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer
disorders Assessments of perceived well-being (or life
satisfaction):
Yes, on an ad hoc basis. Assessments conducted
regularly were reported by 19.4% of Member States
In all prisons In all prisons
(n = 7).
Access to mental health counsellors:
% Member States with “All prisons”
In all prisons. Having mental health counsellors in
Mental health disorders Cancer all prisons was reported by 72.2% of Member States
86.1 83.3 (n =36).
REHABILITATION MORTALITY
Access to: Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
a
Source: Global Burden of Disease database, according to the most recent data available (2019),
In all prisons In all prisons (As the female prison population is 6.3%, the general population data is given only for males
over 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source).
% Member States with “All prisons”
402
Slovenia
MORBIDITY
Number and proportion1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 1 (0.1)
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
SARS-Co-V2 infection laboratory confirmed 2 (0.2)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
Diagnosis on record 678 (52.2)
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
a
There is no active search of tuberculin in Slovenia.
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
Clarification: Missing data is justified because NCDs are screened and treated in Slovenia upon symptoms or when a person is of specific age and this is a national policy for NCD.
There is no centralized database for NCDs in prisons – GPs, who are external providers, hold their records in various databases and thus cannot be extracted.
403
Slovenia
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Missing data is justified because there is no centralized database for NCDs in prisons – GPs, who are external providers, hold their records in various databases and thus
cannot be extracted.
404
Slovenia
YES NO
405
Spain 39 680 230
Population, 2020
High
Income group
US$ 27 056
Gross national income per capital
47 300
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
MISSING
406
Spain
69
Number of prison
n %
establishments
Females 3 502 7.4
in the country
Pregnant MISSING MISSING
Under 18 0 0.0
Mean length of incarceration per individual
over the last 12-month period: MISSING Above 50 MISSING MISSING
Figure 33.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
Psychiatrists 7 0.1
0.2
Dentists 0
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on NO 88.9
the availability of essential medicines
408
Spain
HEALTH INFORMATION
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
409
Spain
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
410
Spain
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 489 (91.4)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 669 (136.8) b
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period
4971 (missing)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 2070 (missing)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 3401 (missing)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed with active TB.
b
The number of individuals achieving sustained viral response is higher than those receiving treatment because the assessment is made some time after completion of treatment;
therefore, it may include individuals terminating treatment in the previous 12 months but also those completing treatment previously.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
411
Spain
D: HEALTH OUTCOMES
Mental health
HEALTH AND WELL-BEING
Cancer Assessments of perceived well-being (or
disorders
life satisfaction): Yes, regularly (for example
once every year or once every two years).
Assessments conducted regularly were reported by
In all prisons In all prisons 19.4% of Member States (n = 7).
Access to mental health counsellors:
% Member States with “All prisons” In all prisons. Having mental health counsellors in
all prisons was reported by 72.2% of Member States
Mental health disorders Cancer
(n =36).
86.1 83.3
REHABILITATION MORTALITY
Access to: Total Mortality Mortality
mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
412
Spain
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
HIV
Active HIV diagnosis 1653 (3.5)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 535 (1.1)
Hepatitis B
Chronic HBV (HBsAg) MISSING
COVID-19
SARS-Co-V2 infection laboratory confirmed 815 (1.7)
Oral health
Individuals keeping 21 or more natural teeth MISSING
Diabetes Mellitus
Diagnosis on record MISSING
Hypertension
Diagnosis on record MISSING
Cardiovascular Disease
Diagnosis on record MISSING
Cancer
Diagnosis on record MISSING
a
The numbers reported do not include any latent TB cases. There is a very extensive active case-finding programme for active and latent TB cases. The priorities of the programme are
as follows:
• Active case finding, health education and investigation of inmates with clinical compatible TB, in order to improve early diagnosis. Respiratory isolation during the infectious
period. Communication to extra-penitentiary services of inmates undergoing treatment.
• Investigation of the disease/infection situation in contacts close to each case of TB and administration of treatment for latent TB if necessary.
Source: http://www.interior.gob.es/documents/642317/1201664 Programa+de+prevenci%C3%B3n+y+control+de+la+tuberculosis+en+el+medio+penitenciari-
o+%28NIPO+126-10-136-9%29.pdf/a60d4338-79ef-4ee6-9c78-57ecedbb2dde#:~:text=En%20los%20centros%20penitenciarios%20se,los%20infectados%20por%20esta%20enferme-
dad.
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data has
been provided for the same reference year.
Clarification: Missing values presented in the table are explained because even though an anamnesis is carried out both on admission and during the clinical follow-up of the digital
history, it is not possible to extract these data globally.
413
Spain
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Even though this data is collected as part of the anamnesis carried out both on admission and during the clinical follow-up of the digital history, it is not
possible to extract these data globally.
414
Spain
415
Switzerland 8 606 033
Population, 2020
High
Income group
US$ 87 100
Gross national income per capita
6897
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
MISSING In Switzerland, the total number of entries is collected
but not the number of “unique individuals” entering
prisons. Considering all types of incarceration, the total
number recorded in the previous year was 34203.
416
Switzerland
87
Number of prison n %
establishments Females 347 5.0
Under 18 52 0.8
Mean length of incarceration per individual
c
over the last 12-month period: 2.1 months Above 50 MISSING MISSING
a
Unsentenced/remand prisoners includes all early execution of a custodial sentence or
measure, in addition to remand prisoners. Intellectually disabled MISSING MISSING
b
The term “serving life sentences” is nor the right indicator for the Swiss penal system.
In the Statistics on the Execution of Sanctions (SVS), there was an average of 34 persons
(thereof 2 female) in execution of a life sentence in 2020. However, in the same year, there
c
Data officially published (Exécution des peines et des mesures: effectif moyen des
was an average of 151 persons (thereof 1 female) in execution of internment in a Swiss penal personnes âgées au-dessus de 49 ans - 1984-2019 | Table | Federal Statistical Office
institution. (Internment refers to persons who have served their sentence but who must (admin.ch) indicates general demographic data statistic of persons entering and
remain in custody until further notice for reasons of public safety). leaving Swiss prisons but only on those who are in early execution of a sentence, early
execution of a measure, execution of a sentence or execution of a measure (gender,
age, nationality, etc.). There is no statistic available to inform about the whole of the
prison population.
Figure 34.2: Health-care staff available in prison and in the general population
Ratio per 1000 people
FTE
30.5
Total staff 197
28.6
18.0
Nurses MISSING prison population
general population a
4.4
Physicians MISSING
a
Source: Eurostat (2019)
0.5
Psychiatrists MISSING
417
Switzerland
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on NO 88.9
the availability of essential medicines
418
Switzerland
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, for infectious diseases only (IDs)1
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
1
Clarification: Mandatory reporting only for infectious diseases
according to Federal Epidemics Act.. However, the reporting
responsibility lies with medical doctors; compliance varies – some MD Information registered in clinical records 2:
report, others do not report - yet, there are no data available on this.
% Member
Yes/No States with
“Yes”
Keep clinical health records Screening tests performed YES 91.7
of people in prison:
Screening tests results YES 94.4
Yes, in some prisons we keep paper-
Vaccination 97.2
based clinical health-records and in YES
2
The clinical record captures all elements, but not systematically in all prisons; this is under
cantonal sovereignty and varies accordingly as there is no national standard available.
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
3
Clarification: In some prisons MDR-TB assessment is made; in others only clinical evaluation.
419
Switzerland
a
Some cantons (GE) follow
an opt-in or out strategy.
Cancer screening offered to prisoners:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
A minority A minority
Offered at All prisons
of prisons of prisons
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
420
Switzerland
n (%)
Tuberculosis (TB)
Individuals receiving TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period 4971 (missing)
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 2070 (missing)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 3401 (missing)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
421
Switzerland
MORTALITY
Education and training Employment Total Mortality Mortality
programmes opportunities mortality rates per rates per
100 000 100 000 people
incarcerated (general pop.)
people
422
Switzerland
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
MISSING
Active TB diagnosis
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
SARS-Co-V2 infection laboratory confirmed 1 (0.0)
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
Clarification: There is no data available on a national level. Such data is not collected. Except to the Federal Epidemic Act, which requires reporting of all newly detected cases of
a defined number of communicable diseases, which, in principle, should cater for the provision of the respective data also from the prison population, there are no national legal
norms, standards, regulations, recommendations or concepts which could serve as a basis for a systematic collection of morbidity data in the prison population. Currently, the
JMIR Research Protocols - The Swiss Prison Study (SWIPS): Protocol for Establishing a Public Health Registry of Prisoners in Switzerland is collecting data on morbidity in prisons
in the region of Zurich. (https://www.researchprotocols.org/2020/12/e23973). Results to be expected late 2021/beginning 2022. Additionally, some more studies are available with
regional/local data, however, no national data is available whatsoever for 2020.
423
Switzerland
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
Clarification: Even though this data is collected as part of the anamnesis carried out both on admission and during the clinical follow-up of the digital history, it is not possible to
extract these data globally.
424
Switzerland
YES NO
425
Ukraine 41 732 779
Population, 2020
Lower middle
Income group
US$ 3 751
Gross national income per capita
426
Ukraine
109
Number of prison Social characterization of people in prison
establishments n %
in the country Females 2 477 5.0
Pregnant MISSING MISSING
sentences individuals:
Minorities MISSING MISSING
n (%)
Number of unsentenced/remand prisoners 18205 (36.5) Disabled 1 244 2.5
Number of individuals serving life sentences 1541 (3.1) Physically disabled MISSING MISSING
Psychiatrists 43 0.9
Dentists 69 1.4
427
Ukraine
ACCEPTABILITY
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
428
Ukraine
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs.
Public health authorities being
informed for both IDs and for
NCDs was reported by 45.5%
of Member States (n =33).
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
1
Clarification: In some prisons MDR-TB assessment is made; in others only clinical evaluation.
429
Ukraine
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
% Member States
with “All prisons”
30.6 28.6 72.2
HEALTH PROMOTION
430
Ukraine
HIV
Individuals with HIV who received treatment over the last 12-month period 3601 (92.3)
Individuals completing HIV treatment over the last 12-month period 1327 (36.9)
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 2145 (74.8)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 378 (17.6)
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period 1325 (100.0)
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period 0 (0.0)
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits 172 (100.0)
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period 172 (100.0)
Individuals who have received pharmacological treatment for diabetes over the last 12-month period 172 (100.0)
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period 716 (100.0)
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period 2550 (100.0)
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period 2550 (100.0)
Cancer
Individuals who have received treatment for cancer over the last 12-month period 231 (100.0)
a
Percentage not reported as number of individuals receiving treatment might be higher than individuals diagnosed.
1
Percentage is calculated by dividing the number of individuals receiving treatment in 2020 by the total number of individuals with diagnosis on record, using the same reference year.
2
Percentage is calculated by dividing the number of individuals completing treatment in 2020 by the total number of individuals with access to treatment, using the same reference year.
431
Ukraine
(As the female prison population is 5.0%, the general population data is given only for males over
restrictions” (38.9%, out of n =36). 20 years)
b
Source: Our World Data Database (2020) (Given for both sexes, as disaggregated data was not
available in open source).
432
Ukraine
MORBIDITY
Number and proportion 1 of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
Active TB diagnosis 978 (2.0)
HIV
Active HIV diagnosis 3901 (7.8)
Hepatitis C
Chronic HCV infection (HCV RNA positive) 2866 (5.8)
Hepatitis B
Chronic HBV (HBsAg) 1325 (2.7)
COVID-19
SARS-Co-V2 infection laboratory confirmed 68 (0.1)
Oral health
Individuals keeping 21 or more natural teeth 26529 (53.2)
Diabetes Mellitus
Diagnosis on record 172 (0.3)
Hypertension
Diagnosis on record 716 (1.4)
Cardiovascular Disease
Diagnosis on record 2550 (5.1)
Cancer
Diagnosis on record 231 (0.5)
1
Percentage is calculated by considering the number of people with a diagnosis on record in 2020 divided by the total number of people in prison in the same country where data
has been provided for the same reference year.
433
Ukraine
E: PRISON ENVIRONMENT
F: HEALTH BEHAVIOURS
434
Ukraine
YES NO
435
United Kingdom 67 025 542 High US$ 41 098
Population, 2020 Income group Gross national income per capita
87019
NUMBER NEWLY ADMITTED IN THE PREVIOUS YEAR:
71319
436
United Kingdom
Number of prison
establishments
in the country
138 Unsentenced and serving life
sentences individuals:
n (%)
Number of unsentenced/
14567 (16.7)
remand prisoners
Mean length of incarceration per Number of individuals
8213 (9.4)
individual over the last 12-month serving life sentences
period: 15.3 months 1
1
Considering prisons from England and Wales.
2
Access to all health care is free at the point of entry and is therefore covered by the state for people in secure settings as it is for people in the community. Access to NHS Dental
services has a cost attached for some people in the community, for those on benefits /limited income it is free and people in prison meet these criteria too. In Scotland only, dental
provision for people in prison is at no cost to them and treatments provided are the same as NHS in the community.
437
United Kingdom
Nurses 7.8
Physicians 3.0
Psychiatrists 0.2
Dentists 0.5
ACCEPTABILITY
Proportion of prison established with vaccines available:
QUALITY OF CARE
% Member States
Yes/No
with “Yes”
Assessments performed in prisons on YES 88.9
the availability of essential medicines
438
United Kingdom
HEALTH INFORMATION
Inform public health authorities
about diseases amongst prisoners:
Yes, both for IDs and for NCDs1.
Public health authorities being informed
for both IDs and for NCDs was reported
by 45.5% of Member States (n =33).
1
Clarification: In Wales, only IDs are reported. In Scotland, a minority didn’t
inform public health authorities, and some prisons did it only for IDs.
% Member
Keep clinical health records Yes/No States with
of people in prison: “Yes”
Yes, we keep electronic clinical health Screening tests performed YES 91.7
records. Electronic clinical health Screening tests results YES 94.4
records in all prisons were reported
by 22.2% of Member States (n =36). Vaccination YES 97.2
C: HEALTH SERVICES
PREVENTIVE SERVICES
DISEASE PREVENTION
2
Clarification: Wales, Scotland and Northern Ireland didn’t offer a diagnostic test.
439
United Kingdom
HEALTH PROTECTION
Products offered free of charge:
% Member States
97.2 47.1 12.1 8.3
with “All prisons”
HEALTH PROMOTION
440
United Kingdom
Individuals completing MDR-TB treatment over the last 12-month period MISSING
HIV
Individuals with HIV who received treatment over the last 12-month period MISSING
Individuals completing HIV treatment over the last 12-month period MISSING
Hepatitis C
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Hepatitis B
Individuals with chronic HCV infection who received antiviral treatment over the last 12-month period MISSING
Individuals who following antiviral treatment achieved sustained viral response over the last 12-month period MISSING
Individuals completing STI treatment over the last 12-month period MISSING
Oral health
Individuals with oral health visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for an opioid use disorder over the last 12-month period MISSING
Diabetes Mellitus
Individuals with a diabetes mellitus diagnosis who had at least two routine health-care visits MISSING
(excluding ophthalmology and other specialty visits) over the last 12-month period
Individuals with a diabetes mellitus diagnosis who had at least one ophthalmology visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for diabetes over the last 12-month period MISSING
Hypertension
Individuals who have received pharmacological treatment for hypertension over the last 12-month period MISSING
Cardiovascular Disease
Individuals with a CVD diagnosis who had at least one routine health-care visit over the last 12-month period MISSING
Individuals who have received pharmacological treatment for cardiovascular disease over the last 12-month period MISSING
Cancer
Individuals who have received treatment for cancer over the last 12-month period MISSING
Clarification: Due to the COVID-19 pandemic the collection of these data was considered insufficiently robust for reporting.
441
United Kingdom
442
United Kingdom
MORBIDITY
Number and proportion of unique individuals living in prison diagnosed with:
n (%)
Tuberculosis (TB)
MISSING
Active TB diagnosis
HIV
MISSING
Active HIV diagnosis
Hepatitis C
MISSING
Chronic HCV infection (HCV RNA positive)
Hepatitis B
MISSING
Chronic HBV (HBsAg)
COVID-19
MISSING
SARS-Co-V2 infection laboratory confirmed
Oral health
MISSING
Individuals keeping 21 or more natural teeth
Diabetes Mellitus
MISSING
Diagnosis on record
Hypertension
MISSING
Diagnosis on record
Cardiovascular Disease
MISSING
Diagnosis on record
Cancer
MISSING
Diagnosis on record
Clarification: Due to the COVID-19 pandemic the collection of these data was considered insufficiently robust for reporting.
443
United Kingdom
E: PRISON ENVIRONMENT
a
All in Northern Ireland.
b
The absolute minimum mandated in England and Wales is 30 mins outdoors, but the general position where a regime is operating normally is a minimum of 1h.
F: HEALTH BEHAVIOURS
Clarification: Due to the COVID-19 pandemic the collection of these data was considered insufficiently robust for reporting.
444
United Kingdom
NO
a Yes, and they are repeated YES
c
at regular intervals b
a
Yes in Scotland and Northern Ireland, no answer for Wales.
b
No data from Wales, in Scotland 5 prisons (out of a total of 15) answered “Yes”.
c
No answer for Wales.
445
446 Status report on prison health in the WHO European Region 2022
Annex 2. Health in Prisons European Database Survey
(HIPEDS)
1. The data requested refers to the most recent year, i.e., from 01.01.2020 to 31.12.2020. In case it is not possible
to provide such updated data, please refer to the previous homologous period (01.01.2019-31.12.2019) and
indicate that in the comments.
2. Where a question refers to the prisoners in your country, please provide a response which applies to all persons
in the prisons of your country, including those held in pre-trial detention (e.g. in remand prison/jail) wherever
available. Questions which refer to the prisons of your country likewise require a response which applies to all
the prisons in your country. Note: even though WHO adopts person-centred wording in all external publications
(people living in prisons, for simplicity of the survey, throughout the questions we will use the term “prisoner”).
3. Wherever your responses refer to a different base (e.g., prisoners excluding those in pre-trial detention), please
indicate this clearly with a comment.
4. This survey does not refer to other prescribed places of detention (e.g. immigration detention centres and
police custody or their equivalent).
6. Where answer categories provided do not apply to the situation in your country, please write a comment.
7. Please document each source that contributed to the data provided, including whether it was obtained from a
published report and if so, the nature of that publication (i.e., scientific journal or government agency), and if any
data was obtained from an unpublished source. Whenever possible, please indicate the links to the source data.
Experts consulted
For the completion of this survey, comprising the sections: A. Penal Statistics; B. Prison Health Systems; C. Health
Services; D. Health Outcomes; E. Prison Environment; F. Health Behaviours; G. Adherence to Equivalence and
Other International Standards; and H. Reducing Health Inequalities, you are encouraged to contact and consult
additional experts. These experts could come from the following areas:
• Person in charge of or involved in prison health in the Ministry of Health/Ministry of Justice/Ministry of Interior of your
country, or the most senior government official in charge of prison health conditions;
• The head of a prominent non-governmental organization dedicated to prison health;
• A health professional (e.g., medical doctor, nurse, pharmacist, social worker, psychologist) specialized in prison
health-related services;
• A faculty member of a university department;
• A police or other law enforcement officer;
• A person at the Ministry of Finance, tax agency or statistical office.
For countries with regional or sub-national arrangements, alternatively you can also select experts from each
of the different regions and eventually then set up meetings to evaluate and decide the comparability of data
and the possibility for national aggregation.
448 Status report on prison health in the WHO European Region 2022
Contact information
Date: _ _ / _ _ / _ _ _ _ (Day/Month/Year)
WHO Region: __________________________
Country: ______________________________
Questionnaire completed by:
Last name: _____________________________ First name: _______________________
Title/Position: _____________________________________________________________
Institute/Ministry/etc. _______________________________________________________
Address: _________________________________________________________________
Telephone: _____________________________
Fax: ___________________________________
E-mail: _________________________________
For those whom you did consult, please enter the following information accordingly:
Expert 1 –
Name:
Position:
Organization:
Expert 2 –
Name:
Position:
Organization:
Expert 3 –
Name:
Position:
Organization:
Comments:
Note: The official capacity of a prison is defined by the total number of detainees that it can accommodate while respecting the
standards set by the relevant authority in the country. When prison buildings are old, prison administrations are not always able
to give figures for the floor space allocated to each detainee or group of detainees. However, the official capacity of prisons at
the time of construction is usually known.
Data No data
a) Female
i) Of those in a), how many
were pregnant during
the last 12 months?
b) Lesbian, gay, bisexual, transgender,
intersex and queer people (LGBTIQ)
i) Physical disabilities
450 Status report on prison health in the WHO European Region 2022
Data No data
Not legally
Data No data permitted in
the country
B1. In your country, what level of government is responsible for prison health care? Please choose the answer
that best describes your country. If none of the options perfectly describes it, please choose “other” and specify.
B2. In your country, what level of government is responsible for the delivery of health care for the general
population (i.e., outside of prisons and can include primary and secondary care)? Please choose the answer that
best describes your country. If none of the options perfectly describes it, please choose “other” and specify.
B3. In your country, which agency or agencies are responsible for delivering prison health care. Please choose
the answer that best describes your country. If none of the options perfectly describes it, please choose “other”
and specify.
a. Ministry of Health only (or health authorities)
b. Ministry of Justice only
c. Ministry of Interior only
d. Other ministry in isolation. Please state which:
e. Both Ministry of Health and Ministry of Justice/Ministry of Interior
f. Another situation. Please specify:
452 Status report on prison health in the WHO European Region 2022
B4. In your country, which agency or agencies are responsible for the inspection of prison hygiene, nutrition and
living conditions? Please choose the answer that best describes your country. If none of the options perfectly
describes it, please choose “other” and specify.
B5. In your country, which agency or agencies are responsible for financing prison health care (i.e., is responsible
for holding and managing the budget for these services).
Note: Financing refers to responsibility for managing the funding necessary for prison health-care services. This may be the
responsibility of one or more ministries. It may be the same agency which is responsible for the delivery of prison health-care
services, or a separate agency. Please choose the answer that best describes your country. If none of the options perfectly
describes it, please choose “another situation” and specify.
a. Health care for people in prison is fully covered by health insurance (the same as for the general community)
b. Health care for people in prison is partly covered by health insurance (the same as for the general community)
c. Health care for people in prison is covered by a separate health insurance system (different to what is available in the
general community)
d. Health care for people in prison is not covered by any health insurance
e. Another situation. Please describe below the situation in your country:
B7. Are prisoners in your country obliged to cover any of the following expenses?
Prescription medication
Other expenses
(please specify):
454 Status report on prison health in the WHO European Region 2022
Health system vision and strategy
B8. Is there a national/subnational prison health policy/strategy? Please choose the best answer.
a. Yes, there is a national/subnational prison health policy/strategy. Please attach or provide a link to the relevant
document(s):
b. Yes, prison health is part of another national/subnational (health) policy/strategy. Please specify and attach or
provide a link to the relevant document(s):
c. No, there is no such policy/strategy at present, but it is envisaged for the future. Please specify and attach or provide
a link to draft/plan/other evidence:
d. No, there is no such policy/strategy at present and there is currently no intention to develop one in the immediate
future
B8.1 If the answer to B8 is ‘Yes’ (a or b), is there an implementation plan for the policy/strategy?
a. Yes, implementation plan is already adopted. Please attach or provide link to evidence:
b. Yes, implementation plan is under development or there are plans for development. Please attach or provide link
to draft/plan/other evidence:
c. No, there is no implementation plan at present and no such plan will be developed
Availability
B9. Please indicate the total number of health-care staff (physicians, nurses, nursing assistants, etc., including
external service providers) in prisons on full-time equivalents (FTEs) for a known year.
Year
Number
Acceptability
B10. In case screening tests and/or health assessments are being offered to prisoners, is informed consent
being obtained and documented (could be for all health assessments/interventions and not necessarily per
assessment/intervention)?
B11. For each of the following programmes for vaccine-preventable diseases, please indicate the proportion of
prison establishments in your country where these are available to be administered to eligible prisoners?
Hepatitis A
Hepatitis B
Seasonal flu
456 Status report on prison health in the WHO European Region 2022
MMR (measles, mumps and rubeola)
Meningococcal vaccination
Pneumococcal vaccination
COVID-19
B12. Please indicate the proportion of prison establishments where prisoners have access to HIV prophylaxis?
Post Exposure
Pre-exposure
Quality of Care
B13. Are regular assessments performed in prisons on the availability of essential medicines?
a. Yes
b. No
B14. Is there a standardized process for reporting medication errors in prisons (Errors or mistakes committed by
health professionals which result in harm to the patient, source: https://meshb.nlm.nih.gov/record/ui?ui=D019300)?
B15. Is there a standardized process for reporting adverse drug events in prisons (Disorders that result from the
intended use of pharmaceuticals, source: https://meshb.nlm.nih.gov/record/ui?ui=D064420)?
B16. Is there a standardized protocol for identifying and helping people with suicide/self-harm risk in prisons?
Health information
a. Yes
b. No
B18.1 If the answer to B18 is ‘Yes’, does this also include the causes of the deaths that occurred in prison?
a. Yes
b. No
B18.2 Please explain how data on deaths and causes of death are being transferred from the prison registration
system to the national Civil Registration and Vital Statistics (CRVS) registration (open question).
B18.3 Are completeness and quality of the data on deaths that are being sent to the national CRVS registration
regularly assessed?
B18.4 Do the physicians that work in the prison health systems receive training for filling in the death certificates?
a. Yes
b. No
B19. Do prisons inform public health authorities about diseases amongst prisoners?
a. Yes
b. No
458 Status report on prison health in the WHO European Region 2022
B19.1 If the answer to B19 is ‘Yes’, is individual imprisonment status captured in the disease registries or
surveillance data (e.g. place of infection, place of diagnosis, risk factor)?
B20.1 If the answer to B20 is ‘Yes’, does the clinical health record system include sections for recording information
on (please mark all that apply):
a. Yes, the same system is being used which is interoperable and allows for individual health data exchange across
the community-prison interface
b. Yes, different systems are being used, but these are interoperable and allow for individual health data exchange
across the community-prison interface
c. Yes, the same system is used or is interoperable and allows for individual health data exchange across the
community-prison interface but only for certain conditions, interventions or population subgroups (e.g., HIV,
immunization). Please specify:
d. No
B21. Does your country have the capacity to provide timely (i.e., equivalent to general community standards)
surveillance data of COVID-19 cases identified in prisons (prisoners and custodial staff)?
B22. Please indicate if prisons in your country undertake contact tracing in relation to COVID-19 cases?
B23. If COVID-19 vaccination is implemented in at least one prison in your country, is the immunization
information system in prison interoperable with immunization information system in the community?
a. Yes
b. Yes, for some prisons
c. No
d. Not applicable
460 Status report on prison health in the WHO European Region 2022
SECTION C: HEALTH SERVICES
Preventive services
Disease Prevention
C1. Is there an initial urgent health needs assessment undertaken in the first 24h after reception?
a. Yes
b. No
C2. Is a more detailed review of health needs subsequently conducted (e.g., within 7 days of admission)?
a. Yes
b. No
C2.1 If the answer to C1 or C2 is ‘Yes’, can you indicate how many unique individuals have received a health examination
following admission to prison in the past 12-month period? (Provide number)
a. Nurse only
b. Physician only
c. Nurse predominantly, but with referral to physician available
d. Another health-care worker. Please indicate who:
e. Member of custodial staff only
f. Other possibility. Please explain:
Alcohol use
Drug use
Smoking status
C3. Are history of TB and current signs and symptoms assessed on or close to reception for all people in prison?
a. No
b. Yes, a clinical evaluation of signs and symptoms is made, including evaluation of previous history
c. Yes, and a diagnostic test is offered in addition to the clinical evaluation
d. Yes, clinical assessment and diagnostic tests are made and when the test is positive, additional assessment for
MDR-TB is ensured
C4. Please mark for the following infectious diseases, if screening is being offered on or close to reception to all
prisoners? For each disease, please choose the situation that best describes your country.
HIV
HCV
462 Status report on prison health in the WHO European Region 2022
HBV
STI
C5. Does your country have any of the following types of cancer screening offered to prisoners?
Yes No
Cervical
Colon
Breast
C6. Do these cancer screenings apply the same eligibility criteria (e.g., age cut-off) as those conducted in the
general population (community model) (please choose all that apply)
C7. Are there any specific restrictions or differences on screening practices for prison and in the community
(please choose all that apply).
a. Yes, the methods used are different (e.g., FOBT or FIT vs colonoscopy for colorectal cancer; Pap test vs cytology for
cervical cancer)
b. Yes, the frequency used is different (e.g., annual vs biannual; this may happen as a result of availability of mobile
units properly equipped)
c. Yes, another situation. Please describe below:
d. No
C8. For each of the following products, please indicate if they are offered free of charge considering the response
options given.
Most A minority
All prisons No prisons
prisons of prisons
Soap
Condoms
Dental dams
Tampons/sanitary towels
C9. Since the emergence of COVID-19, did prisoners have access to:
Yes No
b) Face masks
C10. Did the prisons in your country create space for adequate quarantine of contacts and isolation of COVID-19
cases (e.g., single-cell accommodation or multiple occupation by cohorting?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
C10.1 If the answer to C10 is a, b or c, did this space consider the CPT rules (6m² of living space for a single-
occupancy cell – excluding toilet space – and adding 4m² per additional inmate)?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
Health Promotion
C11. Are there health promotion materials like brochures and leaflets available on safe tattooing practices?
a. Yes
b. No
464 Status report on prison health in the WHO European Region 2022
Health Protection
C12. Are there any policies or procedures in place to promote physical activity in prison?
b. No
C13. Do prisons in your country have therapeutic spaces available for people with drug problems?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. in no prisons
C14. Is there any smoke free policy implemented in your country applicable to prisons?
a. Yes, nationwide
b. Yes, in specific regions of the country
c. No
C15. Are there any preparedness contingency plans for managing the impact of an infectious disease outbreak
in prisons?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
C15.1 If the answer to C15 is a, b or c, in case a pandemic response plan has been developed and is published,
please indicate the link.
a. Yes, everyone in prison has access to laboratory tests when these are necessary
b. Yes, but there are limited resources, so only the priority/vulnerable groups have access
c. No
C17. Are there any arrangements/protocols established to ensure access for people in prison to specialized
treatment of mental health disorders?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
C18. Are there any arrangements/protocols established for transferring people in prison to specialized
institutions to treat cancer?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
466 Status report on prison health in the WHO European Region 2022
Continuity of care
C19. Is there any support service to register people released from prison with a GP/community health services?
a. Yes
b. No
C19.1 If the answer to C19 is ‘Yes’, does this service include any of the following:
C20. Is there a procedure in place to ensure medication is reconciled (procedure in place for transferring a list of
prescribed medication used by new entrants to prisons in the community to the prison health-care service) at admission
(first 24h)?
a. Yes
b. No
C21. When people are released from prison, are they provided with any medication?
C22. When people are released from prison, are they tested for COVID-19 prior to release?
a. Yes
b. No
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
Employment Opportunities
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
Social Relationships
C25. Please indicate the conditions under which people are allowed to continue their family relationships.
By telephone
By web communication
C26. Are people placed in prisons considering the location of their home to facilitate maintaining family
relationships?
a. Yes, always
b. Yes, as much as possible
c. No, allocation is made according to other factors
468 Status report on prison health in the WHO European Region 2022
SECTION D: HEALTH OUTCOMES
D1. Are assessments of perceived well-being (or life satisfaction) of people in prison conducted?
a. Yes, regularly (for example once every year or once every two years)
b. Yes, on an ad hoc basis
c. No, it has never been done
D2. Do all people in prison have access to mental health counsellors (including peer support and external providers
– not specifically for mental health disorders but including support for maintenance of well-being when needed)?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
Mortality
Data No data
D3. Please provide the number of unique individuals who died over past
12 months (any cause)
a) Suicide
b) Drug overdose
c) COVID-19
d) Cause 1:
e) Cause 2:
f) Cause 3:
D4. Please fill in the following table, which asks for data concerning medical care provision (3.1), diagnoses established
(before and during incarceration – 4.2) and treatment provided (including pharmacological and non-pharmacological). For
easier organization, indicators are organized by disease condition. We ask you to indicate in the first column the most recent
data (year 2020) and only in case this is unavailable, use the following column and add the reference year indicating the
year in the last column. For all data we request you to indicate numbers disaggregated by sex and only for a few conditions
(HIV, HCV, HBV and STIs), specify among females the number that were pregnant in the period considered. Please indicate
the reference year in the last column, for data provided in the first two columns, only if it does not refer to 2020.
2020 OTHER
REFERENCE
YEAR
Tuberculosis TB Both M F
sexes
470 Status report on prison health in the WHO European Region 2022
2020 OTHER
REFERENCE
YEAR
COVID-19 Both M F
sexes
472 Status report on prison health in the WHO European Region 2022
2020 OTHER
REFERENCE
YEAR
Hypertension Both M F
sexes
Cancer Both M F
sexes
474 Status report on prison health in the WHO European Region 2022
SECTION E: PRISON ENVIRONMENT
E1. Please indicate the number of individuals put in solitary confinement for behaviour or security reasons (one
or more times during the last 12-month period):
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
E3. Do all people have access to shower & bathing facilities, with water at a temperature suitable to the climate?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
E4. Are there any facilities available for physical activity (e.g., gym, indoors or outdoors)?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
E5. Are people given the opportunity to use these facilities at least once a week?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
E6. Are people in prison given the chance to spend at least one hour per day outdoors?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
E8. Are diets adapted to gender needs (i.e., number of calories varies between female and male prisons)?
a. Yes
b. No
476 Status report on prison health in the WHO European Region 2022
SECTION F: HEALTH BEHAVIOURS
F1. Please provide the following numbers in reference to the situation observed by 31.12.2020.
Both
Male Female No data
sexes
G1. Do health-care services for people in prisons offer the same scope of services as in the community?
a. Yes
b. No
G2. Is there a national vaccine implementation plan establishing the access for people in prison to COVID-19
vaccine?
G2.1 If the answer to G2 is a, please indicate the level of priority attributed (open question):
G3. Are health-care services in prisons subject to the same standards and accreditation procedures as health-care
services in the community?
G4. Is the prison health workforce subject to the same professional standard as the health workforce in the
community?
a. Yes
b. No
G5. Is the prison health workforce subject to the same ethical standard as the health workforce in the community?
a. Yes
b. No
478 Status report on prison health in the WHO European Region 2022
G6. Are the provisions of international law regarding the health of people in prisons and other places of detention
incorporated into national law?
a. Yes
b. No
G7. Can clinical decisions taken by health staff be overruled or ignored by non-health prison staff?
a. Yes
b. No
G8. Are there publicly available reports of prison hygiene, nutrition and living conditions?
G9. Does a national health-care complaints system exist in your country, and is it available to prisoners?
a. Yes
b. No
G9.1 If the answer to G9 is ‘Yes’, please indicate how many complaints were received in the last 12-month period
and provide a link to the latest one.
Number of complaints
Weblink
H1. Are there national standards to meet the health needs of special populations in prison? (select all that apply)
Women
Pregnant
Children and youth
LGBTIQ persons
Foreign nationals
People who use drugs
Elderly prisoners
People with physical disabilities
People with learning disabilities
Ethnic minorities
None of the above (exclusive choice)
H2. Are any of the national standards to meet the health needs of special populations based on relevant
international standards?
a. Yes
b. No
H3. Do prisons have health related information products for people in prison such as brochures and leaflets in
multiple languages?
a. In all prisons
b. In most prisons
c. In a minority of prisons
d. In no prisons
H4. Do women in prison have the option to be attended by female health care staff?
a. Yes
b. No
480 Status report on prison health in the WHO European Region 2022
H5.1. If the answer to H5 is a) or b), are women offered the possibility of prenatal care or termination, in case
of a positive result?
a. Yes
b. No
H6. How many women gave birth whilst in prison in the last 12 months?
Albania No formal data transfer The relatives of the deceased take the death certificate to the
system. Depends Civil Registration.
on the individual to
register the death.
Armenia Unclear if a formal transfer Data are transferred from the Republic of Armenia penitentiary system
system exists and how into the registry system.
operationalized.
Bosnia and Answer given does In Bosnia and Herzegovina there is a registry book. In Republika Sprska,
Herzegovina not address the data in case of death, the prison immediately informs family, competent
transfer process. court and nearest municipal registry office to issue certificate. At the
state level, this is done in accordance with the laws on health care and
registry records.
Bulgaria A formal transfer The registration of deaths in the country is conducted according to
system in place. the Civil Registration Act by issuing a death certificate which is drawn
up on the basis of a death notice issued by a competent medical
person no later than 48 hours after the death. The certificate may be
drawn up after the expiration of the 48-hour period without the need
of a court order when a forensic medical examination of the corpse is
required under the conditions provided in the Penal Procedure Code.
The judicial authorities, appointing the forensic medical examination,
issue a document certifying the reason for delay. The death certificate
contains: place of drawing up the certificate – region, municipality,
settlement/region; number of the certificate and date of drawing
up; date – day, month, year, hour and minutes of the death; place of
the death – region, municipality, settlement or state, if it is not in the
Republic of Bulgaria, and where it occurred; names of the person; data
for the person – date and place of birth, identification number, age, sex,
citizenship, marital status, permanent address; document certifying
the death; official – names, identification number or birth date and
signature; notes. The circumstance that the death occurred in a place
of deprivation of liberty is not mentioned in the certificate. The cause of
death is also not mentioned in the death certificate.
Annex 3. Raw data describing the process of death data transfer to the national registration system 483
Member State Categorization Explanation
Croatia A formal transfer The bodies of all people who die in prison, regardless of the cause of
system in place. death, must undergo an autopsy performed in appropriate institutions
of the public health system. In addition to reports submitted to
the institutes of forensic medicine and criminology, prisons and
penitentiaries (prison hospital included) submit reports to the registry
of deaths kept by the Ministry of Justice and public administration.
Cyprus A formal transfer Via formal notification, by the doctor of prisons and by admissions and
system in place. release office
Denmark No formal data transfer The Department of Prison and Probation Service and the Danish
process, but data are parliamentary ombudsman are informed about cases by email.
sent via email in an
aggregated manner.
Finland Answer given does Causes of death are not determined by Health Services for Prisoners.
not address data
transfer process.
Georgia A formal transfer Data on deaths in prisons provided monthly to the National Statistics
system in place. Office of Georgia. Data are not yet being transferred automatically
though an e-system but with an official letter and attachments.
Germany A formal data transfer In 12 regions cause of death is recorded, but not all regions could
system not in place provide these data.
at national level.
Hungary A formal transfer If the death certificate form is completed online, the data migrate
system in place. automatically. If completed on paper, one of the six copies is mailed to
the registration office.
Ireland A formal transfer All deaths in custody are subject to an inquest held in a coroner’s
system in place. court. The cause of death is determined by a jury on the basis of the
information presented to the coroner’s court. On completion of the
inquest, the coroner issues a certificate to the Civil Registration Service
containing all the details to be registered. The Irish Prison Service is not
party to the death registration.
484 Status report on prison health in the WHO European Region 2022
Member State Categorization Explanation
Italy A formal transfer Data are transmitted in real time by prisons to the statistical
system in place processing centre of the Ministry of Justice.
(electronic).
Lithuania A formal transfer The data are sent to national databases as provided for in national
system in place. legislation.
Malta A formal transfer Every death that occurs in the Maltese prison system is analysed via
system in place. a magisterial inquiry. Cause of death is then added to the national
government database.
Netherlands A formal transfer Every death is mandatorily reported to the Central Bureau of Statistics.
system in place. A physician fills in the form.
Portugal A formal transfer Online registration using Death Certificate Information System (SICO).
system in place
(electronic).
Romania No formal data transfer Data are not transferred from the prison registration system to the
process in place. national civil registration and vital statistics registration. Prison staff do
not fill in death certificates.
San Marino A formal transfer A doctor from the public health system registers the death in the
system in place. relevant module and this registration is sent to the civil office.
Annex 3. Raw data describing the process of death data transfer to the national registration system 485
Member State Categorization Explanation
Slovakia A formal transfer Physicians examining the deceased issue a standardized form (letter on
system in place. the examination of the dead), which is forwarded to the relevant state
organizations, which process and archive it.
Slovenia A formal transfer General practitioner who works in prison transmits data via the national
system in place health information system.
(electronic).
Spain A formal transfer All cases are judicial deaths and are therefore subject to autopsy. The
system in place. cause of death is stated on the death certificate as determined during
autopsy.
United Kingdom A formal transfer In England and Wales, all deaths are reported to coroners for
system in place. independent investigation to determine the cause and circumstances.
In Scotland, when a death in prison occurs, Police Scotland is
responsible for managing the incident and reporting the death to the
Crown Office and Procurator Fiscal Service. In Northern Ireland, all
deaths in custody are recorded by the Northern Ireland Prison Service
and by the Northern Ireland Coroner’s Service. All deaths in custody
require an inquest to be held by the Coroner’s Service and cause of
death is decided at the inquest.
486 Status report on prison health in the WHO European Region 2022
487
THE WHO REGIONAL OFFICE FOR EUROPE
The World Health Organization (WHO) is a specialized agency of the United Nations created in
1948 with the primary responsibility for international health matters and public health. The WHO
Regional Office for Europe is one of six regional offices throughout the world, each with its own
programme geared to the particular health conditions of the countries it serves.
MEMBER STATES
Albania Greece Portugal
Andorra Hungary Republic of Moldova
Armenia Iceland Romania
Austria Ireland Russian Federation
Azerbaijan Israel San Marino
Belarus Italy Serbia
Belgium Kazakhstan Slovakia
Bosnia and Herzegovina Kyrgyzstan Slovenia
Bulgaria Latvia Spain
Croatia Lithuania Sweden
Cyprus Luxembourg Switzerland
Czechia Malta Tajikistan
Denmark Monaco Türkiye
Estonia Montenegro Turkmenistan
Finland Netherlands Ukraine
France North Macedonia United Kingdom
Georgia Norway Uzbekistan
Germany Poland